elisa	Schema Version 3.36																											
Please do not delete or edit this column																												
Column Name	Expsample ID	Biosample ID	Experiment ID	Reagent ID(s)	Treatment ID(s)	Expsample Name	Expsample Description	Additional Result File Names	Study ID	Protocol ID(s)	Subject ID	Planned Visit ID	Type	Subtype	Biosample Name	Biosample Description	Study Time Collected	Study Time Collected Unit	Study Time T0 Event	Study Time T0 Event Specify	Experiment Name	Experiment Description	Measurement Technique	Result Separator Column	Analyte Reported	Value Reported	Unit Reported	Comments
	refr-multi_lat-0	41_100151_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100151	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	10.7	U/mL	Equivocal
	refr-multi_lat-1	41_100179_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100179	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	18.4	U/mL	Equivocal
	refr-multi_lat-2	41_100462_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100462	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	10.1	U/mL	Equivocal
	refr-multi_lat-3	41_100579_100	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100579	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	10.5	U/mL	Equivocal
	refr-multi_lat-4	41_100579_100	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100579	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	18.5	U/mL	Equivocal
	refr-multi_lat-5	14_107588_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_107588	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	21	Au/mL	Positive
	refr-multi_lat-6	14_115671_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_115671	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	23	Au/mL	Positive
	refr-multi_lat-7	14_136068_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_136068	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	16	Au/mL	Positive
	refr-multi_lat-8	14_166589_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_166589	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	26	Au/mL	Positive
	refr-multi_lat-9	14_175078_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_175078	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	18	Au/mL	Positive
	refr-multi_lat-10	14_188155_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_188155	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	18	Au/mL	Positive
	refr-multi_lat-11	14_225211_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_225211	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	21	Au/mL	Positive
	refr-multi_lat-12	14_254215_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_254215	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	29	AU/mL	Positive
	refr-multi_lat-13	14_259046_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_259046	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	39	Au/mL	Positive
	refr-multi_lat-14	14_287186_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_287186	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	26	AU/mL	Positive
	refr-multi_lat-15	14_362791_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_362791	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	16	Au/mL	Positive
	refr-multi_lat-16	14_382861_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_382861	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	33	Au/mL	Positive
	refr-multi_lat-17	14_428897_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_428897	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	16	Au/mL	Positive
	refr-multi_lat-18	14_453592_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_453592	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	28	Au/mL	Positive
	refr-multi_lat-19	14_482383_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_482383	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	37	Au/mL	Positive
	refr-multi_lat-20	14_483903_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_483903	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	18	AU/mL	Positive
	refr-multi_lat-21	14_499594_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_499594	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	29	AU/mL	Positive
	refr-multi_lat-22	14_513053_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_513053	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	33	AU/mL	Positive
	refr-multi_lat-23	14_528185_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_528185	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	21	Au/mL	Positive
	refr-multi_lat-24	14_533782_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_533782	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	30	Au/mL	Positive
	refr-multi_lat-25	14_587174_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_587174	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	24	Au/mL	Positive
	refr-multi_lat-26	14_588864_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_588864	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	29	Au/mL	Positive
	refr-multi_lat-27	14_597395_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_597395	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	28	Au/mL	Positive
	refr-multi_lat-28	14_620328_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_620328	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	23	Au/mL	Positive
	refr-multi_lat-29	14_639229_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_639229	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	30	Au/mL	Positive
	refr-multi_lat-30	14_658367_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_658367	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	16	Au/mL	Positive
	refr-multi_lat-31	14_683717_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_683717	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	28	Au/mL	Positive
	refr-multi_lat-32	14_685588_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_685588	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	16	Au/mL	Positive
	refr-multi_lat-33	14_720781_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_720781	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	27	AU/mL	Positive
	refr-multi_lat-34	14_722081_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_722081	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	34	Au/mL	Positive
	refr-multi_lat-35	14_741906_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_741906	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	28	Au/mL	Positive
	refr-multi_lat-36	14_747586_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_747586	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	22	Au/mL	Positive
	refr-multi_lat-37	14_811101_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_811101	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	17	Au/mL	Positive
	refr-multi_lat-38	14_860417_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_860417	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	17	Au/mL	Positive
	refr-multi_lat-39	14_906595_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_906595	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	32	Au/mL	Positive
	refr-multi_lat-40	14_918413_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_918413	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	16	Au/mL	Positive
	refr-multi_lat-41	14_967972_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_967972	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	22	Au/mL	Positive
	refr-multi_lat-42	14_974137_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_974137	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	23	Au/mL	Positive
	refr-multi_lat-43	14_988602_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_988602	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	30	Au/mL	Positive
	refr-multi_lat-44	14_107588_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_107588	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.44	S/CO	Negative
	refr-multi_lat-45	14_122173_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_122173	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.41	S/CO	Negative
	refr-multi_lat-46	14_123753_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_123753	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.33	S/CO	Negative
	refr-multi_lat-47	14_127552_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_127552	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.41	S/CO	Negative
	refr-multi_lat-48	14_143396_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_143396	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	0.254	COI450	Negative
	refr-multi_lat-49	14_143396_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_143396	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.03	S/CO	Negative
	refr-multi_lat-50	14_143396_222	14_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_143396	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.6	U/mL	Negative
	refr-multi_lat-51	14_148341_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_148341	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.07	S/CO	Negative
	refr-multi_lat-52	14_160668_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_160668	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.44	S/CO	Negative
	refr-multi_lat-53	14_166589_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_166589	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.37	S/CO	Negative
	refr-multi_lat-54	14_171658_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_171658	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	0.1	COI450	Negative
	refr-multi_lat-55	14_171658_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_171658	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.03	S/CO	Negative
	refr-multi_lat-56	14_175078_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_175078	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.16	S/CO	Negative
	refr-multi_lat-57	14_177005_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_177005	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	0.168	COI450	Negative
	refr-multi_lat-58	14_177005_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_177005	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.04	S/CO	Negative
	refr-multi_lat-59	14_183745_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_183745	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	0.092	COI450	Negative
	refr-multi_lat-60	14_183745_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_183745	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.06	S/CO	Negative
	refr-multi_lat-61	14_185965_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_185965	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.43	S/CO	Negative
	refr-multi_lat-62	14_186975_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_186975	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	0.143	COI450	Negative
	refr-multi_lat-63	14_186975_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_186975	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.02	S/CO	Negative
	refr-multi_lat-64	14_186975_222	14_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_186975	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.6	U/mL	Negative
	refr-multi_lat-65	14_188155_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_188155	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.16	S/CO	Negative
	refr-multi_lat-66	14_194396_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_194396	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.07	S/CO	Negative
	refr-multi_lat-67	14_208286_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_208286	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.07	S/CO	Negative
	refr-multi_lat-68	14_212153_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_212153	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.22	S/CO	Negative
	refr-multi_lat-69	14_218423_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_218423	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	0.494	COI450	Negative
	refr-multi_lat-70	14_218423_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_218423	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.1	S/CO	Negative
	refr-multi_lat-71	14_225211_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_225211	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.36	S/CO	Negative
	refr-multi_lat-72	14_239836_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_239836	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.64	S/CO	Negative
	refr-multi_lat-73	14_241807_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_241807	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.28	S/CO	Negative
	refr-multi_lat-74	14_249066_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_249066	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.92	S/CO	Negative
	refr-multi_lat-75	14_254215_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_254215	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.18	S/CO	Negative
	refr-multi_lat-76	14_256634_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_256634	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	0.151	COI450	Negative
	refr-multi_lat-77	14_256634_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_256634	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.02	S/CO	Negative
	refr-multi_lat-78	14_261505_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_261505	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	0.525	COI450	Negative
	refr-multi_lat-79	14_261505_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_261505	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.04	S/CO	Negative
	refr-multi_lat-80	14_263646_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_263646	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	0.327	COI450	Negative
	refr-multi_lat-81	14_263646_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_263646	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.02	S/CO	Negative
	refr-multi_lat-82	14_263646_222	14_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_263646	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.6	U/mL	Negative
	refr-multi_lat-83	14_265479_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_265479	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	0.637	COI450	Negative
	refr-multi_lat-84	14_265479_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_265479	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.05	S/CO	Negative
	refr-multi_lat-85	14_265479_222	14_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_265479	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.6	U/mL	Negative
	refr-multi_lat-86	14_269103_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_269103	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.71	S/CO	Negative
	refr-multi_lat-87	14_270178_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_270178	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	0.554	COI450	Negative
	refr-multi_lat-88	14_270178_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_270178	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.05	S/CO	Negative
	refr-multi_lat-89	14_270178_222	14_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_270178	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.6	U/mL	Negative
	refr-multi_lat-90	14_278647_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_278647	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.06	S/CO	Negative
	refr-multi_lat-91	14_285169_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_285169	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	0.53	COI450	Negative
	refr-multi_lat-92	14_285169_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_285169	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.02	S/CO	Negative
	refr-multi_lat-93	14_286779_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_286779	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	0.077	COI450	Negative
	refr-multi_lat-94	14_286779_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_286779	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.06	S/CO	Negative
	refr-multi_lat-95	14_286779_222	14_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_286779	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.6	U/mL	Negative
	refr-multi_lat-96	14_287186_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_287186	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.99	S/CO	Negative
	refr-multi_lat-97	14_301926_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_301926	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	0.361	COI450	Negative
	refr-multi_lat-98	14_301926_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_301926	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.07	S/CO	Negative
	refr-multi_lat-99	14_301926_222	14_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_301926	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.6	U/mL	Negative
	refr-multi_lat-100	14_304474_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_304474	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.79	S/CO	Negative
	refr-multi_lat-101	14_304492_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_304492	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	0.644	COI450	Negative
	refr-multi_lat-102	14_304492_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_304492	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.03	S/CO	Negative
	refr-multi_lat-103	14_306348_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_306348	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	0.397	COI450	Negative
	refr-multi_lat-104	14_306348_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_306348	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.07	S/CO	Negative
	refr-multi_lat-105	14_313928_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_313928	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	0.194	COI450	Negative
	refr-multi_lat-106	14_313928_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_313928	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.02	S/CO	Negative
	refr-multi_lat-107	14_322676_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_322676	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.72	S/CO	Negative
	refr-multi_lat-108	14_324493_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_324493	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.6	S/CO	Negative
	refr-multi_lat-109	14_327086_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_327086	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	0.237	COI450	Negative
	refr-multi_lat-110	14_327086_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_327086	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.02	S/CO	Negative
	refr-multi_lat-111	14_327086_222	14_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_327086	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.6	U/mL	Negative
	refr-multi_lat-112	14_334077_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_334077	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	0.096	COI450	Negative
	refr-multi_lat-113	14_334077_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_334077	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.03	S/CO	Negative
	refr-multi_lat-114	14_339154_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_339154	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.06	S/CO	Negative
	refr-multi_lat-115	14_339339_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_339339	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.27	S/CO	Negative
	refr-multi_lat-116	14_339739_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_339739	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.5	S/CO	Negative
	refr-multi_lat-117	14_361741_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_361741	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	0.047	COI450	Negative
	refr-multi_lat-118	14_361741_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_361741	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.07	S/CO	Negative
	refr-multi_lat-119	14_361741_222	14_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_361741	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.6	U/mL	Negative
	refr-multi_lat-120	14_361741_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_361741	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Negative
	refr-multi_lat-121	14_367355_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_367355	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.33	S/CO	Negative
	refr-multi_lat-122	14_373975_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_373975	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	0.14	COI450	Negative
	refr-multi_lat-123	14_373975_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_373975	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.1	S/CO	Negative
	refr-multi_lat-124	14_374212_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_374212	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	0.294	COI450	Negative
	refr-multi_lat-125	14_374212_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_374212	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.09	S/CO	Negative
	refr-multi_lat-126	14_379363_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_379363	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.19	S/CO	Negative
	refr-multi_lat-127	14_384727_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_384727	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	0.351	COI450	Negative
	refr-multi_lat-128	14_384727_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_384727	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.03	S/CO	Negative
	refr-multi_lat-129	14_384727_222	14_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_384727	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.6	U/mL	Negative
	refr-multi_lat-130	14_385063_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_385063	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.11	S/CO	Negative
	refr-multi_lat-131	14_391735_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_391735	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.25	S/CO	Negative
	refr-multi_lat-132	14_392122_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_392122	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	0.121	COI450	Negative
	refr-multi_lat-133	14_392122_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_392122	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.04	S/CO	Negative
	refr-multi_lat-134	14_392122_222	14_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_392122	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.6	U/mL	Negative
	refr-multi_lat-135	14_392122_222	14_080	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_392122	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen , p18	Chemiluminescent Assay		IgG	18	U/mL	Negative
	refr-multi_lat-136	14_399432_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_399432	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.45	S/CO	Negative
	refr-multi_lat-137	14_403358_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_403358	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	0.107	COI450	Negative
	refr-multi_lat-138	14_403358_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_403358	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.1	S/CO	Negative
	refr-multi_lat-139	14_404768_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_404768	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.93	S/CO	Negative
	refr-multi_lat-140	14_408074_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_408074	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	0.196	COI450	Negative
	refr-multi_lat-141	14_408074_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_408074	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.04	S/CO	Negative
	refr-multi_lat-142	14_408074_222	14_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_408074	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.6	U/mL	Negative
	refr-multi_lat-143	14_410477_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_410477	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	0.102	COI450	Negative
	refr-multi_lat-144	14_410477_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_410477	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.02	S/CO	Negative
	refr-multi_lat-145	14_412766_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_412766	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	0.137	COI450	Negative
	refr-multi_lat-146	14_412766_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_412766	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.04	S/CO	Negative
	refr-multi_lat-147	14_413507_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_413507	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	0.363	COI450	Negative
	refr-multi_lat-148	14_413507_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_413507	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.04	S/CO	Negative
	refr-multi_lat-149	14_420792_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_420792	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	0.13	COI450	Negative
	refr-multi_lat-150	14_420792_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_420792	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.03	S/CO	Negative
	refr-multi_lat-151	14_429588_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_429588	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	0.065	COI450	Negative
	refr-multi_lat-152	14_429588_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_429588	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.06	S/CO	Negative
	refr-multi_lat-153	14_437688_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_437688	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.37	S/CO	Negative
	refr-multi_lat-154	14_446374_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_446374	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	0.134	COI450	Negative
	refr-multi_lat-155	14_446374_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_446374	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.03	S/CO	Negative
	refr-multi_lat-156	14_446374_222	14_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_446374	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.6	U/mL	Negative
	refr-multi_lat-157	14_456907_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_456907	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	0.122	COI450	Negative
	refr-multi_lat-158	14_456907_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_456907	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.09	S/CO	Negative
	refr-multi_lat-159	14_456907_222	14_080	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_456907	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen , p18	Chemiluminescent Assay		IgG	18	U/mL	Negative
	refr-multi_lat-160	14_464837_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_464837	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	0.11	COI450	Negative
	refr-multi_lat-161	14_464837_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_464837	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.03	S/CO	Negative
	refr-multi_lat-162	14_464837_222	14_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_464837	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.6	U/mL	Negative
	refr-multi_lat-163	14_471327_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_471327	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	0.283	COI450	Negative
	refr-multi_lat-164	14_471327_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_471327	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.06	S/CO	Negative
	refr-multi_lat-165	14_482383_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_482383	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.41	S/CO	Negative
	refr-multi_lat-166	14_483903_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_483903	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.22	S/CO	Negative
	refr-multi_lat-167	14_491531_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_491531	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	0.214	COI450	Negative
	refr-multi_lat-168	14_491531_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_491531	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.03	S/CO	Negative
	refr-multi_lat-169	14_491696_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_491696	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	0.112	COI450	Negative
	refr-multi_lat-170	14_491696_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_491696	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.02	S/CO	Negative
	refr-multi_lat-171	14_491696_222	14_080	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_491696	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen , p18	Chemiluminescent Assay		IgG	18	U/mL	Negative
	refr-multi_lat-172	14_493466_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_493466	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	0.107	COI450	Negative
	refr-multi_lat-173	14_493466_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_493466	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.06	S/CO	Negative
	refr-multi_lat-174	14_493466_222	14_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_493466	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.6	U/mL	Negative
	refr-multi_lat-175	14_495208_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_495208	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	0.088	COI450	Negative
	refr-multi_lat-176	14_495208_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_495208	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.2	S/CO	Negative
	refr-multi_lat-177	14_499594_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_499594	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.21	S/CO	Negative
	refr-multi_lat-178	14_500745_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_500745	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	0.432	COI450	Negative
	refr-multi_lat-179	14_500745_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_500745	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.03	S/CO	Negative
	refr-multi_lat-180	14_512561_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_512561	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.55	S/CO	Negative
	refr-multi_lat-181	14_513053_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_513053	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.69	S/CO	Negative
	refr-multi_lat-182	14_528185_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_528185	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.21	S/CO	Negative
	refr-multi_lat-183	14_529422_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_529422	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.07	S/CO	Negative
	refr-multi_lat-184	14_533782_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_533782	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.45	S/CO	Negative
	refr-multi_lat-185	14_536104_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_536104	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	0.138	COI450	Negative
	refr-multi_lat-186	14_536104_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_536104	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.04	S/CO	Negative
	refr-multi_lat-187	14_536104_222	14_080	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_536104	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen , p18	Chemiluminescent Assay		IgG	18	U/mL	Negative
	refr-multi_lat-188	14_562035_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_562035	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.15	S/CO	Negative
	refr-multi_lat-189	14_562891_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_562891	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	0.666	COI450	Negative
	refr-multi_lat-190	14_562891_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_562891	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.13	S/CO	Negative
	refr-multi_lat-191	14_562891_222	14_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_562891	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.6	U/mL	Negative
	refr-multi_lat-192	14_563092_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_563092	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.3	S/CO	Negative
	refr-multi_lat-193	14_568176_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_568176	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	0.479	COI450	Negative
	refr-multi_lat-194	14_568176_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_568176	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.05	S/CO	Negative
	refr-multi_lat-195	14_569615_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_569615	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	0.518	COI450	Negative
	refr-multi_lat-196	14_569615_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_569615	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.06	S/CO	Negative
	refr-multi_lat-197	14_569615_222	14_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_569615	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	10	U/mL	Negative
	refr-multi_lat-198	14_571359_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_571359	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	0.445	COI450	Negative
	refr-multi_lat-199	14_571359_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_571359	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.06	S/CO	Negative
	refr-multi_lat-200	14_573413_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_573413	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.09	S/CO	Negative
	refr-multi_lat-201	14_582321_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_582321	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.29	S/CO	Negative
	refr-multi_lat-202	14_588864_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_588864	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.3	S/CO	Negative
	refr-multi_lat-203	14_591664_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_591664	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.24	S/CO	Negative
	refr-multi_lat-204	14_594272_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_594272	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.05	S/CO	Negative
	refr-multi_lat-205	14_597395_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_597395	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.6	S/CO	Negative
	refr-multi_lat-206	14_607014_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_607014	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	0.162	COI450	Negative
	refr-multi_lat-207	14_607014_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_607014	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.13	S/CO	Negative
	refr-multi_lat-208	14_607014_222	14_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_607014	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.6	U/mL	Negative
	refr-multi_lat-209	14_616772_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_616772	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	0.06	COI450	Negative
	refr-multi_lat-210	14_616772_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_616772	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.02	S/CO	Negative
	refr-multi_lat-211	14_620328_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_620328	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.94	S/CO	Negative
	refr-multi_lat-212	14_628758_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_628758	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.09	S/CO	Negative
	refr-multi_lat-213	14_636569_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_636569	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	0.07	COI450	Negative
	refr-multi_lat-214	14_636569_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_636569	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.02	S/CO	Negative
	refr-multi_lat-215	14_636569_222	14_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_636569	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.6	U/mL	Negative
	refr-multi_lat-216	14_639824_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_639824	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	0.096	COI450	Negative
	refr-multi_lat-217	14_639824_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_639824	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.05	S/CO	Negative
	refr-multi_lat-218	14_649515_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_649515	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.4	S/CO	Negative
	refr-multi_lat-219	14_653364_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_653364	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.63	S/CO	Negative
	refr-multi_lat-220	14_658367_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_658367	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.13	S/CO	Negative
	refr-multi_lat-221	14_670351_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_670351	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.16	S/CO	Negative
	refr-multi_lat-222	14_672894_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_672894	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.09	S/CO	Negative
	refr-multi_lat-223	14_675231_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_675231	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.49	S/CO	Negative
	refr-multi_lat-224	14_681897_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_681897	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	0.102	COI450	Negative
	refr-multi_lat-225	14_681897_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_681897	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.08	S/CO	Negative
	refr-multi_lat-226	14_681897_222	14_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_681897	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.6	U/mL	Negative
	refr-multi_lat-227	14_681897_222	14_080	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_681897	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen , p18	Chemiluminescent Assay		IgG	18	U/mL	Negative
	refr-multi_lat-228	14_685588_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_685588	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.08	S/CO	Negative
	refr-multi_lat-229	14_693608_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_693608	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	0.468	COI450	Negative
	refr-multi_lat-230	14_693608_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_693608	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.04	S/CO	Negative
	refr-multi_lat-231	14_698954_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_698954	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.51	S/CO	Negative
	refr-multi_lat-232	14_713146_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_713146	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	0.282	COI450	Negative
	refr-multi_lat-233	14_713146_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_713146	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.03	S/CO	Negative
	refr-multi_lat-234	14_719447_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_719447	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.04	S/CO	Negative
	refr-multi_lat-235	14_720781_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_720781	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.26	S/CO	Negative
	refr-multi_lat-236	14_722081_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_722081	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.6	S/CO	Negative
	refr-multi_lat-237	14_724174_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_724174	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.48	S/CO	Negative
	refr-multi_lat-238	14_741906_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_741906	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.93	S/CO	Negative
	refr-multi_lat-239	14_743991_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_743991	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.85	S/CO	Negative
	refr-multi_lat-240	14_752797_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_752797	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.19	S/CO	Negative
	refr-multi_lat-241	14_753466_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_753466	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	0.492	COI450	Negative
	refr-multi_lat-242	14_753466_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_753466	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.05	S/CO	Negative
	refr-multi_lat-243	14_754797_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_754797	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.13	S/CO	Negative
	refr-multi_lat-244	14_758241_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_758241	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	0.096	COI450	Negative
	refr-multi_lat-245	14_758241_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_758241	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.06	S/CO	Negative
	refr-multi_lat-246	14_758241_222	14_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_758241	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.6	U/mL	Negative
	refr-multi_lat-247	14_761696_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_761696	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	0.088	COI450	Negative
	refr-multi_lat-248	14_761696_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_761696	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.05	S/CO	Negative
	refr-multi_lat-249	14_761696_222	14_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_761696	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.6	U/mL	Negative
	refr-multi_lat-250	14_776628_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_776628	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	0.039	COI450	Negative
	refr-multi_lat-251	14_776628_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_776628	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.03	S/CO	Negative
	refr-multi_lat-252	14_776628_222	14_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_776628	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.6	U/mL	Negative
	refr-multi_lat-253	14_779347_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_779347	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	0.199	COI450	Negative
	refr-multi_lat-254	14_779347_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_779347	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.05	S/CO	Negative
	refr-multi_lat-255	14_795323_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_795323	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.06	S/CO	Negative
	refr-multi_lat-256	14_809758_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_809758	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	0.133	COI450	Negative
	refr-multi_lat-257	14_809758_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_809758	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.11	S/CO	Negative
	refr-multi_lat-258	14_820803_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_820803	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	0.17	COI450	Negative
	refr-multi_lat-259	14_820803_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_820803	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.02	S/CO	Negative
	refr-multi_lat-260	14_831542_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_831542	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	0.09	COI450	Negative
	refr-multi_lat-261	14_831542_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_831542	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.08	S/CO	Negative
	refr-multi_lat-262	14_836565_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_836565	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.15	S/CO	Negative
	refr-multi_lat-263	14_841836_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_841836	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.73	S/CO	Negative
	refr-multi_lat-264	14_845339_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_845339	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.18	S/CO	Negative
	refr-multi_lat-265	14_860417_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_860417	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.11	S/CO	Negative
	refr-multi_lat-266	14_861721_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_861721	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	0.384	COI450	Negative
	refr-multi_lat-267	14_861721_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_861721	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.05	S/CO	Negative
	refr-multi_lat-268	14_861721_222	14_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_861721	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.6	U/mL	Negative
	refr-multi_lat-269	14_864277_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_864277	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	0.131	COI450	Negative
	refr-multi_lat-270	14_864277_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_864277	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.13	S/CO	Negative
	refr-multi_lat-271	14_864277_222	14_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_864277	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.6	U/mL	Negative
	refr-multi_lat-272	14_864277_222	14_080	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_864277	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen , p18	Chemiluminescent Assay		IgG	18	U/mL	Negative
	refr-multi_lat-273	14_873075_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_873075	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	0.207	COI450	Negative
	refr-multi_lat-274	14_873075_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_873075	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.05	S/CO	Negative
	refr-multi_lat-275	14_873075_222	14_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_873075	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.6	U/mL	Negative
	refr-multi_lat-276	14_875077_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_875077	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	0.078	COI450	Negative
	refr-multi_lat-277	14_875077_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_875077	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.1	S/CO	Negative
	refr-multi_lat-278	14_881576_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_881576	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.08	S/CO	Negative
	refr-multi_lat-279	14_884177_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_884177	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	0.616	COI450	Negative
	refr-multi_lat-280	14_884177_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_884177	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.79	S/CO	Negative
	refr-multi_lat-281	14_896884_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_896884	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.63	S/CO	Negative
	refr-multi_lat-282	14_900776_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_900776	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.11	S/CO	Negative
	refr-multi_lat-283	14_906595_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_906595	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.84	S/CO	Negative
	refr-multi_lat-284	14_910475_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_910475	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	0.278	COI450	Negative
	refr-multi_lat-285	14_910475_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_910475	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.08	S/CO	Negative
	refr-multi_lat-286	14_910475_222	14_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_910475	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.6	U/mL	Negative
	refr-multi_lat-287	14_918413_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_918413	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.31	S/CO	Negative
	refr-multi_lat-288	14_967972_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_967972	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.24	S/CO	Negative
	refr-multi_lat-289	14_973416_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_973416	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	0.06	COI450	Negative
	refr-multi_lat-290	14_973416_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_973416	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.07	S/CO	Negative
	refr-multi_lat-291	14_973416_222	14_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_973416	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.6	U/mL	Negative
	refr-multi_lat-292	14_974137_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_974137	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.4	S/CO	Negative
	refr-multi_lat-293	14_981447_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_981447	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.79	S/CO	Negative
	refr-multi_lat-294	14_991643_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_991643	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	0.251	COI450	Negative
	refr-multi_lat-295	14_991643_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_991643	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.1	S/CO	Negative
	refr-multi_lat-296	14_991643_222	14_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_991643	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.6	U/mL	Negative
	refr-multi_lat-297	14_994521_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_994521	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	0.08	COI450	Negative
	refr-multi_lat-298	14_994521_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_994521	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.02	S/CO	Negative
	refr-multi_lat-299	14_994827_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_994827	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	0.62	S/CO	Negative
	refr-multi_lat-300	27_100002_200	27_501	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100002	SeroNet_Reference_Study_visit-01									Elecsys Anti-SARS-CoV-2 S Immunoassay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		Total	0.4	U/mL	Negative
	refr-multi_lat-301	27_100002_200	27_504	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100002	SeroNet_Reference_Study_visit-01									BioPlex 2200 ToRC IgM Kit	Cytomegalovirus, CMV antigens	Multiplex Immunoassay		IgG	0.2	AI	Negative
	refr-multi_lat-302	27_100003_200	27_501	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100003	SeroNet_Reference_Study_visit-01									Elecsys Anti-SARS-CoV-2 S Immunoassay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		Total	0.4	U/mL	Negative
	refr-multi_lat-303	27_100004_200	27_503	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100004	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgM Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgM	100	titer	Negative
	refr-multi_lat-304	27_100005_200	27_503	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100005	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgM Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgM	50	titer	Negative
	refr-multi_lat-305	27_100007_200	27_503	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100007	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgM Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgM	100	titer	Negative
	refr-multi_lat-306	27_100008_200	27_501	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100008	SeroNet_Reference_Study_visit-01									Elecsys Anti-SARS-CoV-2 S Immunoassay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		Total	0.4	U/mL	Negative
	refr-multi_lat-307	27_100009_200	27_503	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100009	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgM Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgM	50	titer	Negative
	refr-multi_lat-308	27_100010_200	27_503	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100010	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgM Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgM	50	titer	Negative
	refr-multi_lat-309	27_100012_200	27_501	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100012	SeroNet_Reference_Study_visit-01									Elecsys Anti-SARS-CoV-2 S Immunoassay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		Total	0.4	U/mL	Negative
	refr-multi_lat-310	27_100013_200	27_501	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100013	SeroNet_Reference_Study_visit-01									Elecsys Anti-SARS-CoV-2 S Immunoassay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		Total	0.4	U/mL	Negative
	refr-multi_lat-311	27_100015_200	27_503	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100015	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgM Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgM	50	titer	Negative
	refr-multi_lat-312	27_100016_200	27_501	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100016	SeroNet_Reference_Study_visit-01									Elecsys Anti-SARS-CoV-2 S Immunoassay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		Total	0.4	U/mL	Negative
	refr-multi_lat-313	27_100017_200	27_501	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100017	SeroNet_Reference_Study_visit-01									Elecsys Anti-SARS-CoV-2 S Immunoassay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		Total	0.4	U/mL	Negative
	refr-multi_lat-314	27_100017_200	27_504	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100017	SeroNet_Reference_Study_visit-01									BioPlex 2200 ToRC IgM Kit	Cytomegalovirus, CMV antigens	Multiplex Immunoassay		IgG	0.2	AI	Negative
	refr-multi_lat-315	27_100018_200	27_501	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100018	SeroNet_Reference_Study_visit-01									Elecsys Anti-SARS-CoV-2 S Immunoassay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		Total	0.4	U/mL	Negative
	refr-multi_lat-316	27_100020_200	27_501	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100020	SeroNet_Reference_Study_visit-01									Elecsys Anti-SARS-CoV-2 S Immunoassay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		Total	0.4	U/mL	Negative
	refr-multi_lat-317	27_100020_200	27_504	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100020	SeroNet_Reference_Study_visit-01									BioPlex 2200 ToRC IgM Kit	Cytomegalovirus, CMV antigens	Multiplex Immunoassay		IgG	0.2	AI	Negative
	refr-multi_lat-318	27_100024_200	27_503	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100024	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgM Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgM	50	titer	Negative
	refr-multi_lat-319	27_100026_200	27_503	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100026	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgM Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgM	50	titer	Negative
	refr-multi_lat-320	27_100028_200	27_503	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100028	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgM Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgM	100	titer	Negative
	refr-multi_lat-321	27_100029_200	27_503	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100029	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgM Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgM	100	titer	Negative
	refr-multi_lat-322	27_100031_200	27_503	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100031	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgM Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgM	50	titer	Negative
	refr-multi_lat-323	27_100032_200	27_503	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100032	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgM Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgM	100	titer	Negative
	refr-multi_lat-324	27_100033_200	27_503	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100033	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgM Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgM	50	titer	Negative
	refr-multi_lat-325	27_100035_200	27_501	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100035	SeroNet_Reference_Study_visit-01									Elecsys Anti-SARS-CoV-2 S Immunoassay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		Total	0.4	U/mL	Negative
	refr-multi_lat-326	27_100035_200	27_504	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100035	SeroNet_Reference_Study_visit-01									BioPlex 2200 ToRC IgM Kit	Cytomegalovirus, CMV antigens	Multiplex Immunoassay		IgG	0.2	AI	Negative
	refr-multi_lat-327	27_100042_200	27_503	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100042	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgM Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgM	100	titer	Negative
	refr-multi_lat-328	27_100045_100	27_501	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100045	SeroNet_Reference_Study_visit-01									Elecsys Anti-SARS-CoV-2 S Immunoassay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		Total	0.4	U/mL	Negative
	refr-multi_lat-329	27_100045_100	27_504	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100045	SeroNet_Reference_Study_visit-01									BioPlex 2200 ToRC IgM Kit	Cytomegalovirus, CMV antigens	Multiplex Immunoassay		IgG	0.2	AI	Negative
	refr-multi_lat-330	27_100046_200	27_501	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100046	SeroNet_Reference_Study_visit-01									Elecsys Anti-SARS-CoV-2 S Immunoassay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		Total	0.4	U/mL	Negative
	refr-multi_lat-331	27_100047_200	27_501	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100047	SeroNet_Reference_Study_visit-01									Elecsys Anti-SARS-CoV-2 S Immunoassay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		Total	0.4	U/mL	Negative
	refr-multi_lat-332	27_100047_200	27_504	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100047	SeroNet_Reference_Study_visit-01									BioPlex 2200 ToRC IgM Kit	Cytomegalovirus, CMV antigens	Multiplex Immunoassay		IgG	0.2	AI	Negative
	refr-multi_lat-333	27_100048_200	27_501	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100048	SeroNet_Reference_Study_visit-01									Elecsys Anti-SARS-CoV-2 S Immunoassay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		Total	0.4	U/mL	Negative
	refr-multi_lat-334	27_100049_200	27_501	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100049	SeroNet_Reference_Study_visit-01									Elecsys Anti-SARS-CoV-2 S Immunoassay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		Total	0.4	U/mL	Negative
	refr-multi_lat-335	27_100051_200	27_501	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100051	SeroNet_Reference_Study_visit-01									Elecsys Anti-SARS-CoV-2 S Immunoassay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		Total	0.4	U/mL	Negative
	refr-multi_lat-336	27_100051_200	27_510	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100051	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-337	27_100052_200	27_501	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100052	SeroNet_Reference_Study_visit-01									Elecsys Anti-SARS-CoV-2 S Immunoassay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		Total	0.4	U/mL	Negative
	refr-multi_lat-338	27_100052_200	27_510	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100052	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-339	27_100053_200	27_501	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100053	SeroNet_Reference_Study_visit-01									Elecsys Anti-SARS-CoV-2 S Immunoassay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		Total	0.4	U/mL	Negative
	refr-multi_lat-340	27_100053_200	27_510	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100053	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-341	27_100079_200	27_503	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100079	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgM Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgM	50	titer	Negative
	refr-multi_lat-342	27_100088_200	27_503	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100088	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgM Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgM	100	titer	Negative
	refr-multi_lat-343	27_100092_200	27_502	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100092	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgG Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgG	100	titer	Negative
	refr-multi_lat-344	27_100093_200	27_501	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100093	SeroNet_Reference_Study_visit-01									Elecsys Anti-SARS-CoV-2 S Immunoassay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		Total	0.4	U/mL	Negative
	refr-multi_lat-345	27_100101_200	27_503	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100101	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgM Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgM	50	titer	Negative
	refr-multi_lat-346	27_100112_200	27_501	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100112	SeroNet_Reference_Study_visit-01									Elecsys Anti-SARS-CoV-2 S Immunoassay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		Total	0.4	U/mL	Negative
	refr-multi_lat-347	27_100132_200	27_503	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100132	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgM Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgM	50	titer	Negative
	refr-multi_lat-348	27_100134_200	27_503	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100134	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgM Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgM	50	titer	Negative
	refr-multi_lat-349	27_100135_200	27_503	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100135	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgM Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgM	50	titer	Negative
	refr-multi_lat-350	27_100136_200	27_503	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100136	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgM Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgM	100	titer	Negative
	refr-multi_lat-351	32_111001_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_111001	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-352	32_111006_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_111006	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-353	32_111006_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_111006	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-354	32_111007_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_111007	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-355	32_111008_301	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_111008	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-356	32_111008_301	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_111008	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-357	32_111009_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_111009	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-358	32_111009_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_111009	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-359	32_111010_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_111010	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-360	32_111010_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_111010	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-361	32_111011_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_111011	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-362	32_111011_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_111011	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-363	32_111012_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_111012	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-364	32_111012_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_111012	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-365	32_111013_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_111013	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-366	32_111013_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_111013	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-367	32_111014_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_111014	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-368	32_111014_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_111014	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-369	32_111015_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_111015	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-370	32_111015_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_111015	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-371	32_111016_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_111016	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-372	32_111016_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_111016	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-373	32_111018_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_111018	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-374	32_111018_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_111018	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-375	32_111019_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_111019	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-376	32_111020_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_111020	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-377	32_111020_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_111020	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-378	32_111021_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_111021	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-379	32_111021_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_111021	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-380	32_111023_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_111023	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-381	32_111024_301	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_111024	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-382	32_111026_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_111026	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-383	32_111028_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_111028	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-384	32_111028_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_111028	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-385	32_111029_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_111029	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-386	32_111029_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_111029	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-387	32_111030_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_111030	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-388	32_111031_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_111031	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-389	32_111032_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_111032	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-390	32_111033_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_111033	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-391	32_111035_301	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_111035	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-392	32_111036_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_111036	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-393	32_111036_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_111036	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-394	32_111037_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_111037	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-395	32_111037_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_111037	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-396	32_111038_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_111038	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-397	32_111038_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_111038	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-398	32_111045_301	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_111045	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-399	32_111045_301	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_111045	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-400	32_111046_301	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_111046	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-401	32_111046_301	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_111046	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-402	32_111047_301	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_111047	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-403	32_551004_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551004	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-404	32_551004_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551004	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-405	32_551020_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551020	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-406	32_551028_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551028	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-407	32_551033_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551033	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-408	32_551034_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551034	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-409	32_551034_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551034	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-410	32_551037_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551037	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-411	32_551037_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551037	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-412	32_551045_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551045	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-413	32_551045_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551045	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-414	32_551046_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551046	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-415	32_551046_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551046	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-416	32_551049_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551049	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-417	32_551049_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551049	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-418	32_551054_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551054	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-419	32_551054_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551054	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-420	32_551056_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551056	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-421	32_551056_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551056	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-422	32_551058_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551058	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-423	32_551058_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551058	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-424	32_551061_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551061	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-425	32_551064_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551064	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-426	32_551064_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551064	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-427	32_551065_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551065	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-428	32_551068_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551068	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-429	32_551068_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551068	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-430	32_551068_101	32_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551068	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-NL63, Nucleocapsid	ELISA		IgG	0.3	OD	Negative
	refr-multi_lat-431	32_551075_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551075	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-432	32_551075_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551075	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-433	32_551076_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551076	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-434	32_551076_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551076	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-435	32_551078_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551078	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-436	32_551078_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551078	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-437	32_551079_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551079	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-438	32_551079_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551079	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-439	32_551080_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551080	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-440	32_551080_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551080	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-441	32_551081_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551081	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-442	32_551082_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551082	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-443	32_551087_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551087	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-444	32_551087_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551087	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-445	32_551091_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551091	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-446	32_551091_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551091	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-447	32_551092_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551092	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-448	32_551092_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551092	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-449	32_551093_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551093	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-450	32_551094_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551094	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-451	32_551097_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551097	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-452	32_551097_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551097	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-453	32_551098_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551098	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-454	32_551098_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551098	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-455	32_551101_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551101	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-456	32_551101_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551101	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-457	32_551106_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551106	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-458	32_551106_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551106	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-459	32_551109_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551109	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-460	32_551109_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551109	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-461	32_551110_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551110	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-462	32_551111_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551111	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-463	32_551111_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551111	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-464	32_551113_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551113	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-465	32_551113_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551113	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-466	32_551115_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551115	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-467	32_551115_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551115	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-468	32_551116_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551116	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-469	32_551118_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551118	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-470	32_551118_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551118	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-471	32_551119_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551119	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-472	32_551119_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551119	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-473	32_551120_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551120	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-474	32_551120_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551120	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-475	32_551122_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551122	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-476	32_551122_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551122	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-477	32_551123_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551123	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-478	32_551123_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551123	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-479	32_551127_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551127	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-480	32_551127_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551127	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-481	32_551129_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551129	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-482	32_551129_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551129	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-483	32_551130_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551130	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-484	32_551130_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551130	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-485	32_551132_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551132	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-486	32_551133_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551133	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-487	32_551134_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551134	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-488	32_551134_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551134	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-489	32_551135_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551135	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-490	32_551135_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551135	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-491	32_551136_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551136	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-492	32_551137_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551137	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-493	32_551137_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551137	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-494	32_551138_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551138	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-495	32_551138_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551138	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-496	32_551139_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551139	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-497	32_551139_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551139	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-498	32_551140_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551140	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-499	32_551140_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551140	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-500	32_551141_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551141	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-501	32_551141_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551141	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-502	32_551142_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551142	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-503	32_551142_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551142	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-504	32_551143_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551143	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-505	32_551143_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551143	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-506	32_551144_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551144	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-507	32_551144_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551144	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-508	32_551146_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551146	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-509	32_551146_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551146	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-510	32_551148_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551148	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-511	32_551148_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551148	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-512	32_551149_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551149	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-513	32_551149_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551149	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-514	32_551152_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551152	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-515	32_551152_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551152	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-516	32_551156_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551156	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-517	32_551156_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551156	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-518	32_551157_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551157	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-519	32_551157_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551157	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-520	32_551158_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551158	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-521	32_551158_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551158	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-522	32_551159_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551159	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-523	32_551159_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551159	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-524	32_551160_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551160	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-525	32_551160_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551160	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-526	32_551162_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551162	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-527	32_551162_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551162	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-528	32_551163_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551163	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-529	32_551163_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551163	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-530	32_551165_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551165	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-531	32_551165_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551165	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-532	32_551167_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551167	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-533	32_551167_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551167	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-534	32_551168_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551168	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-535	32_551168_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551168	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-536	32_551169_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551169	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-537	32_551170_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551170	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-538	32_551170_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551170	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-539	32_551171_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551171	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-540	32_551171_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551171	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-541	32_551172_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551172	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-542	32_551172_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551172	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-543	32_551173_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551173	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-544	32_551173_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551173	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-545	32_551174_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551174	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-546	32_551174_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551174	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-547	32_551176_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551176	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-548	32_551176_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551176	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-549	32_551177_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551177	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-550	32_551177_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551177	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-551	32_551178_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551178	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-552	32_551178_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551178	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-553	32_551179_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551179	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-554	32_551179_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551179	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-555	32_551180_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551180	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-556	32_551180_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551180	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-557	32_551181_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551181	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-558	32_551181_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551181	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-559	32_551182_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551182	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-560	32_551182_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551182	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-561	32_551183_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551183	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-562	32_551183_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551183	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-563	32_551184_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551184	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-564	32_551184_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551184	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-565	32_551185_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551185	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-566	32_551185_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551185	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-567	32_551186_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551186	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-568	32_551186_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551186	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-569	32_551187_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551187	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-570	32_551187_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551187	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-571	32_551188_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551188	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-572	32_551188_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551188	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-573	32_551189_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551189	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-574	32_551189_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551189	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-575	32_551190_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551190	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-576	32_551190_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551190	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-577	32_551191_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551191	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-578	32_551191_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551191	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-579	32_551192_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551192	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-580	32_551192_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551192	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-581	32_551193_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551193	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-582	32_551193_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551193	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-583	32_551194_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551194	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-584	32_551194_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551194	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-585	32_551195_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551195	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-586	32_551195_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551195	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-587	32_551196_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551196	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-588	32_551196_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551196	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-589	32_551197_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551197	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-590	32_551197_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551197	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-591	32_551198_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551198	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-592	32_551198_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551198	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-593	32_551201_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551201	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-594	32_551201_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551201	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-595	32_551202_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551202	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-596	32_551202_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551202	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-597	32_551204_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551204	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-598	32_551204_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551204	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-599	32_551206_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551206	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-600	32_551206_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551206	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-601	32_551207_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551207	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-602	32_551207_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551207	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-603	32_551208_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551208	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-604	32_551208_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551208	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-605	32_551209_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551209	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-606	32_551209_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551209	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-607	32_551210_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551210	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-608	32_551210_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551210	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-609	32_551211_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551211	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-610	32_551211_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551211	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-611	32_551212_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551212	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-612	32_551212_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551212	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-613	32_551213_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551213	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-614	32_551213_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551213	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-615	32_551214_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551214	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-616	32_551214_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551214	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-617	32_551215_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551215	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-618	32_551215_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551215	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-619	32_551216_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551216	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-620	32_551216_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551216	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-621	32_551217_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551217	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-622	32_551217_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551217	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-623	32_551219_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551219	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-624	32_551220_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551220	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-625	32_551220_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551220	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-626	32_551220_101	32_065	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551220	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-HKU1, Nucleocapsid	ELISA		IgG	0.3	OD	Negative
	refr-multi_lat-627	32_551221_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551221	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-628	32_551222_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551222	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-629	32_551222_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551222	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-630	32_551223_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551223	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-631	32_551223_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551223	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-632	32_551224_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551224	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-633	32_551224_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551224	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-634	32_551225_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551225	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-635	32_551225_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551225	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-636	32_551225_101	32_065	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551225	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-HKU1, Nucleocapsid	ELISA		IgG	0.4	OD	Negative
	refr-multi_lat-637	32_551226_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551226	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-638	32_551226_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551226	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-639	32_551227_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551227	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-640	32_551227_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551227	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-641	32_551228_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551228	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-642	32_551228_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551228	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-643	32_551229_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551229	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-644	32_551229_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551229	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-645	32_551230_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551230	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-646	32_551230_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551230	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-647	32_551231_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551231	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-648	32_551231_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551231	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-649	32_551232_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551232	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-650	32_551232_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551232	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-651	32_551234_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551234	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-652	32_551234_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551234	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-653	32_551235_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551235	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-654	32_551235_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551235	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-655	32_551236_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551236	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-656	32_551236_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551236	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-657	32_551237_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551237	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-658	32_551237_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551237	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-659	32_551238_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551238	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-660	32_551238_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551238	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-661	32_551239_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551239	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-662	32_551239_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551239	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-663	32_551240_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551240	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-664	32_551240_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551240	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-665	32_551241_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551241	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-666	32_551241_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551241	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-667	32_551242_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551242	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-668	32_551242_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551242	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-669	32_551244_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551244	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-670	32_551244_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551244	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-671	32_551245_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551245	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-672	32_551245_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551245	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-673	32_551246_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551246	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-674	32_551246_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551246	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-675	32_551248_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551248	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-676	32_551248_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551248	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-677	32_551249_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551249	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-678	32_551249_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551249	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-679	32_551252_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551252	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-680	32_551252_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551252	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-681	32_551253_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551253	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-682	32_551253_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551253	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-683	32_551257_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551257	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-684	32_551257_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551257	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-685	32_551258_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551258	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-686	32_551258_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551258	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-687	32_551259_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551259	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-688	32_551259_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551259	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-689	32_551260_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551260	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-690	32_551260_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551260	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-691	32_551261_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551261	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-692	32_551261_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551261	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-693	32_551263_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551263	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-694	32_551263_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551263	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-695	32_551264_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551264	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-696	32_551264_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551264	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-697	32_551265_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551265	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-698	32_551265_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551265	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-699	32_551266_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551266	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-700	32_551266_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551266	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-701	32_551267_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551267	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-702	32_551267_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551267	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-703	32_551268_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551268	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-704	32_551268_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551268	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-705	32_551270_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551270	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-706	32_551270_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551270	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-707	32_551271_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551271	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-708	32_551271_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551271	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-709	32_551273_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551273	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-710	32_551273_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551273	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-711	32_551274_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551274	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-712	32_551274_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551274	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-713	32_551275_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551275	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-714	32_551275_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551275	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-715	32_551276_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551276	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-716	32_551276_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551276	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-717	32_551277_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551277	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-718	32_551277_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551277	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-719	32_551279_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551279	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-720	32_551279_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551279	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-721	32_551280_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551280	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-722	32_551280_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551280	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-723	32_551281_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551281	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-724	32_551281_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551281	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-725	32_551282_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551282	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-726	32_551282_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551282	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-727	32_551283_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551283	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-728	32_551283_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551283	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-729	32_551284_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551284	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-730	32_551284_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551284	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-731	32_551286_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551286	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-732	32_551286_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551286	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-733	32_551287_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551287	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-734	32_551287_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551287	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-735	32_551288_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551288	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-736	32_551288_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551288	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-737	32_551289_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551289	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-738	32_551289_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551289	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-739	32_551290_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551290	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-740	32_551290_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551290	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-741	32_551294_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551294	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-742	32_551294_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551294	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-743	32_551295_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551295	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-744	32_551295_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551295	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-745	32_551296_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551296	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-746	32_551296_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551296	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-747	32_551299_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551299	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-748	32_551299_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551299	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-749	32_551300_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551300	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-750	32_551300_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551300	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-751	32_551300_101	32_065	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551300	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-HKU1, Nucleocapsid	ELISA		IgG	0.3	OD	Negative
	refr-multi_lat-752	32_551301_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551301	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-753	32_551301_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551301	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-754	32_551302_103	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551302	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-755	32_551302_103	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551302	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-756	32_551302_103	32_065	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551302	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-HKU1, Nucleocapsid	ELISA		IgG	0.4	OD	Negative
	refr-multi_lat-757	32_551303_103	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551303	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-758	32_551303_103	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551303	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-759	32_551305_103	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551305	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-760	32_551305_103	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551305	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-761	32_551307_103	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551307	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-762	32_551307_103	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551307	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-763	32_551308_103	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551308	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-764	32_551308_103	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551308	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-765	32_551308_103	32_065	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551308	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-HKU1, Nucleocapsid	ELISA		IgG	0.3	OD	Negative
	refr-multi_lat-766	32_551309_103	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551309	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-767	32_551309_103	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551309	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-768	32_551310_103	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551310	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-769	32_551310_103	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551310	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-770	32_551313_103	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551313	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-771	32_551313_103	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551313	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-772	32_551314_103	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551314	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-773	32_551314_103	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551314	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-774	32_551315_103	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551315	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-775	32_551315_103	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551315	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-776	32_551316_103	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551316	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-777	32_551316_103	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551316	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-778	32_551318_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551318	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-779	32_551318_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551318	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-780	32_551319_103	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551319	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-781	32_551319_103	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551319	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-782	32_551320_103	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551320	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-783	32_551320_103	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551320	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-784	32_551320_103	32_065	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551320	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-HKU1, Nucleocapsid	ELISA		IgG	0.2	OD	Negative
	refr-multi_lat-785	32_551320_103	32_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551320	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-NL63, Nucleocapsid	ELISA		IgG	0.4	OD	Negative
	refr-multi_lat-786	32_551321_103	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551321	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-787	32_551321_103	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551321	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-788	32_551322_103	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551322	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-789	32_551322_103	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551322	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-790	32_551323_103	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551323	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-791	32_551323_103	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551323	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-792	32_551324_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551324	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-793	32_551324_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551324	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-794	32_551325_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551325	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-795	32_551325_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551325	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-796	32_551326_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551326	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-797	32_551326_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551326	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-798	32_551327_103	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551327	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-799	32_551327_103	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551327	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-800	32_551328_103	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551328	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-801	32_551328_103	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551328	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-802	32_551331_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551331	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-803	32_551331_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551331	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-804	32_551332_103	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551332	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-805	32_551332_103	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551332	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-806	32_551333_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551333	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-807	32_551333_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551333	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-808	32_551334_103	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551334	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-809	32_551334_103	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551334	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-810	32_551337_103	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551337	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-811	32_551337_103	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551337	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-812	32_551338_103	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551338	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-813	32_551338_103	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551338	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-814	32_551339_103	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551339	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-815	32_551339_103	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551339	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-816	32_551342_103	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551342	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-817	32_551342_103	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551342	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-818	32_551343_103	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551343	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-819	32_551343_103	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551343	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-820	32_551361_103	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551361	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-821	32_551361_103	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551361	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-822	32_551362_103	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551362	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-823	32_551362_103	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551362	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-824	32_551364_103	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551364	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-825	32_551364_103	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551364	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-826	32_551366_103	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551366	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-827	32_551366_103	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551366	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-828	32_551367_103	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551367	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-829	32_551367_103	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551367	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-830	32_551368_103	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551368	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-831	32_551368_103	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551368	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-832	32_551369_103	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551369	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-833	32_551369_103	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551369	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-834	32_551370_103	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551370	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-835	32_551370_103	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551370	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-836	32_551372_103	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551372	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-837	32_551372_103	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551372	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-838	32_551373_103	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551373	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-839	32_551373_103	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551373	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-840	32_551374_103	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551374	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-841	32_551374_103	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551374	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-842	32_551375_103	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551375	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-843	32_551375_103	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551375	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-844	32_551376_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551376	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-845	32_551376_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551376	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-846	32_551377_103	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551377	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-847	32_551377_103	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551377	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-848	32_551378_103	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551378	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-849	32_551378_103	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551378	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-850	32_551379_103	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551379	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-851	32_551379_103	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551379	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-852	32_551380_103	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551380	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-853	32_551380_103	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551380	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-854	32_551381_103	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551381	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-855	32_551381_103	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551381	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-856	32_551382_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551382	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-857	32_551382_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551382	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-858	32_551383_103	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551383	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-859	32_551383_103	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551383	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-860	32_551384_103	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551384	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-861	32_551384_103	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551384	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-862	32_551385_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551385	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-863	32_551385_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551385	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-864	32_551386_103	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551386	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-865	32_551386_103	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551386	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-866	32_551387_103	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551387	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-867	32_551387_103	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551387	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-868	32_551388_103	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551388	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-869	32_551388_103	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551388	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-870	32_551389_103	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551389	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-871	32_551389_103	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551389	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-872	32_551391_103	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551391	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-873	32_551391_103	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551391	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-874	32_551392_103	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551392	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-875	32_551392_103	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551392	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-876	32_551393_103	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551393	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-877	32_551393_103	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551393	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-878	32_551394_103	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551394	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-879	32_551394_103	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551394	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-880	32_551395_103	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551395	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-881	32_551395_103	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551395	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-882	32_551396_103	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551396	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-883	32_551396_103	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551396	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-884	32_551399_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551399	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-885	32_551399_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551399	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-886	32_551400_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551400	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-887	32_551400_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551400	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-888	32_551401_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551401	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-889	32_551401_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551401	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-890	32_551402_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551402	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-891	32_551402_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551402	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-892	32_551409_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551409	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-893	32_551409_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551409	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-894	32_551410_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551410	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-895	32_551410_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551410	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-896	32_551411_103	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551411	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-897	32_551411_103	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551411	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-898	32_551412_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551412	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-899	32_551412_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551412	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-900	32_551413_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551413	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-901	32_551413_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551413	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-902	32_551414_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551414	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-903	32_551414_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551414	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-904	32_551415_103	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551415	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-905	32_551415_103	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551415	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-906	32_551416_103	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551416	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-907	32_551416_103	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551416	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-908	32_551417_103	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551417	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-909	32_551417_103	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551417	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-910	32_551418_103	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551418	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Negative
	refr-multi_lat-911	32_551418_103	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551418	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Negative
	refr-multi_lat-912	41_100009_100	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100009	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-913	41_100009_100	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100009	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-914	41_100011_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100011	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-915	41_100011_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100011	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-916	41_100011_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100011	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-917	41_100011_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100011	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.13	Index	Negative
	refr-multi_lat-918	41_100012_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100012	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-919	41_100012_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100012	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-920	41_100012_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100012	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.5	Index	Negative
	refr-multi_lat-921	41_100014_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100014	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-922	41_100014_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100014	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-923	41_100014_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100014	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-924	41_100014_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100014	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.2	Index	Negative
	refr-multi_lat-925	41_100015_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100015	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.28	U/mL	Negative
	refr-multi_lat-926	41_100015_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100015	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-927	41_100015_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100015	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-928	41_100015_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100015	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-929	41_100015_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100015	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.13	Index	Negative
	refr-multi_lat-930	41_100021_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100021	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	20.4	U/mL	Negative
	refr-multi_lat-931	41_100021_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100021	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5.4	U/mL	Negative
	refr-multi_lat-932	41_100021_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100021	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-933	41_100021_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100021	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.04	Index	Negative
	refr-multi_lat-934	41_100033_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100033	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-935	41_100033_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100033	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	8.4	U/mL	Negative
	refr-multi_lat-936	41_100033_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100033	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	5.6	U/mL	Negative
	refr-multi_lat-937	41_100033_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100033	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.13	Index	Negative
	refr-multi_lat-938	41_100057_102	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100057	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-939	41_100057_102	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100057	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-940	41_100057_102	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100057	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-941	41_100057_102	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100057	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-942	41_100057_102	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100057	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.12	Index	Negative
	refr-multi_lat-943	41_100059_100	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100059	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-944	41_100059_100	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100059	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-945	41_100059_100	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100059	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-946	41_100059_100	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100059	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-947	41_100059_100	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100059	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.17	Index	Negative
	refr-multi_lat-948	41_100062_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100062	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-949	41_100062_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100062	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	4.25	AU/mL	Negative
	refr-multi_lat-950	41_100062_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100062	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.06	Index	Negative
	refr-multi_lat-951	41_100063_100	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100063	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-952	41_100063_100	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100063	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	6	U/mL	Negative
	refr-multi_lat-953	41_100063_100	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100063	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-954	41_100063_100	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100063	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.13	Index	Negative
	refr-multi_lat-955	41_100064_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100064	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-956	41_100064_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100064	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-957	41_100064_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100064	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-958	41_100064_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100064	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-959	41_100064_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100064	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.16	Index	Negative
	refr-multi_lat-960	41_100066_100	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100066	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-961	41_100066_100	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100066	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-962	41_100066_100	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100066	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-963	41_100066_100	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100066	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-964	41_100066_100	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100066	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.06	Index	Negative
	refr-multi_lat-965	41_100069_100	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100069	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-966	41_100069_100	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100069	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-967	41_100069_100	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100069	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	3.4	U/mL	Negative
	refr-multi_lat-968	41_100069_100	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100069	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-969	41_100069_100	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100069	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.8	Index	Negative
	refr-multi_lat-970	41_100070_100	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100070	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-971	41_100070_100	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100070	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-972	41_100070_100	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100070	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	10	U/mL	Negative
	refr-multi_lat-973	41_100070_100	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100070	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-974	41_100070_100	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100070	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	3	U/mL	Negative
	refr-multi_lat-975	41_100070_100	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100070	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-976	41_100070_100	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100070	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.25	Index	Negative
	refr-multi_lat-977	41_100071_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100071	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-978	41_100071_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100071	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-979	41_100071_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100071	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-980	41_100071_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100071	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-981	41_100071_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100071	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.11	Index	Negative
	refr-multi_lat-982	41_100072_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100072	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-983	41_100072_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100072	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-984	41_100072_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100072	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-985	41_100072_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100072	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-986	41_100072_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100072	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.07	Index	Negative
	refr-multi_lat-987	41_100074_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100074	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-988	41_100074_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100074	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	10.1	U/mL	Negative
	refr-multi_lat-989	41_100074_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100074	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-990	41_100074_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100074	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.06	Index	Negative
	refr-multi_lat-991	41_100076_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100076	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-992	41_100076_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100076	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-993	41_100076_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100076	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-994	41_100076_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100076	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.07	Index	Negative
	refr-multi_lat-995	41_100077_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100077	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-996	41_100077_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100077	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-997	41_100077_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100077	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-998	41_100077_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100077	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-999	41_100077_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100077	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.11	Index	Negative
	refr-multi_lat-1000	41_100078_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100078	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1001	41_100078_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100078	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1002	41_100078_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100078	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1003	41_100078_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100078	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.1	Index	Negative
	refr-multi_lat-1004	41_100079_100	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100079	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1005	41_100079_100	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100079	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1006	41_100079_100	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100079	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1007	41_100079_100	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100079	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.08	Index	Negative
	refr-multi_lat-1008	41_100080_100	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100080	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1009	41_100080_100	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100080	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1010	41_100080_100	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100080	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1011	41_100080_100	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100080	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.1	Index	Negative
	refr-multi_lat-1012	41_100081_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100081	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.36	U/mL	Negative
	refr-multi_lat-1013	41_100081_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100081	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1014	41_100081_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100081	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1015	41_100081_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100081	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	7.8	U/mL	Negative
	refr-multi_lat-1016	41_100081_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100081	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1017	41_100081_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100081	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.2	Index	Negative
	refr-multi_lat-1018	41_100083_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100083	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1019	41_100083_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100083	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1020	41_100083_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100083	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1021	41_100083_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100083	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1022	41_100083_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100083	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.2	Index	Negative
	refr-multi_lat-1023	41_100085_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100085	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1024	41_100085_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100085	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	31	U/mL	Negative
	refr-multi_lat-1025	41_100085_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100085	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1026	41_100085_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100085	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1027	41_100085_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100085	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.09	Index	Negative
	refr-multi_lat-1028	41_100090_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100090	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1029	41_100090_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100090	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	3	U/mL	Negative
	refr-multi_lat-1030	41_100091_102	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100091	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1031	41_100091_102	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100091	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1032	41_100091_102	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100091	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1033	41_100091_102	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100091	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1034	41_100091_102	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100091	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.1	Index	Negative
	refr-multi_lat-1035	41_100092_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100092	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1036	41_100092_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100092	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	14.3	U/mL	Negative
	refr-multi_lat-1037	41_100092_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100092	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1038	41_100092_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100092	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	3	U/mL	Negative
	refr-multi_lat-1039	41_100092_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100092	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	8.74	AU/mL	Negative
	refr-multi_lat-1040	41_100093_100	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100093	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1041	41_100093_100	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100093	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1042	41_100093_100	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100093	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1043	41_100093_100	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100093	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	8.5	U/mL	Negative
	refr-multi_lat-1044	41_100094_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100094	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1045	41_100094_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100094	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1046	41_100094_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100094	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	10	U/mL	Negative
	refr-multi_lat-1047	41_100094_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100094	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1048	41_100094_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100094	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	3	U/mL	Negative
	refr-multi_lat-1049	41_100094_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100094	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1050	41_100094_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100094	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.1	Index	Negative
	refr-multi_lat-1051	41_100096_100	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100096	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1052	41_100096_100	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100096	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	5.77	AU/mL	Negative
	refr-multi_lat-1053	41_100096_100	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100096	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.38	Index	Negative
	refr-multi_lat-1054	41_100097_100	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100097	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1055	41_100097_100	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100097	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1056	41_100097_100	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100097	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.6	Index	Negative
	refr-multi_lat-1057	41_100098_100	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100098	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1058	41_100098_100	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100098	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1059	41_100098_100	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100098	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1060	41_100098_100	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100098	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.14	Index	Negative
	refr-multi_lat-1061	41_100099_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100099	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1062	41_100099_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100099	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1063	41_100099_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100099	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1064	41_100099_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100099	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.18	Index	Negative
	refr-multi_lat-1065	41_100100_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100100	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1066	41_100100_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100100	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1067	41_100100_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100100	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5.1	U/mL	Negative
	refr-multi_lat-1068	41_100100_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100100	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1069	41_100100_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100100	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.15	Index	Negative
	refr-multi_lat-1070	41_100101_100	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100101	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1071	41_100101_100	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100101	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1072	41_100101_100	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100101	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.16	Index	Negative
	refr-multi_lat-1073	41_100102_100	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100102	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1074	41_100102_100	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100102	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	12	U/mL	Negative
	refr-multi_lat-1075	41_100102_100	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100102	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	8.2	U/mL	Negative
	refr-multi_lat-1076	41_100102_100	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100102	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	8.28	AU/mL	Negative
	refr-multi_lat-1077	41_100102_100	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100102	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.23	Index	Negative
	refr-multi_lat-1078	41_100104_100	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100104	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1079	41_100104_100	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100104	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1080	41_100104_100	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100104	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1081	41_100104_100	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100104	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.08	Index	Negative
	refr-multi_lat-1082	41_100105_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100105	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1083	41_100105_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100105	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1084	41_100106_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100106	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1085	41_100106_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100106	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1086	41_100106_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100106	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.12	Index	Negative
	refr-multi_lat-1087	41_100107_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100107	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1088	41_100107_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100107	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5.2	U/mL	Negative
	refr-multi_lat-1089	41_100107_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100107	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1090	41_100107_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100107	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.1	Index	Negative
	refr-multi_lat-1091	41_100108_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100108	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1092	41_100108_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100108	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1093	41_100108_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100108	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	5.04	AU/mL	Negative
	refr-multi_lat-1094	41_100108_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100108	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.12	Index	Negative
	refr-multi_lat-1095	41_100109_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100109	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1096	41_100109_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100109	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1097	41_100109_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100109	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1098	41_100109_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100109	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.05	Index	Negative
	refr-multi_lat-1099	41_100110_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100110	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1100	41_100110_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100110	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1101	41_100110_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100110	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.07	Index	Negative
	refr-multi_lat-1102	41_100111_100	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100111	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1103	41_100111_100	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100111	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1104	41_100111_100	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100111	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1105	41_100111_100	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100111	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1106	41_100111_100	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100111	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.06	Index	Negative
	refr-multi_lat-1107	41_100112_100	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100112	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1108	41_100112_100	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100112	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1109	41_100112_100	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100112	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1110	41_100112_100	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100112	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.14	Index	Negative
	refr-multi_lat-1111	41_100114_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100114	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1112	41_100114_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100114	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1113	41_100114_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100114	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1114	41_100114_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100114	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.07	Index	Negative
	refr-multi_lat-1115	41_100115_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100115	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1116	41_100115_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100115	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1117	41_100115_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100115	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1118	41_100115_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100115	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1119	41_100116_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100116	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1120	41_100116_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100116	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1121	41_100116_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100116	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.11	Index	Negative
	refr-multi_lat-1122	41_100119_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100119	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1123	41_100119_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100119	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1124	41_100119_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100119	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	13	AU/mL	Negative
	refr-multi_lat-1125	41_100119_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100119	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.09	Index	Negative
	refr-multi_lat-1126	41_100120_100	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100120	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	18.2	U/mL	Negative
	refr-multi_lat-1127	41_100120_100	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100120	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.52	Index	Negative
	refr-multi_lat-1128	41_100121_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100121	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1129	41_100121_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100121	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1130	41_100121_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100121	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	10	U/mL	Negative
	refr-multi_lat-1131	41_100121_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100121	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1132	41_100121_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100121	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	3	U/mL	Negative
	refr-multi_lat-1133	41_100121_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100121	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1134	41_100121_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100121	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.09	Index	Negative
	refr-multi_lat-1135	41_100122_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100122	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1136	41_100122_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100122	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	18.7	U/mL	Negative
	refr-multi_lat-1137	41_100122_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100122	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1138	41_100122_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100122	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1139	41_100122_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100122	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.1	Index	Negative
	refr-multi_lat-1140	41_100123_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100123	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	21.1	U/mL	Negative
	refr-multi_lat-1141	41_100123_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100123	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1142	41_100123_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100123	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.1	Index	Negative
	refr-multi_lat-1143	41_100124_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100124	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1144	41_100124_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100124	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1145	41_100124_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100124	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1146	41_100124_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100124	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1147	41_100124_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100124	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.08	Index	Negative
	refr-multi_lat-1148	41_100125_100	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100125	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1149	41_100125_100	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100125	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	32.6	U/mL	Negative
	refr-multi_lat-1150	41_100125_100	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100125	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1151	41_100125_100	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100125	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1152	41_100125_100	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100125	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.37	Index	Negative
	refr-multi_lat-1153	41_100126_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100126	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1154	41_100126_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100126	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	7.51	AU/mL	Negative
	refr-multi_lat-1155	41_100127_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100127	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1156	41_100127_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100127	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1157	41_100127_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100127	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1158	41_100128_100	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100128	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1159	41_100128_100	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100128	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1160	41_100128_100	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100128	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1161	41_100128_100	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100128	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.2	Index	Negative
	refr-multi_lat-1162	41_100132_100	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100132	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1163	41_100132_100	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100132	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1164	41_100132_100	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100132	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1165	41_100132_100	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100132	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	13.8	U/mL	Negative
	refr-multi_lat-1166	41_100132_100	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100132	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1167	41_100132_100	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100132	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.07	Index	Negative
	refr-multi_lat-1168	41_100133_100	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100133	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1169	41_100133_100	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100133	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1170	41_100133_100	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100133	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1171	41_100133_100	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100133	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.95	AU/mL	Negative
	refr-multi_lat-1172	41_100133_100	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100133	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.08	Index	Negative
	refr-multi_lat-1173	41_100135_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100135	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1174	41_100135_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100135	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1175	41_100135_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100135	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1176	41_100135_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100135	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	5.72	AU/mL	Negative
	refr-multi_lat-1177	41_100135_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100135	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.33	Index	Negative
	refr-multi_lat-1178	41_100136_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100136	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1179	41_100136_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100136	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1180	41_100136_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100136	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1181	41_100136_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100136	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.09	Index	Negative
	refr-multi_lat-1182	41_100138_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100138	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1183	41_100138_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100138	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1184	41_100138_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100138	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.31	Index	Negative
	refr-multi_lat-1185	41_100139_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100139	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1186	41_100139_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100139	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	12.1	U/mL	Negative
	refr-multi_lat-1187	41_100139_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100139	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1188	41_100139_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100139	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.11	Index	Negative
	refr-multi_lat-1189	41_100140_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100140	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1190	41_100140_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100140	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1191	41_100140_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100140	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1192	41_100140_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100140	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1193	41_100140_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100140	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	1.03	Index	Negative
	refr-multi_lat-1194	41_100144_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100144	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1195	41_100144_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100144	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1196	41_100144_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100144	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5.1	U/mL	Negative
	refr-multi_lat-1197	41_100144_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100144	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.59	Index	Negative
	refr-multi_lat-1198	41_100145_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100145	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1199	41_100145_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100145	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	34.8	U/mL	Negative
	refr-multi_lat-1200	41_100145_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100145	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1201	41_100145_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100145	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	7.85	AU/mL	Negative
	refr-multi_lat-1202	41_100145_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100145	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.12	Index	Negative
	refr-multi_lat-1203	41_100147_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100147	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1204	41_100147_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100147	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1205	41_100147_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100147	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1206	41_100147_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100147	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.19	Index	Negative
	refr-multi_lat-1207	41_100148_100	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100148	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1208	41_100148_100	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100148	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	8.6	U/mL	Negative
	refr-multi_lat-1209	41_100148_100	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100148	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	5.33	AU/mL	Negative
	refr-multi_lat-1210	41_100148_100	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100148	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.07	Index	Negative
	refr-multi_lat-1211	41_100149_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100149	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1212	41_100149_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100149	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1213	41_100149_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100149	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	12.6	U/mL	Negative
	refr-multi_lat-1214	41_100149_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100149	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1215	41_100149_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100149	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1216	41_100149_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100149	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.05	Index	Negative
	refr-multi_lat-1217	41_100150_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100150	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1218	41_100150_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100150	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1219	41_100150_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100150	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1220	41_100150_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100150	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.03	Index	Negative
	refr-multi_lat-1221	41_100151_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100151	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1222	41_100151_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100151	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	32.3	U/mL	Negative
	refr-multi_lat-1223	41_100151_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100151	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1224	41_100151_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100151	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.08	Index	Negative
	refr-multi_lat-1225	41_100152_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100152	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1226	41_100152_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100152	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1227	41_100152_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100152	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	4.79	AU/mL	Negative
	refr-multi_lat-1228	41_100152_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100152	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.1	Index	Negative
	refr-multi_lat-1229	41_100153_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100153	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1230	41_100153_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100153	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1231	41_100153_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100153	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1232	41_100153_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100153	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.07	Index	Negative
	refr-multi_lat-1233	41_100154_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100154	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	11	U/mL	Negative
	refr-multi_lat-1234	41_100154_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100154	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1235	41_100154_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100154	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1236	41_100154_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100154	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.06	Index	Negative
	refr-multi_lat-1237	41_100155_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100155	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1238	41_100155_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100155	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	13.9	U/mL	Negative
	refr-multi_lat-1239	41_100155_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100155	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1240	41_100155_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100155	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	6.72	AU/mL	Negative
	refr-multi_lat-1241	41_100155_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100155	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.07	Index	Negative
	refr-multi_lat-1242	41_100158_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100158	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1243	41_100158_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100158	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1244	41_100158_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100158	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1245	41_100158_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100158	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	7.67	AU/mL	Negative
	refr-multi_lat-1246	41_100158_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100158	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.2	Index	Negative
	refr-multi_lat-1247	41_100164_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100164	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1248	41_100164_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100164	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1249	41_100164_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100164	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1250	41_100164_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100164	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.18	Index	Negative
	refr-multi_lat-1251	41_100167_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100167	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1252	41_100167_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100167	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1253	41_100167_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100167	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	6.3	U/mL	Negative
	refr-multi_lat-1254	41_100167_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100167	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	12.3	U/mL	Negative
	refr-multi_lat-1255	41_100167_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100167	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1256	41_100167_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100167	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.06	Index	Negative
	refr-multi_lat-1257	41_100168_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100168	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	11.6	U/mL	Negative
	refr-multi_lat-1258	41_100168_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100168	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1259	41_100169_100	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100169	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1260	41_100169_100	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100169	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1261	41_100169_100	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100169	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1262	41_100169_100	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100169	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.08	Index	Negative
	refr-multi_lat-1263	41_100170_100	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100170	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1264	41_100170_100	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100170	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	8.5	U/mL	Negative
	refr-multi_lat-1265	41_100170_100	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100170	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1266	41_100170_100	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100170	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.57	Index	Negative
	refr-multi_lat-1267	41_100171_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100171	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1268	41_100171_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100171	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1269	41_100171_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100171	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1270	41_100171_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100171	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1271	41_100171_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100171	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.1	Index	Negative
	refr-multi_lat-1272	41_100172_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100172	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	16.2	U/mL	Negative
	refr-multi_lat-1273	41_100172_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100172	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1274	41_100172_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100172	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.4	Index	Negative
	refr-multi_lat-1275	41_100175_100	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100175	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1276	41_100175_100	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100175	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1277	41_100175_100	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100175	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1278	41_100175_100	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100175	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.11	Index	Negative
	refr-multi_lat-1279	41_100176_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100176	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1280	41_100176_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100176	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1281	41_100176_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100176	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1282	41_100176_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100176	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1283	41_100176_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100176	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.23	Index	Negative
	refr-multi_lat-1284	41_100178_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100178	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1285	41_100178_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100178	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1286	41_100178_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100178	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1287	41_100178_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100178	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.78	Index	Negative
	refr-multi_lat-1288	41_100179_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100179	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1289	41_100179_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100179	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1290	41_100179_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100179	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1291	41_100179_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100179	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.2	Index	Negative
	refr-multi_lat-1292	41_100181_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100181	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1293	41_100181_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100181	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1294	41_100181_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100181	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1295	41_100181_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100181	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.06	Index	Negative
	refr-multi_lat-1296	41_100184_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100184	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	19.1	U/mL	Negative
	refr-multi_lat-1297	41_100184_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100184	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1298	41_100184_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100184	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	12.1	AU/mL	Negative
	refr-multi_lat-1299	41_100184_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100184	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.74	Index	Negative
	refr-multi_lat-1300	41_100185_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100185	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1301	41_100185_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100185	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	14	U/mL	Negative
	refr-multi_lat-1302	41_100185_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100185	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.6	Index	Negative
	refr-multi_lat-1303	41_100189_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100189	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.31	U/mL	Negative
	refr-multi_lat-1304	41_100189_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100189	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1305	41_100189_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100189	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5.6	U/mL	Negative
	refr-multi_lat-1306	41_100189_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100189	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	4.92	AU/mL	Negative
	refr-multi_lat-1307	41_100189_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100189	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.16	Index	Negative
	refr-multi_lat-1308	41_100190_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100190	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1309	41_100190_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100190	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1310	41_100190_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100190	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	11.2	AU/mL	Negative
	refr-multi_lat-1311	41_100190_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100190	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.11	Index	Negative
	refr-multi_lat-1312	41_100193_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100193	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1313	41_100193_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100193	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	16.9	U/mL	Negative
	refr-multi_lat-1314	41_100193_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100193	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	14.3	U/mL	Negative
	refr-multi_lat-1315	41_100193_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100193	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1316	41_100193_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100193	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	8.8	U/mL	Negative
	refr-multi_lat-1317	41_100193_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100193	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1318	41_100193_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100193	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.14	Index	Negative
	refr-multi_lat-1319	41_100194_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100194	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1320	41_100194_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100194	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	10	U/mL	Negative
	refr-multi_lat-1321	41_100194_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100194	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1322	41_100194_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100194	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	3	U/mL	Negative
	refr-multi_lat-1323	41_100194_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100194	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1324	41_100194_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100194	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.14	Index	Negative
	refr-multi_lat-1325	41_100195_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100195	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1326	41_100195_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100195	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1327	41_100195_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100195	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.44	Index	Negative
	refr-multi_lat-1328	41_100196_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100196	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1329	41_100196_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100196	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1330	41_100196_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100196	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.86	Index	Negative
	refr-multi_lat-1331	41_100197_100	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100197	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1332	41_100197_100	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100197	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1333	41_100197_100	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100197	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.43	Index	Negative
	refr-multi_lat-1334	41_100198_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100198	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1335	41_100198_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100198	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	6.2	U/mL	Negative
	refr-multi_lat-1336	41_100198_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100198	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.51	Index	Negative
	refr-multi_lat-1337	41_100202_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100202	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1338	41_100202_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100202	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1339	41_100202_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100202	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1340	41_100202_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100202	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1341	41_100202_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100202	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.11	Index	Negative
	refr-multi_lat-1342	41_100203_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100203	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1343	41_100203_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100203	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1344	41_100203_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100203	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	10	U/mL	Negative
	refr-multi_lat-1345	41_100203_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100203	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1346	41_100203_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100203	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	3	U/mL	Negative
	refr-multi_lat-1347	41_100203_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100203	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.5	Index	Negative
	refr-multi_lat-1348	41_100207_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100207	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1349	41_100207_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100207	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1350	41_100207_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100207	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5.5	U/mL	Negative
	refr-multi_lat-1351	41_100207_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100207	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1352	41_100207_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100207	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.28	Index	Negative
	refr-multi_lat-1353	41_100208_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100208	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1354	41_100208_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100208	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1355	41_100208_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100208	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1356	41_100208_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100208	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.76	Index	Negative
	refr-multi_lat-1357	41_100209_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100209	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	31.5	U/mL	Negative
	refr-multi_lat-1358	41_100209_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100209	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1359	41_100209_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100209	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.3	Index	Negative
	refr-multi_lat-1360	41_100211_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100211	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1361	41_100211_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100211	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1362	41_100211_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100211	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	10	U/mL	Negative
	refr-multi_lat-1363	41_100211_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100211	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1364	41_100211_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100211	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	3	U/mL	Negative
	refr-multi_lat-1365	41_100212_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100212	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1366	41_100212_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100212	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1367	41_100212_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100212	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1368	41_100214_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100214	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1369	41_100214_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100214	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1370	41_100214_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100214	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1371	41_100214_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100214	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.92	Index	Negative
	refr-multi_lat-1372	41_100216_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100216	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	11.4	U/mL	Negative
	refr-multi_lat-1373	41_100218_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100218	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1374	41_100218_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100218	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1375	41_100222_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100222	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1376	41_100222_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100222	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1377	41_100222_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100222	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1378	41_100222_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100222	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1379	41_100222_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100222	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.06	Index	Negative
	refr-multi_lat-1380	41_100228_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100228	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1381	41_100228_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100228	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1382	41_100230_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100230	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1383	41_100230_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100230	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1384	41_100230_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100230	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1385	41_100239_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100239	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1386	41_100239_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100239	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1387	41_100239_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100239	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	3	U/mL	Negative
	refr-multi_lat-1388	41_100239_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100239	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.29	Index	Negative
	refr-multi_lat-1389	41_100240_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100240	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1390	41_100240_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100240	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1391	41_100240_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100240	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1392	41_100241_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100241	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1393	41_100241_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100241	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1394	41_100241_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100241	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1395	41_100241_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100241	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.84	Index	Negative
	refr-multi_lat-1396	41_100242_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100242	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1397	41_100242_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100242	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1398	41_100242_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100242	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.1	Index	Negative
	refr-multi_lat-1399	41_100246_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100246	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1400	41_100246_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100246	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1401	41_100249_100	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100249	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1402	41_100249_100	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100249	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1403	41_100249_100	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100249	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1404	41_100249_100	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100249	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.28	Index	Negative
	refr-multi_lat-1405	41_100250_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100250	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1406	41_100250_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100250	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1407	41_100251_100	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100251	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	27.1	U/mL	Negative
	refr-multi_lat-1408	41_100251_100	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100251	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1409	41_100251_100	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100251	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1410	41_100251_100	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100251	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.16	Index	Negative
	refr-multi_lat-1411	41_100253_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100253	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1412	41_100253_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100253	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1413	41_100253_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100253	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1414	41_100253_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100253	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	14.5	AU/mL	Negative
	refr-multi_lat-1415	41_100254_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100254	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1416	41_100254_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100254	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1417	41_100255_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100255	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1418	41_100255_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100255	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1419	41_100255_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100255	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.36	Index	Negative
	refr-multi_lat-1420	41_100257_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100257	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1421	41_100257_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100257	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.4	Index	Negative
	refr-multi_lat-1422	41_100258_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100258	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1423	41_100258_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100258	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	18.3	U/mL	Negative
	refr-multi_lat-1424	41_100258_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100258	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1425	41_100259_100	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100259	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1426	41_100259_100	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100259	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1427	41_100259_100	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100259	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1428	41_100259_100	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100259	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1429	41_100259_100	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100259	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.2	Index	Negative
	refr-multi_lat-1430	41_100263_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100263	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1431	41_100263_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100263	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1432	41_100263_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100263	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.09	Index	Negative
	refr-multi_lat-1433	41_100264_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100264	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1434	41_100264_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100264	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1435	41_100264_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100264	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	10	U/mL	Negative
	refr-multi_lat-1436	41_100264_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100264	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1437	41_100264_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100264	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	3	U/mL	Negative
	refr-multi_lat-1438	41_100264_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100264	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.34	Index	Negative
	refr-multi_lat-1439	41_100270_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100270	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1440	41_100270_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100270	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1441	41_100270_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100270	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.59	Index	Negative
	refr-multi_lat-1442	41_100274_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100274	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	22.9	U/mL	Negative
	refr-multi_lat-1443	41_100274_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100274	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.14	Index	Negative
	refr-multi_lat-1444	41_100276_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100276	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1445	41_100276_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100276	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1446	41_100276_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100276	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	5.79	AU/mL	Negative
	refr-multi_lat-1447	41_100276_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100276	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.26	Index	Negative
	refr-multi_lat-1448	41_100278_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100278	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1449	41_100280_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100280	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1450	41_100280_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100280	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1451	41_100280_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100280	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1452	41_100280_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100280	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.08	Index	Negative
	refr-multi_lat-1453	41_100285_100	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100285	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1454	41_100285_100	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100285	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1455	41_100285_100	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100285	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1456	41_100285_100	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100285	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.25	Index	Negative
	refr-multi_lat-1457	41_100292_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100292	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1458	41_100292_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100292	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1459	41_100292_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100292	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1460	41_100292_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100292	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.25	Index	Negative
	refr-multi_lat-1461	41_100295_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100295	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1462	41_100295_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100295	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	13.2	U/mL	Negative
	refr-multi_lat-1463	41_100295_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100295	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	1	Index	Negative
	refr-multi_lat-1464	41_100298_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100298	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	3	U/mL	Negative
	refr-multi_lat-1465	41_100298_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100298	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.6	Index	Negative
	refr-multi_lat-1466	41_100300_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100300	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1467	41_100300_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100300	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1468	41_100300_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100300	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1469	41_100304_100	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100304	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1470	41_100304_100	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100304	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1471	41_100304_100	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100304	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	13.3	U/mL	Negative
	refr-multi_lat-1472	41_100304_100	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100304	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1473	41_100304_100	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100304	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.08	Index	Negative
	refr-multi_lat-1474	41_100306_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100306	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1475	41_100306_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100306	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1476	41_100306_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100306	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.1	Index	Negative
	refr-multi_lat-1477	41_100307_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100307	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1478	41_100307_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100307	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1479	41_100307_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100307	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	11.5	U/mL	Negative
	refr-multi_lat-1480	41_100307_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100307	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1481	41_100307_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100307	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.14	Index	Negative
	refr-multi_lat-1482	41_100313_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100313	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1483	41_100313_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100313	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1484	41_100313_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100313	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.23	Index	Negative
	refr-multi_lat-1485	41_100315_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100315	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1486	41_100315_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100315	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1487	41_100315_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100315	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.13	Index	Negative
	refr-multi_lat-1488	41_100320_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100320	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1489	41_100320_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100320	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1490	41_100320_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100320	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1491	41_100320_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100320	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	5.19	AU/mL	Negative
	refr-multi_lat-1492	41_100320_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100320	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.09	Index	Negative
	refr-multi_lat-1493	41_100321_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100321	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1494	41_100321_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100321	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.82	Index	Negative
	refr-multi_lat-1495	41_100322_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100322	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1496	41_100322_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100322	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	24.9	U/mL	Negative
	refr-multi_lat-1497	41_100322_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100322	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1498	41_100322_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100322	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1499	41_100322_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100322	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.18	Index	Negative
	refr-multi_lat-1500	41_100323_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100323	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1501	41_100323_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100323	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1502	41_100323_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100323	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	10	U/mL	Negative
	refr-multi_lat-1503	41_100323_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100323	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1504	41_100323_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100323	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	3	U/mL	Negative
	refr-multi_lat-1505	41_100323_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100323	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	5.88	AU/mL	Negative
	refr-multi_lat-1506	41_100323_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100323	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.1	Index	Negative
	refr-multi_lat-1507	41_100332_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100332	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1508	41_100332_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100332	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1509	41_100332_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100332	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	8.5	U/mL	Negative
	refr-multi_lat-1510	41_100332_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100332	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1511	41_100332_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100332	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.16	Index	Negative
	refr-multi_lat-1512	41_100333_100	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100333	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1513	41_100333_100	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100333	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1514	41_100333_100	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100333	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	6.13	AU/mL	Negative
	refr-multi_lat-1515	41_100333_100	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100333	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.14	Index	Negative
	refr-multi_lat-1516	41_100336_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100336	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	12.2	U/mL	Negative
	refr-multi_lat-1517	41_100336_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100336	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	4.9	AU/mL	Negative
	refr-multi_lat-1518	41_100336_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100336	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.11	Index	Negative
	refr-multi_lat-1519	41_100337_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100337	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1520	41_100337_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100337	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1521	41_100337_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100337	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	7.96	AU/mL	Negative
	refr-multi_lat-1522	41_100337_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100337	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.25	Index	Negative
	refr-multi_lat-1523	41_100371_100	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100371	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1524	41_100371_100	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100371	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1525	41_100371_100	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100371	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1526	41_100371_100	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100371	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.29	Index	Negative
	refr-multi_lat-1527	41_100396_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100396	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	15.1	U/mL	Negative
	refr-multi_lat-1528	41_100396_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100396	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1529	41_100396_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100396	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1530	41_100396_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100396	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.28	Index	Negative
	refr-multi_lat-1531	41_100399_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100399	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1532	41_100399_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100399	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1533	41_100399_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100399	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1534	41_100399_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100399	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.14	Index	Negative
	refr-multi_lat-1535	41_100409_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100409	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1536	41_100409_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100409	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1537	41_100409_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100409	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.96	Index	Negative
	refr-multi_lat-1538	41_100410_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100410	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1539	41_100410_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100410	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10.2	U/mL	Negative
	refr-multi_lat-1540	41_100410_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100410	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	10	U/mL	Negative
	refr-multi_lat-1541	41_100410_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100410	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1542	41_100410_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100410	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	3	U/mL	Negative
	refr-multi_lat-1543	41_100410_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100410	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1544	41_100410_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100410	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.24	Index	Negative
	refr-multi_lat-1545	41_100428_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100428	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1546	41_100428_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100428	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1547	41_100428_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100428	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.69	Index	Negative
	refr-multi_lat-1548	41_100430_100	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100430	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1549	41_100430_100	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100430	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1550	41_100430_100	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100430	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1551	41_100430_100	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100430	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.43	Index	Negative
	refr-multi_lat-1552	41_100431_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100431	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1553	41_100431_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100431	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1554	41_100431_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100431	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1555	41_100431_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100431	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1556	41_100431_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100431	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.1	Index	Negative
	refr-multi_lat-1557	41_100434_100	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100434	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1558	41_100434_100	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100434	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1559	41_100434_100	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100434	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1560	41_100434_100	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100434	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.11	Index	Negative
	refr-multi_lat-1561	41_100437_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100437	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1562	41_100437_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100437	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1563	41_100437_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100437	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	4.34	AU/mL	Negative
	refr-multi_lat-1564	41_100437_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100437	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.12	Index	Negative
	refr-multi_lat-1565	41_100438_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100438	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1566	41_100438_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100438	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1567	41_100438_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100438	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1568	41_100438_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100438	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1569	41_100438_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100438	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.1	Index	Negative
	refr-multi_lat-1570	41_100439_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100439	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1571	41_100439_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100439	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1572	41_100439_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100439	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1573	41_100439_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100439	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	9.6	AU/mL	Negative
	refr-multi_lat-1574	41_100439_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100439	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.22	Index	Negative
	refr-multi_lat-1575	41_100446_100	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100446	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1576	41_100446_100	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100446	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	11	U/mL	Negative
	refr-multi_lat-1577	41_100446_100	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100446	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.18	Index	Negative
	refr-multi_lat-1578	41_100447_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100447	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1579	41_100447_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100447	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1580	41_100447_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100447	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1581	41_100447_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100447	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	4.88	AU/mL	Negative
	refr-multi_lat-1582	41_100447_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100447	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.05	Index	Negative
	refr-multi_lat-1583	41_100450_100	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100450	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1584	41_100450_100	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100450	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1585	41_100450_100	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100450	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5.4	U/mL	Negative
	refr-multi_lat-1586	41_100453_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100453	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1587	41_100453_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100453	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	12.4	U/mL	Negative
	refr-multi_lat-1588	41_100453_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100453	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	6.54	AU/mL	Negative
	refr-multi_lat-1589	41_100453_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100453	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.13	Index	Negative
	refr-multi_lat-1590	41_100457_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100457	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1591	41_100457_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100457	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1592	41_100457_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100457	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1593	41_100457_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100457	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.14	Index	Negative
	refr-multi_lat-1594	41_100458_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100458	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1595	41_100458_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100458	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	20.4	U/mL	Negative
	refr-multi_lat-1596	41_100458_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100458	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	6.4	U/mL	Negative
	refr-multi_lat-1597	41_100458_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100458	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1598	41_100458_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100458	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.39	Index	Negative
	refr-multi_lat-1599	41_100461_100	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100461	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1600	41_100461_100	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100461	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1601	41_100461_100	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100461	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1602	41_100461_100	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100461	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.08	Index	Negative
	refr-multi_lat-1603	41_100462_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100462	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	20.3	U/mL	Negative
	refr-multi_lat-1604	41_100462_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100462	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1605	41_100462_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100462	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.21	Index	Negative
	refr-multi_lat-1606	41_100466_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100466	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1607	41_100466_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100466	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1608	41_100467_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100467	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1609	41_100467_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100467	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1610	41_100467_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100467	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1611	41_100467_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100467	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.2	Index	Negative
	refr-multi_lat-1612	41_100468_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100468	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1613	41_100468_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100468	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1614	41_100468_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100468	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1615	41_100469_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100469	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1616	41_100469_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100469	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1617	41_100469_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100469	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.39	Index	Negative
	refr-multi_lat-1618	41_100475_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100475	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1619	41_100475_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100475	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1620	41_100475_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100475	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.14	Index	Negative
	refr-multi_lat-1621	41_100476_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100476	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1622	41_100476_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100476	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1623	41_100476_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100476	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1624	41_100476_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100476	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	6.21	AU/mL	Negative
	refr-multi_lat-1625	41_100476_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100476	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.07	Index	Negative
	refr-multi_lat-1626	41_100478_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100478	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.57	U/mL	Negative
	refr-multi_lat-1627	41_100478_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100478	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1628	41_100478_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100478	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1629	41_100478_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100478	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.53	Index	Negative
	refr-multi_lat-1630	41_100479_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100479	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.4	U/mL	Negative
	refr-multi_lat-1631	41_100479_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100479	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1632	41_100479_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100479	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1633	41_100479_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100479	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1634	41_100479_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100479	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.11	Index	Negative
	refr-multi_lat-1635	41_100480_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100480	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1636	41_100480_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100480	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1637	41_100480_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100480	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	5.71	AU/mL	Negative
	refr-multi_lat-1638	41_100480_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100480	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.21	Index	Negative
	refr-multi_lat-1639	41_100485_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100485	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1640	41_100485_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100485	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1641	41_100485_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100485	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1642	41_100485_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100485	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1643	41_100485_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100485	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.13	Index	Negative
	refr-multi_lat-1644	41_100486_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100486	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1645	41_100486_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100486	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1646	41_100486_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100486	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	13.2	U/mL	Negative
	refr-multi_lat-1647	41_100486_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100486	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1648	41_100486_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100486	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	12.4	AU/mL	Negative
	refr-multi_lat-1649	41_100486_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100486	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.38	Index	Negative
	refr-multi_lat-1650	41_100487_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100487	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1651	41_100488_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100488	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1652	41_100488_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100488	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1653	41_100488_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100488	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1654	41_100488_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100488	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1655	41_100488_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100488	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.08	Index	Negative
	refr-multi_lat-1656	41_100490_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100490	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1657	41_100490_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100490	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1658	41_100490_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100490	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.07	Index	Negative
	refr-multi_lat-1659	41_100491_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100491	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1660	41_100491_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100491	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1661	41_100491_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100491	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1662	41_100491_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100491	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.3	Index	Negative
	refr-multi_lat-1663	41_100492_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100492	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1664	41_100492_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100492	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	4.03	AU/mL	Negative
	refr-multi_lat-1665	41_100492_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100492	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.06	Index	Negative
	refr-multi_lat-1666	41_100493_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100493	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1667	41_100493_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100493	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1668	41_100493_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100493	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	11.4	U/mL	Negative
	refr-multi_lat-1669	41_100493_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100493	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1670	41_100493_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100493	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	3	U/mL	Negative
	refr-multi_lat-1671	41_100493_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100493	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1672	41_100493_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100493	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.24	Index	Negative
	refr-multi_lat-1673	41_100494_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100494	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1674	41_100494_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100494	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1675	41_100494_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100494	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1676	41_100494_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100494	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.68	Index	Negative
	refr-multi_lat-1677	41_100495_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100495	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1678	41_100495_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100495	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1679	41_100495_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100495	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.1	Index	Negative
	refr-multi_lat-1680	41_100496_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100496	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1681	41_100496_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100496	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1682	41_100496_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100496	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.26	Index	Negative
	refr-multi_lat-1683	41_100497_100	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100497	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1684	41_100497_100	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100497	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1685	41_100497_100	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100497	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1686	41_100497_100	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100497	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.07	Index	Negative
	refr-multi_lat-1687	41_100498_100	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100498	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	20.8	U/mL	Negative
	refr-multi_lat-1688	41_100498_100	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100498	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1689	41_100498_100	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100498	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.11	Index	Negative
	refr-multi_lat-1690	41_100499_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100499	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1691	41_100499_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100499	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1692	41_100499_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100499	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	8.9	U/mL	Negative
	refr-multi_lat-1693	41_100499_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100499	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.13	Index	Negative
	refr-multi_lat-1694	41_100500_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100500	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1695	41_100500_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100500	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	16.1	U/mL	Negative
	refr-multi_lat-1696	41_100500_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100500	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	6.6	U/mL	Negative
	refr-multi_lat-1697	41_100500_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100500	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	3	U/mL	Negative
	refr-multi_lat-1698	41_100500_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100500	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1699	41_100500_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100500	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.24	Index	Negative
	refr-multi_lat-1700	41_100501_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100501	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1701	41_100501_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100501	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1702	41_100501_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100501	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.41	Index	Negative
	refr-multi_lat-1703	41_100503_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100503	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1704	41_100503_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100503	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1705	41_100503_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100503	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	12	AU/mL	Negative
	refr-multi_lat-1706	41_100503_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100503	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.06	Index	Negative
	refr-multi_lat-1707	41_100505_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100505	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1708	41_100505_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100505	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5.4	U/mL	Negative
	refr-multi_lat-1709	41_100505_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100505	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	9.2	U/mL	Negative
	refr-multi_lat-1710	41_100505_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100505	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1711	41_100505_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100505	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.06	Index	Negative
	refr-multi_lat-1712	41_100507_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100507	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1713	41_100507_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100507	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1714	41_100507_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100507	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1715	41_100510_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100510	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1716	41_100510_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100510	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1717	41_100510_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100510	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	6.8	U/mL	Negative
	refr-multi_lat-1718	41_100510_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100510	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1719	41_100510_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100510	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.06	Index	Negative
	refr-multi_lat-1720	41_100511_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100511	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.32	U/mL	Negative
	refr-multi_lat-1721	41_100511_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100511	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1722	41_100511_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100511	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1723	41_100511_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100511	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.37	Index	Negative
	refr-multi_lat-1724	41_100512_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100512	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1725	41_100512_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100512	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1726	41_100512_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100512	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1727	41_100512_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100512	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.08	Index	Negative
	refr-multi_lat-1728	41_100513_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100513	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1729	41_100513_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100513	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1730	41_100513_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100513	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1731	41_100513_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100513	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.24	Index	Negative
	refr-multi_lat-1732	41_100514_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100514	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1733	41_100514_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100514	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1734	41_100514_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100514	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	17.3	U/mL	Negative
	refr-multi_lat-1735	41_100514_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100514	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1736	41_100514_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100514	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.34	Index	Negative
	refr-multi_lat-1737	41_100515_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100515	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1738	41_100515_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100515	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1739	41_100515_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100515	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1740	41_100515_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100515	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.21	Index	Negative
	refr-multi_lat-1741	41_100535_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100535	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1742	41_100535_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100535	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1743	41_100535_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100535	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1744	41_100535_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100535	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.07	Index	Negative
	refr-multi_lat-1745	41_100540_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100540	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1746	41_100540_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100540	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1747	41_100540_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100540	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1748	41_100540_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100540	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.1	Index	Negative
	refr-multi_lat-1749	41_100541_100	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100541	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1750	41_100541_100	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100541	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1751	41_100541_100	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100541	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	6.71	AU/mL	Negative
	refr-multi_lat-1752	41_100541_100	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100541	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.14	Index	Negative
	refr-multi_lat-1753	41_100542_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100542	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1754	41_100542_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100542	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1755	41_100542_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100542	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.12	Index	Negative
	refr-multi_lat-1756	41_100544_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100544	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1757	41_100544_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100544	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	26.1	U/mL	Negative
	refr-multi_lat-1758	41_100544_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100544	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1759	41_100544_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100544	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1760	41_100544_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100544	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.07	Index	Negative
	refr-multi_lat-1761	41_100546_100	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100546	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1762	41_100546_100	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100546	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1763	41_100546_100	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100546	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1764	41_100546_100	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100546	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1765	41_100546_100	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100546	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.14	Index	Negative
	refr-multi_lat-1766	41_100547_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100547	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1767	41_100547_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100547	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	6.8	U/mL	Negative
	refr-multi_lat-1768	41_100547_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100547	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1769	41_100547_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100547	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.07	Index	Negative
	refr-multi_lat-1770	41_100549_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100549	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	22.7	U/mL	Negative
	refr-multi_lat-1771	41_100550_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100550	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1772	41_100550_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100550	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.9	Index	Negative
	refr-multi_lat-1773	41_100552_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100552	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1774	41_100552_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100552	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	4.9	AU/mL	Negative
	refr-multi_lat-1775	41_100552_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100552	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.08	Index	Negative
	refr-multi_lat-1776	41_100553_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100553	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1777	41_100553_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100553	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5.6	U/mL	Negative
	refr-multi_lat-1778	41_100553_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100553	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1779	41_100553_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100553	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.16	Index	Negative
	refr-multi_lat-1780	41_100559_100	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100559	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1781	41_100559_100	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100559	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1782	41_100559_100	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100559	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1783	41_100559_100	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100559	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1784	41_100559_100	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100559	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.17	Index	Negative
	refr-multi_lat-1785	41_100560_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100560	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1786	41_100560_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100560	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1787	41_100560_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100560	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	3	U/mL	Negative
	refr-multi_lat-1788	41_100560_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100560	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1789	41_100560_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100560	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.18	Index	Negative
	refr-multi_lat-1790	41_100561_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100561	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1791	41_100561_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100561	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1792	41_100561_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100561	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1793	41_100561_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100561	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.05	Index	Negative
	refr-multi_lat-1794	41_100562_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100562	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1795	41_100562_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100562	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1796	41_100562_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100562	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	4.35	AU/mL	Negative
	refr-multi_lat-1797	41_100562_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100562	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.14	Index	Negative
	refr-multi_lat-1798	41_100563_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100563	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1799	41_100563_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100563	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1800	41_100563_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100563	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	5.34	AU/mL	Negative
	refr-multi_lat-1801	41_100563_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100563	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.07	Index	Negative
	refr-multi_lat-1802	41_100564_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100564	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1803	41_100564_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100564	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1804	41_100564_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100564	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	4.8	AU/mL	Negative
	refr-multi_lat-1805	41_100564_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100564	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.11	Index	Negative
	refr-multi_lat-1806	41_100565_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100565	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1807	41_100565_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100565	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1808	41_100565_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100565	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1809	41_100565_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100565	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1810	41_100565_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100565	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.17	Index	Negative
	refr-multi_lat-1811	41_100566_100	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100566	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1812	41_100566_100	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100566	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	13.7	U/mL	Negative
	refr-multi_lat-1813	41_100566_100	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100566	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1814	41_100566_100	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100566	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.63	Index	Negative
	refr-multi_lat-1815	41_100567_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100567	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1816	41_100567_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100567	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1817	41_100567_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100567	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.07	Index	Negative
	refr-multi_lat-1818	41_100568_100	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100568	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1819	41_100568_100	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100568	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1820	41_100568_100	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100568	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	8.32	AU/mL	Negative
	refr-multi_lat-1821	41_100568_100	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100568	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.4	Index	Negative
	refr-multi_lat-1822	41_100569_100	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100569	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1823	41_100569_100	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100569	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1824	41_100569_100	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100569	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	10	U/mL	Negative
	refr-multi_lat-1825	41_100569_100	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100569	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1826	41_100569_100	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100569	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	3	U/mL	Negative
	refr-multi_lat-1827	41_100569_100	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100569	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1828	41_100571_100	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100571	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1829	41_100571_100	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100571	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1830	41_100571_100	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100571	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1831	41_100571_100	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100571	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.29	Index	Negative
	refr-multi_lat-1832	41_100572_100	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100572	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1833	41_100572_100	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100572	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1834	41_100572_100	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100572	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1835	41_100572_100	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100572	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	14.9	AU/mL	Negative
	refr-multi_lat-1836	41_100572_100	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100572	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.45	Index	Negative
	refr-multi_lat-1837	41_100574_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100574	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1838	41_100574_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100574	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1839	41_100574_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100574	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	6.2	U/mL	Negative
	refr-multi_lat-1840	41_100574_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100574	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1841	41_100574_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100574	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.14	Index	Negative
	refr-multi_lat-1842	41_100579_100	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100579	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1843	41_100580_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100580	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1844	41_100581_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100581	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1845	41_100581_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100581	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	10	U/mL	Negative
	refr-multi_lat-1846	41_100581_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100581	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1847	41_100582_100	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100582	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1848	41_100582_100	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100582	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1849	41_100582_100	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100582	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1850	41_100582_100	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100582	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1851	41_100582_100	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100582	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.27	Index	Negative
	refr-multi_lat-1852	41_100583_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100583	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1853	41_100583_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100583	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1854	41_100583_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100583	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.12	Index	Negative
	refr-multi_lat-1855	41_100584_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100584	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1856	41_100584_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100584	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1857	41_100584_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100584	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	8.8	U/mL	Negative
	refr-multi_lat-1858	41_100584_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100584	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1859	41_100584_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100584	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.11	Index	Negative
	refr-multi_lat-1860	41_100585_100	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100585	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1861	41_100585_100	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100585	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1862	41_100585_100	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100585	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1863	41_100585_100	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100585	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1864	41_100585_100	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100585	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.08	Index	Negative
	refr-multi_lat-1865	41_100586_100	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100586	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1866	41_100586_100	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100586	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1867	41_100586_100	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100586	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1868	41_100586_100	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100586	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1869	41_100586_100	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100586	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.29	Index	Negative
	refr-multi_lat-1870	41_100588_100	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100588	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1871	41_100588_100	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100588	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1872	41_100588_100	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100588	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.95	Index	Negative
	refr-multi_lat-1873	41_100600_100	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100600	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1874	41_100600_100	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100600	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1875	41_100601_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100601	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1876	41_100601_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100601	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1877	41_100601_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100601	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1878	41_100601_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100601	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	5.02	AU/mL	Negative
	refr-multi_lat-1879	41_100601_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100601	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.14	Index	Negative
	refr-multi_lat-1880	41_100602_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100602	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1881	41_100602_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100602	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1882	41_100602_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100602	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.12	Index	Negative
	refr-multi_lat-1883	41_100603_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100603	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1884	41_100603_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100603	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1885	41_100603_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100603	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	3	U/mL	Negative
	refr-multi_lat-1886	41_100603_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100603	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.86	Index	Negative
	refr-multi_lat-1887	41_100604_100	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100604	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1888	41_100604_100	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100604	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1889	41_100604_100	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100604	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	4.22	AU/mL	Negative
	refr-multi_lat-1890	41_100604_100	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100604	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.14	Index	Negative
	refr-multi_lat-1891	41_100605_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100605	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1892	41_100605_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100605	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	7.3	U/mL	Negative
	refr-multi_lat-1893	41_100609_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100609	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1894	41_100609_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100609	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1895	41_100609_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100609	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.16	Index	Negative
	refr-multi_lat-1896	41_100610_100	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100610	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1897	41_100610_100	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100610	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1898	41_100610_100	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100610	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1899	41_100610_100	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100610	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1900	41_100610_100	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100610	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.13	Index	Negative
	refr-multi_lat-1901	41_100611_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100611	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1902	41_100611_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100611	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1903	41_100611_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100611	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.9	Index	Negative
	refr-multi_lat-1904	41_100612_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100612	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1905	41_100612_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100612	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1906	41_100612_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100612	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1907	41_100612_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100612	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.16	Index	Negative
	refr-multi_lat-1908	41_100617_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100617	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1909	41_100618_100	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100618	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1910	41_100618_100	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100618	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1911	41_100618_100	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100618	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1912	41_100618_100	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100618	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.32	Index	Negative
	refr-multi_lat-1913	41_100635_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100635	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.41	U/mL	Negative
	refr-multi_lat-1914	41_100635_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100635	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1915	41_100635_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100635	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	8.1	U/mL	Negative
	refr-multi_lat-1916	41_100635_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100635	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1917	41_100635_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100635	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.48	Index	Negative
	refr-multi_lat-1918	41_100636_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100636	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1919	41_100636_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100636	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1920	41_100636_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100636	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.17	Index	Negative
	refr-multi_lat-1921	41_100637_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100637	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1922	41_100637_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100637	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1923	41_100637_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100637	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1924	41_100637_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100637	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.11	Index	Negative
	refr-multi_lat-1925	41_100638_100	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100638	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1926	41_100638_100	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100638	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	15.4	U/mL	Negative
	refr-multi_lat-1927	41_100638_100	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100638	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1928	41_100638_100	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100638	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	5.32	AU/mL	Negative
	refr-multi_lat-1929	41_100639_100	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100639	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1930	41_100639_100	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100639	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1931	41_100639_100	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100639	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1932	41_100639_100	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100639	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.14	Index	Negative
	refr-multi_lat-1933	41_100642_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100642	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1934	41_100642_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100642	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1935	41_100642_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100642	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1936	41_100642_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100642	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.17	Index	Negative
	refr-multi_lat-1937	41_100643_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100643	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1938	41_100643_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100643	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1939	41_100643_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100643	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.07	Index	Negative
	refr-multi_lat-1940	41_100644_100	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100644	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1941	41_100644_100	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100644	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	13.1	U/mL	Negative
	refr-multi_lat-1942	41_100644_100	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100644	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1943	41_100644_100	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100644	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.11	Index	Negative
	refr-multi_lat-1944	41_100645_100	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100645	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1945	41_100645_100	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100645	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1946	41_100645_100	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100645	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1947	41_100645_100	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100645	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	13.6	AU/mL	Negative
	refr-multi_lat-1948	41_100645_100	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100645	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.26	Index	Negative
	refr-multi_lat-1949	41_100656_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100656	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1950	41_100656_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100656	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1951	41_100656_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100656	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1952	41_100656_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100656	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.09	Index	Negative
	refr-multi_lat-1953	41_100657_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100657	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1954	41_100657_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100657	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1955	41_100657_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100657	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.08	Index	Negative
	refr-multi_lat-1956	41_100660_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100660	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1957	41_100660_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100660	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	11.2	U/mL	Negative
	refr-multi_lat-1958	41_100660_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100660	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1959	41_100660_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100660	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.63	Index	Negative
	refr-multi_lat-1960	41_100662_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100662	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1961	41_100662_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100662	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1962	41_100662_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100662	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1963	41_100662_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100662	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.09	Index	Negative
	refr-multi_lat-1964	41_100663_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100663	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1965	41_100663_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100663	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.42	Index	Negative
	refr-multi_lat-1966	41_100664_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100664	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.46	U/mL	Negative
	refr-multi_lat-1967	41_100664_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100664	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1968	41_100664_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100664	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1969	41_100664_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100664	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.18	Index	Negative
	refr-multi_lat-1970	41_100665_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100665	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1971	41_100665_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100665	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1972	41_100665_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100665	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1973	41_100665_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100665	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1974	41_100665_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100665	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.05	Index	Negative
	refr-multi_lat-1975	41_100672_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100672	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1976	41_100672_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100672	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1977	41_100672_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100672	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.12	Index	Negative
	refr-multi_lat-1978	41_100673_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100673	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1979	41_100673_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100673	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1980	41_100673_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100673	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.09	Index	Negative
	refr-multi_lat-1981	41_100674_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100674	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1982	41_100674_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100674	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1983	41_100674_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100674	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1984	41_100681_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100681	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1985	41_100681_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100681	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1986	41_100681_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100681	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.22	Index	Negative
	refr-multi_lat-1987	41_100682_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100682	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1988	41_100682_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100682	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1989	41_100682_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100682	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-1990	41_100682_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100682	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.06	Index	Negative
	refr-multi_lat-1991	41_100683_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100683	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1992	41_100683_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100683	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1993	41_100690_100	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100690	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	33.4	U/mL	Negative
	refr-multi_lat-1994	41_100690_100	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100690	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1995	41_100693_100	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100693	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-1996	41_100693_100	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100693	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-1997	41_100693_100	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100693	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	10	U/mL	Negative
	refr-multi_lat-1998	41_100693_100	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100693	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-1999	41_100693_100	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100693	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	3	U/mL	Negative
	refr-multi_lat-2000	41_100693_100	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100693	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.85	AU/mL	Negative
	refr-multi_lat-2001	41_100693_100	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100693	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.49	Index	Negative
	refr-multi_lat-2002	41_100694_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100694	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-2003	41_100694_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100694	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-2004	41_100694_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100694	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-2005	41_100694_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100694	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	8.55	AU/mL	Negative
	refr-multi_lat-2006	41_100694_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100694	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.33	Index	Negative
	refr-multi_lat-2007	41_100698_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100698	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-2008	41_100698_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100698	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	27.5	U/mL	Negative
	refr-multi_lat-2009	41_100698_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100698	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.3	Index	Negative
	refr-multi_lat-2010	41_100699_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100699	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-2011	41_100699_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100699	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-2012	41_100699_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100699	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-2013	41_100699_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100699	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-2014	41_100699_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100699	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.25	Index	Negative
	refr-multi_lat-2015	41_100711_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100711	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-2016	41_100711_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100711	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-2017	41_100711_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100711	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	5.64	AU/mL	Negative
	refr-multi_lat-2018	41_100711_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100711	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.24	Index	Negative
	refr-multi_lat-2019	41_100712_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100712	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-2020	41_100712_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100712	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-2021	41_100712_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100712	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-2022	41_100712_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100712	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	5.48	AU/mL	Negative
	refr-multi_lat-2023	41_100712_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100712	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.26	Index	Negative
	refr-multi_lat-2024	41_100719_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100719	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-2025	41_100719_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100719	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-2026	41_100719_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100719	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	3	U/mL	Negative
	refr-multi_lat-2027	41_100719_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100719	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	6.4	AU/mL	Negative
	refr-multi_lat-2028	41_100719_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100719	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.09	Index	Negative
	refr-multi_lat-2029	41_100721_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100721	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-2030	41_100721_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100721	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-2031	41_100721_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100721	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	11	U/mL	Negative
	refr-multi_lat-2032	41_100721_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100721	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-2033	41_100721_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100721	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	5.59	AU/mL	Negative
	refr-multi_lat-2034	41_100721_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100721	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.56	Index	Negative
	refr-multi_lat-2035	41_100724_100	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100724	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-2036	41_100724_100	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100724	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-2037	41_100724_100	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100724	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	3	U/mL	Negative
	refr-multi_lat-2038	41_100724_100	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100724	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-2039	41_100724_100	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100724	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.06	Index	Negative
	refr-multi_lat-2040	41_100726_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100726	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-2041	41_100726_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100726	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-2042	41_100726_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100726	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-2043	41_100726_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100726	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.4	Index	Negative
	refr-multi_lat-2044	41_100730_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100730	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-2045	41_100730_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100730	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	10	U/mL	Negative
	refr-multi_lat-2046	41_100730_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100730	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-2047	41_100730_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100730	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	12.3	U/mL	Negative
	refr-multi_lat-2048	41_100730_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100730	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-2049	41_100730_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100730	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.29	Index	Negative
	refr-multi_lat-2050	41_100737_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100737	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-2051	41_100737_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100737	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-2052	41_100737_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100737	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.12	Index	Negative
	refr-multi_lat-2053	41_100738_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100738	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10.8	U/mL	Negative
	refr-multi_lat-2054	41_100738_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100738	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-2055	41_100738_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100738	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-2056	41_100738_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100738	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.08	Index	Negative
	refr-multi_lat-2057	41_100739_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100739	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-2058	41_100739_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100739	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-2059	41_100739_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100739	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	14	U/mL	Negative
	refr-multi_lat-2060	41_100739_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100739	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-2061	41_100739_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100739	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	3	U/mL	Negative
	refr-multi_lat-2062	41_100739_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100739	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.43	Index	Negative
	refr-multi_lat-2063	41_100740_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100740	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-2064	41_100740_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100740	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-2065	41_100740_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100740	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-2066	41_100740_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100740	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	9.66	AU/mL	Negative
	refr-multi_lat-2067	41_100740_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100740	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.21	Index	Negative
	refr-multi_lat-2068	41_100742_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100742	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-2069	41_100742_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100742	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-2070	41_100742_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100742	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.73	Index	Negative
	refr-multi_lat-2071	41_100743_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100743	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-2072	41_100743_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100743	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-2073	41_100743_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100743	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-2074	41_100744_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100744	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-2075	41_100744_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100744	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	12.4	U/mL	Negative
	refr-multi_lat-2076	41_100744_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100744	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-2077	41_100744_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100744	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	14.9	AU/mL	Negative
	refr-multi_lat-2078	41_100744_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100744	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.24	Index	Negative
	refr-multi_lat-2079	41_100745_100	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100745	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-2080	41_100745_100	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100745	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-2081	41_100745_100	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100745	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	13.4	U/mL	Negative
	refr-multi_lat-2082	41_100745_100	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100745	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-2083	41_100745_100	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100745	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-2084	41_100745_100	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100745	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.2	Index	Negative
	refr-multi_lat-2085	41_100747_100	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100747	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-2086	41_100747_100	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100747	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-2087	41_100747_100	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100747	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-2088	41_100747_100	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100747	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-2089	41_100747_100	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100747	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.07	Index	Negative
	refr-multi_lat-2090	41_100748_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100748	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	12.7	U/mL	Negative
	refr-multi_lat-2091	41_100748_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100748	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-2092	41_100748_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100748	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.12	Index	Negative
	refr-multi_lat-2093	41_100749_100	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100749	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-2094	41_100749_100	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100749	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	13	U/mL	Negative
	refr-multi_lat-2095	41_100749_100	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100749	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-2096	41_100749_100	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100749	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.67	Index	Negative
	refr-multi_lat-2097	41_100754_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100754	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-2098	41_100754_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100754	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-2099	41_100754_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100754	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-2100	41_100754_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100754	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	8.34	AU/mL	Negative
	refr-multi_lat-2101	41_100754_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100754	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.12	Index	Negative
	refr-multi_lat-2102	41_100755_100	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100755	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-2103	41_100755_100	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100755	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-2104	41_100755_100	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100755	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-2105	41_100755_100	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100755	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.23	Index	Negative
	refr-multi_lat-2106	41_100756_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100756	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-2107	41_100756_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100756	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-2108	41_100756_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100756	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	7.2	U/mL	Negative
	refr-multi_lat-2109	41_100756_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100756	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	17.7	U/mL	Negative
	refr-multi_lat-2110	41_100756_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100756	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-2111	41_100756_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100756	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.08	Index	Negative
	refr-multi_lat-2112	41_100757_100	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100757	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-2113	41_100757_100	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100757	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-2114	41_100757_100	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100757	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-2115	41_100757_100	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100757	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.72	Index	Negative
	refr-multi_lat-2116	41_100770_100	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100770	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-2117	41_100770_100	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100770	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.48	Index	Negative
	refr-multi_lat-2118	41_100771_100	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100771	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-2119	41_100771_100	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100771	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-2120	41_100771_100	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100771	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-2121	41_100771_100	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100771	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.43	Index	Negative
	refr-multi_lat-2122	41_100773_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100773	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-2123	41_100773_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100773	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-2124	41_100773_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100773	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-2125	41_100773_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100773	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.04	Index	Negative
	refr-multi_lat-2126	41_100776_100	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100776	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-2127	41_100776_100	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100776	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-2128	41_100776_100	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100776	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-2129	41_100776_100	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100776	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	6.81	AU/mL	Negative
	refr-multi_lat-2130	41_100776_100	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100776	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.46	Index	Negative
	refr-multi_lat-2131	41_100777_100	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100777	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-2132	41_100777_100	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100777	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	12.7	U/mL	Negative
	refr-multi_lat-2133	41_100777_100	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100777	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-2134	41_100777_100	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100777	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.16	Index	Negative
	refr-multi_lat-2135	41_100779_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100779	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-2136	41_100779_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100779	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-2137	41_100779_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100779	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-2138	41_100779_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100779	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.16	Index	Negative
	refr-multi_lat-2139	41_100781_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100781	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-2140	41_100781_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100781	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-2141	41_100781_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100781	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	9.61	AU/mL	Negative
	refr-multi_lat-2142	41_100781_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100781	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.29	Index	Negative
	refr-multi_lat-2143	41_100782_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100782	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-2144	41_100782_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100782	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-2145	41_100782_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100782	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	5.61	AU/mL	Negative
	refr-multi_lat-2146	41_100782_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100782	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.26	Index	Negative
	refr-multi_lat-2147	41_100783_100	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100783	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-2148	41_100783_100	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100783	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-2149	41_100783_100	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100783	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-2150	41_100783_100	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100783	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.18	Index	Negative
	refr-multi_lat-2151	41_100784_100	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100784	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-2152	41_100784_100	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100784	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-2153	41_100784_100	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100784	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	10	U/mL	Negative
	refr-multi_lat-2154	41_100784_100	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100784	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-2155	41_100784_100	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100784	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	3	U/mL	Negative
	refr-multi_lat-2156	41_100784_100	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100784	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	6.53	AU/mL	Negative
	refr-multi_lat-2157	41_100784_100	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100784	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.17	Index	Negative
	refr-multi_lat-2158	41_100785_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100785	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-2159	41_100785_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100785	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-2160	41_100785_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100785	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-2161	41_100785_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100785	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.25	Index	Negative
	refr-multi_lat-2162	41_100787_100	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100787	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-2163	41_100787_100	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100787	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-2164	41_100787_100	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100787	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-2165	41_100787_100	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100787	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	14.1	U/mL	Negative
	refr-multi_lat-2166	41_100787_100	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100787	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-2167	41_100787_100	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100787	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.16	Index	Negative
	refr-multi_lat-2168	41_100798_100	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100798	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-2169	41_100798_100	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100798	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	11.3	U/mL	Negative
	refr-multi_lat-2170	41_100798_100	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100798	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	7.1	U/mL	Negative
	refr-multi_lat-2171	41_100798_100	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100798	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-2172	41_100798_100	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100798	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.33	Index	Negative
	refr-multi_lat-2173	41_100799_100	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100799	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-2174	41_100799_100	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100799	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-2175	41_100799_100	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100799	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-2176	41_100799_100	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100799	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.19	Index	Negative
	refr-multi_lat-2177	41_100800_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100800	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-2178	41_100800_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100800	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-2179	41_100800_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100800	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.11	Index	Negative
	refr-multi_lat-2180	41_100801_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100801	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-2181	41_100801_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100801	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-2182	41_100801_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100801	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-2183	41_100801_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100801	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.17	Index	Negative
	refr-multi_lat-2184	41_100802_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100802	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-2185	41_100802_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100802	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-2186	41_100802_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100802	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.13	Index	Negative
	refr-multi_lat-2187	41_100804_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100804	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-2188	41_100804_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100804	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	15.2	U/mL	Negative
	refr-multi_lat-2189	41_100804_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100804	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-2190	41_100804_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100804	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.29	Index	Negative
	refr-multi_lat-2191	41_100805_100	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100805	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-2192	41_100805_100	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100805	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-2193	41_100805_100	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100805	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	7.4	AU/mL	Negative
	refr-multi_lat-2194	41_100805_100	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100805	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.08	Index	Negative
	refr-multi_lat-2195	41_100806_100	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100806	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-2196	41_100806_100	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100806	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-2197	41_100806_100	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100806	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-2198	41_100806_100	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100806	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	4.63	AU/mL	Negative
	refr-multi_lat-2199	41_100806_100	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100806	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.08	Index	Negative
	refr-multi_lat-2200	41_100808_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100808	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-2201	41_100808_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100808	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-2202	41_100808_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100808	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	5.21	AU/mL	Negative
	refr-multi_lat-2203	41_100808_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100808	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	1	Index	Negative
	refr-multi_lat-2204	41_100818_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100818	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-2205	41_100818_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100818	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-2206	41_100818_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100818	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	4.84	AU/mL	Negative
	refr-multi_lat-2207	41_100818_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100818	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.11	Index	Negative
	refr-multi_lat-2208	41_100819_100	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100819	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-2209	41_100819_100	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100819	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-2210	41_100819_100	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100819	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-2211	41_100819_100	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100819	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-2212	41_100819_100	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100819	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.1	Index	Negative
	refr-multi_lat-2213	41_100820_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100820	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-2214	41_100820_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100820	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-2215	41_100820_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100820	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-2216	41_100820_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100820	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.09	Index	Negative
	refr-multi_lat-2217	41_100821_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100821	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-2218	41_100821_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100821	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-2219	41_100821_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100821	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.22	Index	Negative
	refr-multi_lat-2220	41_100822_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100822	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-2221	41_100822_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100822	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-2222	41_100822_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100822	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-2223	41_100822_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100822	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-2224	41_100822_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100822	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.17	Index	Negative
	refr-multi_lat-2225	41_100824_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100824	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-2226	41_100824_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100824	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-2227	41_100824_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100824	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-2228	41_100824_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100824	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.13	Index	Negative
	refr-multi_lat-2229	41_100826_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100826	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-2230	41_100826_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100826	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-2231	41_100826_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100826	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-2232	41_100826_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100826	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-2233	41_100826_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100826	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.07	Index	Negative
	refr-multi_lat-2234	41_100827_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100827	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-2235	41_100827_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100827	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-2236	41_100827_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100827	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-2237	41_100827_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100827	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.26	Index	Negative
	refr-multi_lat-2238	41_100830_100	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100830	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-2239	41_100830_100	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100830	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-2240	41_100830_100	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100830	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-2241	41_100830_100	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100830	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	3	U/mL	Negative
	refr-multi_lat-2242	41_100830_100	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100830	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-2243	41_100830_100	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100830	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.12	Index	Negative
	refr-multi_lat-2244	41_100832_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100832	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-2245	41_100832_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100832	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-2246	41_100832_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100832	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.93	Index	Negative
	refr-multi_lat-2247	41_100833_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100833	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-2248	41_100833_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100833	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-2249	41_100833_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100833	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-2250	41_100833_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100833	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.09	Index	Negative
	refr-multi_lat-2251	41_100834_100	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100834	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.59	Index	Negative
	refr-multi_lat-2252	41_100836_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100836	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-2253	41_100836_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100836	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.19	Index	Negative
	refr-multi_lat-2254	41_100837_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100837	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-2255	41_100837_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100837	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	14.7	U/mL	Negative
	refr-multi_lat-2256	41_100837_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100837	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-2257	41_100837_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100837	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-2258	41_100837_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100837	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.17	Index	Negative
	refr-multi_lat-2259	41_100840_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100840	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-2260	41_100840_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100840	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-2261	41_100840_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100840	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	3	U/mL	Negative
	refr-multi_lat-2262	41_100840_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100840	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	4.31	AU/mL	Negative
	refr-multi_lat-2263	41_100840_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100840	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.13	Index	Negative
	refr-multi_lat-2264	41_100841_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100841	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-2265	41_100841_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100841	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-2266	41_100841_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100841	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	10.7	AU/mL	Negative
	refr-multi_lat-2267	41_100841_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100841	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.28	Index	Negative
	refr-multi_lat-2268	41_100842_100	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100842	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.2	U/mL	Negative
	refr-multi_lat-2269	41_100842_100	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100842	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-2270	41_100842_100	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100842	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	10.2	U/mL	Negative
	refr-multi_lat-2271	41_100842_100	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100842	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-2272	41_100842_100	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100842	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	3	U/mL	Negative
	refr-multi_lat-2273	41_100842_100	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100842	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	3.8	AU/mL	Negative
	refr-multi_lat-2274	41_100842_100	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100842	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.15	Index	Negative
	refr-multi_lat-2275	41_100844_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100844	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-2276	41_100844_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100844	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	5	U/mL	Negative
	refr-multi_lat-2277	41_100844_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100844	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.22	Index	Negative
	refr-multi_lat-2278	41_100851_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100851	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	10	U/mL	Negative
	refr-multi_lat-2279	41_100851_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100851	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	8	U/mL	Negative
	refr-multi_lat-2280	41_100851_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100851	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	0.33	Index	Negative
	refr-multi_lat-2281	27_100002_200	27_506	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100002	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Assay	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	0.05	S/CO	Negative
	refr-multi_lat-2282	27_100002_200	27_507	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100002	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT HIV Ag/Ab Combo Assay	HIV, HIV 1 and HIV 2 antigens	Chemiluminescent Assay		IgG + IgM	0.24	S/CO	Negative
	refr-multi_lat-2283	27_100003_200	27_506	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100003	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Assay	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	0.46	S/CO	Negative
	refr-multi_lat-2284	27_100008_200	27_506	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100008	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Assay	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	0.07	S/CO	Negative
	refr-multi_lat-2285	27_100012_200	27_506	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100012	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Assay	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	0.06	S/CO	Negative
	refr-multi_lat-2286	27_100012_200	27_507	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100012	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT HIV Ag/Ab Combo Assay	HIV, HIV 1 and HIV 2 antigens	Chemiluminescent Assay		IgG + IgM	0.27	S/CO	Negative
	refr-multi_lat-2287	27_100013_200	27_506	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100013	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Assay	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	0.04	S/CO	Negative
	refr-multi_lat-2288	27_100013_200	27_507	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100013	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT HIV Ag/Ab Combo Assay	HIV, HIV 1 and HIV 2 antigens	Chemiluminescent Assay		IgG + IgM	0.14	S/CO	Negative
	refr-multi_lat-2289	27_100017_200	27_506	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100017	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Assay	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	0.08	S/CO	Negative
	refr-multi_lat-2290	27_100017_200	27_507	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100017	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT HIV Ag/Ab Combo Assay	HIV, HIV 1 and HIV 2 antigens	Chemiluminescent Assay		IgG + IgM	0.21	S/CO	Negative
	refr-multi_lat-2291	27_100018_200	27_506	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100018	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Assay	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	0.04	S/CO	Negative
	refr-multi_lat-2292	27_100018_200	27_507	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100018	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT HIV Ag/Ab Combo Assay	HIV, HIV 1 and HIV 2 antigens	Chemiluminescent Assay		IgG + IgM	0.26	S/CO	Negative
	refr-multi_lat-2293	27_100020_200	27_506	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100020	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Assay	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	0.05	S/CO	Negative
	refr-multi_lat-2294	27_100020_200	27_507	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100020	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT HIV Ag/Ab Combo Assay	HIV, HIV 1 and HIV 2 antigens	Chemiluminescent Assay		IgG + IgM	0.2	S/CO	Negative
	refr-multi_lat-2295	27_100035_200	27_506	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100035	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Assay	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	0.07	S/CO	Negative
	refr-multi_lat-2296	27_100035_200	27_507	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100035	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT HIV Ag/Ab Combo Assay	HIV, HIV 1 and HIV 2 antigens	Chemiluminescent Assay		IgG + IgM	0.21	S/CO	Negative
	refr-multi_lat-2297	27_100045_100	27_506	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100045	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Assay	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	0.06	S/CO	Negative
	refr-multi_lat-2298	27_100045_100	27_507	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100045	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT HIV Ag/Ab Combo Assay	HIV, HIV 1 and HIV 2 antigens	Chemiluminescent Assay		IgG + IgM	0.24	S/CO	Negative
	refr-multi_lat-2299	27_100046_200	27_506	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100046	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Assay	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	0.04	S/CO	Negative
	refr-multi_lat-2300	27_100046_200	27_507	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100046	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT HIV Ag/Ab Combo Assay	HIV, HIV 1 and HIV 2 antigens	Chemiluminescent Assay		IgG + IgM	0.13	S/CO	Negative
	refr-multi_lat-2301	27_100047_200	27_506	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100047	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Assay	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	0.06	S/CO	Negative
	refr-multi_lat-2302	27_100047_200	27_507	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100047	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT HIV Ag/Ab Combo Assay	HIV, HIV 1 and HIV 2 antigens	Chemiluminescent Assay		IgG + IgM	0.31	S/CO	Negative
	refr-multi_lat-2303	27_100048_200	27_506	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100048	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Assay	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	0.05	S/CO	Negative
	refr-multi_lat-2304	27_100048_200	27_507	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100048	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT HIV Ag/Ab Combo Assay	HIV, HIV 1 and HIV 2 antigens	Chemiluminescent Assay		IgG + IgM	0.36	S/CO	Negative
	refr-multi_lat-2305	27_100051_200	27_506	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100051	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Assay	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	0.04	S/CO	Negative
	refr-multi_lat-2306	27_100051_200	27_507	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100051	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT HIV Ag/Ab Combo Assay	HIV, HIV 1 and HIV 2 antigens	Chemiluminescent Assay		IgG + IgM	0.13	S/CO	Negative
	refr-multi_lat-2307	27_100052_200	27_506	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100052	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Assay	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	0.06	S/CO	Negative
	refr-multi_lat-2308	27_100052_200	27_507	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100052	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT HIV Ag/Ab Combo Assay	HIV, HIV 1 and HIV 2 antigens	Chemiluminescent Assay		IgG + IgM	0.13	S/CO	Negative
	refr-multi_lat-2309	27_100053_200	27_506	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100053	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Assay	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	0.07	S/CO	Negative
	refr-multi_lat-2310	27_100053_200	27_507	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100053	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT HIV Ag/Ab Combo Assay	HIV, HIV 1 and HIV 2 antigens	Chemiluminescent Assay		IgG + IgM	0.47	S/CO	Negative
	refr-multi_lat-2311	27_100093_200	27_506	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100093	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Assay	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	0.06	S/CO	Negative
	refr-multi_lat-2312	27_100093_200	27_507	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100093	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT HIV Ag/Ab Combo Assay	HIV, HIV 1 and HIV 2 antigens	Chemiluminescent Assay		IgG + IgM	0.14	S/CO	Negative
	refr-multi_lat-2313	27_100112_200	27_506	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100112	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Assay	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	0.07	S/CO	Negative
	refr-multi_lat-2314	27_100112_200	27_507	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100112	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT HIV Ag/Ab Combo Assay	HIV, HIV 1 and HIV 2 antigens	Chemiluminescent Assay		IgG + IgM	0.39	S/CO	Negative
	refr-multi_lat-2315	41_100033_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100033	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2316	41_100057_102	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100057	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2317	41_100080_100	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100080	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2318	41_100091_102	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100091	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2319	41_100121_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100121	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2320	41_100126_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100126	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2321	41_100127_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100127	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2322	41_100139_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100139	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2323	41_100145_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100145	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2324	41_100147_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100147	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2325	41_100149_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100149	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2326	41_100150_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100150	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2327	41_100151_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100151	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2328	41_100152_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100152	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2329	41_100154_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100154	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2330	41_100155_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100155	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2331	41_100158_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100158	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2332	41_100164_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100164	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2333	41_100167_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100167	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2334	41_100168_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100168	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2335	41_100169_100	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100169	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2336	41_100170_100	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100170	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2337	41_100171_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100171	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2338	41_100172_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100172	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2339	41_100176_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100176	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2340	41_100178_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100178	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2341	41_100179_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100179	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2342	41_100181_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100181	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2343	41_100184_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100184	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2344	41_100185_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100185	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2345	41_100189_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100189	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2346	41_100190_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100190	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2347	41_100193_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100193	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2348	41_100194_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100194	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2349	41_100195_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100195	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2350	41_100196_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100196	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2351	41_100197_100	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100197	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2352	41_100198_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100198	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2353	41_100202_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100202	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2354	41_100203_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100203	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2355	41_100208_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100208	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2356	41_100209_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100209	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2357	41_100211_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100211	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2358	41_100212_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100212	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2359	41_100214_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100214	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2360	41_100216_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100216	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2361	41_100218_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100218	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2362	41_100222_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100222	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2363	41_100228_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100228	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2364	41_100230_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100230	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2365	41_100239_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100239	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2366	41_100240_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100240	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2367	41_100241_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100241	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2368	41_100242_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100242	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2369	41_100246_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100246	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2370	41_100249_100	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100249	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2371	41_100250_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100250	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2372	41_100253_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100253	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2373	41_100254_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100254	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2374	41_100255_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100255	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2375	41_100257_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100257	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2376	41_100258_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100258	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2377	41_100259_100	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100259	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2378	41_100263_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100263	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2379	41_100264_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100264	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2380	41_100270_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100270	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2381	41_100274_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100274	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2382	41_100276_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100276	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2383	41_100280_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100280	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2384	41_100285_100	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100285	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2385	41_100292_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100292	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2386	41_100295_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100295	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2387	41_100298_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100298	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2388	41_100300_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100300	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2389	41_100307_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100307	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2390	41_100313_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100313	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2391	41_100315_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100315	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2392	41_100320_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100320	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2393	41_100321_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100321	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2394	41_100322_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100322	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2395	41_100323_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100323	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2396	41_100332_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100332	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2397	41_100333_100	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100333	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2398	41_100336_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100336	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2399	41_100337_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100337	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2400	41_100371_100	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100371	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2401	41_100396_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100396	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2402	41_100399_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100399	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2403	41_100409_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100409	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2404	41_100410_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100410	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2405	41_100428_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100428	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2406	41_100430_100	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100430	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2407	41_100431_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100431	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2408	41_100434_100	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100434	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2409	41_100437_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100437	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2410	41_100438_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100438	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2411	41_100439_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100439	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2412	41_100446_100	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100446	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2413	41_100447_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100447	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2414	41_100450_100	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100450	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2415	41_100453_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100453	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2416	41_100457_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100457	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2417	41_100458_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100458	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2418	41_100461_100	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100461	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2419	41_100462_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100462	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2420	41_100466_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100466	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2421	41_100467_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100467	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2422	41_100468_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100468	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2423	41_100469_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100469	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2424	41_100475_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100475	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2425	41_100476_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100476	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2426	41_100478_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100478	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2427	41_100479_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100479	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2428	41_100480_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100480	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2429	41_100485_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100485	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2430	41_100486_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100486	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2431	41_100487_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100487	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2432	41_100488_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100488	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2433	41_100490_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100490	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2434	41_100491_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100491	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2435	41_100492_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100492	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2436	41_100493_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100493	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2437	41_100494_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100494	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2438	41_100495_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100495	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2439	41_100496_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100496	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2440	41_100497_100	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100497	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2441	41_100498_100	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100498	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2442	41_100499_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100499	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2443	41_100500_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100500	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2444	41_100501_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100501	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2445	41_100503_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100503	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2446	41_100505_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100505	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2447	41_100507_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100507	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2448	41_100510_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100510	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2449	41_100511_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100511	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2450	41_100512_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100512	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2451	41_100513_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100513	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2452	41_100514_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100514	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2453	41_100515_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100515	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2454	41_100535_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100535	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2455	41_100540_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100540	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2456	41_100541_100	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100541	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2457	41_100542_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100542	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2458	41_100544_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100544	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2459	41_100546_100	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100546	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2460	41_100547_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100547	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2461	41_100549_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100549	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2462	41_100550_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100550	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2463	41_100552_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100552	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2464	41_100553_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100553	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2465	41_100559_100	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100559	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2466	41_100560_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100560	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2467	41_100561_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100561	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2468	41_100562_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100562	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2469	41_100563_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100563	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2470	41_100564_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100564	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2471	41_100565_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100565	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2472	41_100566_100	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100566	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2473	41_100567_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100567	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2474	41_100568_100	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100568	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2475	41_100569_100	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100569	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2476	41_100571_100	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100571	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2477	41_100572_100	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100572	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2478	41_100574_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100574	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2479	41_100579_100	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100579	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2480	41_100580_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100580	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2481	41_100581_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100581	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2482	41_100582_100	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100582	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2483	41_100583_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100583	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2484	41_100584_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100584	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2485	41_100585_100	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100585	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2486	41_100586_100	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100586	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2487	41_100588_100	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100588	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2488	41_100600_100	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100600	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2489	41_100602_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100602	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2490	41_100603_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100603	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2491	41_100604_100	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100604	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2492	41_100605_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100605	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2493	41_100607_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100607	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2494	41_100609_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100609	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2495	41_100610_100	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100610	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2496	41_100611_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100611	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2497	41_100612_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100612	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2498	41_100617_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100617	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2499	41_100618_100	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100618	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2500	41_100635_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100635	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2501	41_100636_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100636	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2502	41_100637_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100637	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2503	41_100638_100	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100638	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2504	41_100639_100	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100639	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2505	41_100642_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100642	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2506	41_100643_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100643	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2507	41_100644_100	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100644	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2508	41_100645_100	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100645	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2509	41_100656_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100656	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2510	41_100657_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100657	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2511	41_100660_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100660	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2512	41_100662_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100662	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2513	41_100663_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100663	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2514	41_100664_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100664	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2515	41_100672_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100672	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2516	41_100673_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100673	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2517	41_100674_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100674	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2518	41_100681_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100681	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2519	41_100682_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100682	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2520	41_100683_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100683	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2521	41_100690_100	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100690	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2522	41_100693_100	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100693	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2523	41_100694_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100694	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2524	41_100698_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100698	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2525	41_100699_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100699	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2526	41_100711_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100711	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2527	41_100712_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100712	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2528	41_100719_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100719	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2529	41_100721_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100721	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2530	41_100724_100	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100724	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2531	41_100726_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100726	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2532	41_100730_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100730	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2533	41_100737_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100737	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2534	41_100738_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100738	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2535	41_100739_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100739	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2536	41_100740_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100740	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2537	41_100742_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100742	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2538	41_100743_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100743	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2539	41_100744_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100744	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2540	41_100745_100	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100745	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2541	41_100747_100	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100747	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2542	41_100749_100	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100749	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2543	41_100754_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100754	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2544	41_100755_100	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100755	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2545	41_100756_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100756	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2546	41_100757_100	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100757	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2547	41_100770_100	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100770	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2548	41_100771_100	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100771	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2549	41_100773_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100773	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2550	41_100776_100	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100776	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2551	41_100777_100	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100777	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2552	41_100779_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100779	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2553	41_100781_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100781	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2554	41_100782_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100782	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2555	41_100783_100	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100783	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2556	41_100784_100	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100784	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2557	41_100785_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100785	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2558	41_100787_100	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100787	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2559	41_100798_100	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100798	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2560	41_100799_100	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100799	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2561	41_100800_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100800	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2562	41_100801_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100801	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2563	41_100802_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100802	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2564	41_100804_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100804	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2565	41_100805_100	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100805	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2566	41_100806_100	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100806	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2567	41_100808_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100808	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2568	41_100818_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100818	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2569	41_100819_100	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100819	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2570	41_100820_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100820	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2571	41_100821_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100821	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2572	41_100822_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100822	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2573	41_100826_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100826	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2574	41_100827_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100827	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2575	41_100830_100	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100830	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2576	41_100832_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100832	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2577	41_100833_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100833	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2578	41_100834_100	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100834	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2579	41_100836_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100836	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2580	41_100837_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100837	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2581	41_100840_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100840	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2582	41_100841_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100841	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2583	41_100842_100	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100842	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2584	41_100844_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100844	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2585	41_100851_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100851	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Negative
	refr-multi_lat-2586	14_143396_222	14_050	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_143396	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Assay	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG+IgM	Negative	Not Specified	Negative
	refr-multi_lat-2587	14_171658_222	14_050	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_171658	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Assay	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG+IgM	Negative	Not Specified	Negative
	refr-multi_lat-2588	14_186975_222	14_050	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_186975	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Assay	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG+IgM	Negative	Not Specified	Negative
	refr-multi_lat-2589	14_218423_222	14_050	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_218423	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Assay	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG+IgM	Negative	Not Specified	Negative
	refr-multi_lat-2590	14_256634_222	14_050	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_256634	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Assay	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG+IgM	Negative	Not Specified	Negative
	refr-multi_lat-2591	14_261505_222	14_050	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_261505	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Assay	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG+IgM	Negative	Not Specified	Negative
	refr-multi_lat-2592	14_263646_222	14_050	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_263646	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Assay	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG+IgM	Negative	Not Specified	Negative
	refr-multi_lat-2593	14_265479_222	14_050	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_265479	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Assay	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG+IgM	Negative	Not Specified	Negative
	refr-multi_lat-2594	14_285169_222	14_050	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_285169	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Assay	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG+IgM	Negative	Not Specified	Negative
	refr-multi_lat-2595	14_301926_222	14_050	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_301926	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Assay	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG+IgM	Negative	Not Specified	Negative
	refr-multi_lat-2596	14_304492_222	14_050	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_304492	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Assay	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG+IgM	Negative	Not Specified	Negative
	refr-multi_lat-2597	14_306348_222	14_050	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_306348	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Assay	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG+IgM	Negative	Not Specified	Negative
	refr-multi_lat-2598	14_313928_222	14_050	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_313928	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Assay	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG+IgM	Negative	Not Specified	Negative
	refr-multi_lat-2599	14_327086_222	14_050	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_327086	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Assay	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG+IgM	Negative	Not Specified	Negative
	refr-multi_lat-2600	14_334077_222	14_050	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_334077	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Assay	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG+IgM	Negative	Not Specified	Negative
	refr-multi_lat-2601	14_373975_222	14_050	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_373975	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Assay	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG+IgM	Negative	Not Specified	Negative
	refr-multi_lat-2602	14_374212_222	14_050	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_374212	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Assay	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG+IgM	Negative	Not Specified	Negative
	refr-multi_lat-2603	14_384727_222	14_050	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_384727	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Assay	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG+IgM	Negative	Not Specified	Negative
	refr-multi_lat-2604	14_408074_222	14_050	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_408074	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Assay	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG+IgM	Negative	Not Specified	Negative
	refr-multi_lat-2605	14_413507_222	14_050	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_413507	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Assay	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG+IgM	Negative	Not Specified	Negative
	refr-multi_lat-2606	14_420792_222	14_050	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_420792	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Assay	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG+IgM	Negative	Not Specified	Negative
	refr-multi_lat-2607	14_446374_222	14_050	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_446374	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Assay	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG+IgM	Negative	Not Specified	Negative
	refr-multi_lat-2608	14_456907_222	14_050	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_456907	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Assay	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG+IgM	Negative	Not Specified	Negative
	refr-multi_lat-2609	14_491696_222	14_050	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_491696	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Assay	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG+IgM	Negative	Not Specified	Negative
	refr-multi_lat-2610	14_493466_222	14_050	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_493466	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Assay	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG+IgM	Negative	Not Specified	Negative
	refr-multi_lat-2611	14_495208_222	14_050	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_495208	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Assay	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG+IgM	Negative	Not Specified	Negative
	refr-multi_lat-2612	14_500745_222	14_050	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_500745	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Assay	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG+IgM	Negative	Not Specified	Negative
	refr-multi_lat-2613	14_568176_222	14_050	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_568176	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Assay	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG+IgM	Negative	Not Specified	Negative
	refr-multi_lat-2614	14_569615_222	14_050	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_569615	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Assay	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG+IgM	Negative	Not Specified	Negative
	refr-multi_lat-2615	14_571359_222	14_050	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_571359	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Assay	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG+IgM	Negative	Not Specified	Negative
	refr-multi_lat-2616	14_607014_222	14_050	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_607014	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Assay	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG+IgM	Negative	Not Specified	Negative
	refr-multi_lat-2617	14_681897_222	14_050	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_681897	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Assay	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG+IgM	Negative	Not Specified	Negative
	refr-multi_lat-2618	14_713146_222	14_050	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_713146	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Assay	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG+IgM	Negative	Not Specified	Negative
	refr-multi_lat-2619	14_753466_222	14_050	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_753466	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Assay	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG+IgM	Negative	Not Specified	Negative
	refr-multi_lat-2620	14_758241_222	14_050	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_758241	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Assay	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG+IgM	Negative	Not Specified	Negative
	refr-multi_lat-2621	14_779347_222	14_050	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_779347	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Assay	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG+IgM	Negative	Not Specified	Negative
	refr-multi_lat-2622	14_809758_222	14_050	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_809758	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Assay	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG+IgM	Negative	Not Specified	Negative
	refr-multi_lat-2623	14_820803_222	14_050	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_820803	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Assay	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG+IgM	Negative	Not Specified	Negative
	refr-multi_lat-2624	14_875077_222	14_050	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_875077	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Assay	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG+IgM	Negative	Not Specified	Negative
	refr-multi_lat-2625	14_910475_222	14_050	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_910475	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Assay	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG+IgM	Negative	Not Specified	Negative
	refr-multi_lat-2626	14_991643_222	14_050	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_991643	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Assay	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG+IgM	Negative	Not Specified	Negative
	refr-multi_lat-2627	14_994521_222	14_050	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_994521	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Assay	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG+IgM	Negative	Not Specified	Negative
	refr-multi_lat-2628	14_107588_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_107588	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	2.131	COI450	Positive
	refr-multi_lat-2629	14_108656_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_108656	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	1.451	COI450	Positive
	refr-multi_lat-2630	14_108656_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_108656	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	1.6	S/CO	Positive
	refr-multi_lat-2631	14_115671_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_115671	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	2.267	COI450	Positive
	refr-multi_lat-2632	14_115671_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_115671	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	2.02	S/CO	Positive
	refr-multi_lat-2633	14_120858_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_120858	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	2.805	COI450	Positive
	refr-multi_lat-2634	14_120858_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_120858	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	1.47	S/CO	Positive
	refr-multi_lat-2635	14_122173_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_122173	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	1.21	COI450	Positive
	refr-multi_lat-2636	14_123753_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_123753	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	3.199	COI450	Positive
	refr-multi_lat-2637	14_127552_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_127552	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	3.571	COI450	Positive
	refr-multi_lat-2638	14_136068_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_136068	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	1.165	COI450	Positive
	refr-multi_lat-2639	14_136068_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_136068	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	2.8	S/CO	Positive
	refr-multi_lat-2640	14_143396_222	14_080	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_143396	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen , p18	Chemiluminescent Assay		IgG	147	U/mL	Positive
	refr-multi_lat-2641	14_148341_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_148341	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	3.056	COI450	Positive
	refr-multi_lat-2642	14_160668_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_160668	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	3.834	COI450	Positive
	refr-multi_lat-2643	14_166589_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_166589	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	2.695	COI450	Positive
	refr-multi_lat-2644	14_171658_222	14_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_171658	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	5.9	U/mL	Positive
	refr-multi_lat-2645	14_171658_222	14_080	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_171658	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen , p18	Chemiluminescent Assay		IgG	181	U/mL	Positive
	refr-multi_lat-2646	14_175078_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_175078	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	1.442	COI450	Positive
	refr-multi_lat-2647	14_177005_222	14_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_177005	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	7.2	U/mL	Positive
	refr-multi_lat-2648	14_177005_222	14_080	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_177005	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen , p18	Chemiluminescent Assay		IgG	158	U/mL	Positive
	refr-multi_lat-2649	14_177005_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_177005	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2650	14_177005_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_177005	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2651	14_177005_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_177005	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2652	14_177005_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_177005	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2653	14_183745_222	14_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_183745	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	2.6	U/mL	Positive
	refr-multi_lat-2654	14_183745_222	14_080	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_183745	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen , p18	Chemiluminescent Assay		IgG	330	U/mL	Positive
	refr-multi_lat-2655	14_183745_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_183745	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2656	14_183745_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_183745	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2657	14_183745_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_183745	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2658	14_183745_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_183745	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2659	14_185965_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_185965	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	2.129	COI450	Positive
	refr-multi_lat-2660	14_186975_222	14_080	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_186975	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen , p18	Chemiluminescent Assay		IgG	600	U/mL	Positive
	refr-multi_lat-2661	14_188155_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_188155	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	2.571	COI450	Positive
	refr-multi_lat-2662	14_194396_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_194396	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	1.088	COI450	Positive
	refr-multi_lat-2663	14_208286_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_208286	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	1.142	COI450	Positive
	refr-multi_lat-2664	14_212153_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_212153	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	1.405	COI450	Positive
	refr-multi_lat-2665	14_213236_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_213236	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	2.42	COI450	Positive
	refr-multi_lat-2666	14_213236_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_213236	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	1.26	S/CO	Positive
	refr-multi_lat-2667	14_217514_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_217514	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	4.268	COI450	Positive
	refr-multi_lat-2668	14_217514_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_217514	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	1.24	S/CO	Positive
	refr-multi_lat-2669	14_218423_222	14_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_218423	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	8.8	U/mL	Positive
	refr-multi_lat-2670	14_218423_222	14_080	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_218423	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen , p18	Chemiluminescent Assay		IgG	47.9	U/mL	Positive
	refr-multi_lat-2671	14_225211_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_225211	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	2.801	COI450	Positive
	refr-multi_lat-2672	14_239836_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_239836	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	3.233	COI450	Positive
	refr-multi_lat-2673	14_241807_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_241807	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	3.31	COI450	Positive
	refr-multi_lat-2674	14_249066_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_249066	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	5.748	COI450	Positive
	refr-multi_lat-2675	14_254215_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_254215	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	1.82	COI450	Positive
	refr-multi_lat-2676	14_256634_222	14_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_256634	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	2.8	U/mL	Positive
	refr-multi_lat-2677	14_256634_222	14_080	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_256634	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen , p18	Chemiluminescent Assay		IgG	470	U/mL	Positive
	refr-multi_lat-2678	14_256634_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_256634	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2679	14_256634_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_256634	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2680	14_256634_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_256634	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2681	14_256634_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_256634	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2682	14_259046_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_259046	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	2.841	COI450	Positive
	refr-multi_lat-2683	14_259046_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_259046	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	6.8	S/CO	Positive
	refr-multi_lat-2684	14_261505_222	14_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_261505	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	8.6	U/mL	Positive
	refr-multi_lat-2685	14_261505_222	14_080	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_261505	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen , p18	Chemiluminescent Assay		IgG	186	U/mL	Positive
	refr-multi_lat-2686	14_263646_222	14_080	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_263646	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen , p18	Chemiluminescent Assay		IgG	322	U/mL	Positive
	refr-multi_lat-2687	14_263646_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_263646	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2688	14_263646_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_263646	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2689	14_263646_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_263646	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2690	14_263646_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_263646	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2691	14_265479_222	14_080	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_265479	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen , p18	Chemiluminescent Assay		IgG	500	U/mL	Positive
	refr-multi_lat-2692	14_265479_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_265479	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2693	14_265479_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_265479	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2694	14_265479_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_265479	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2695	14_265479_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_265479	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2696	14_269103_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_269103	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	1.116	COI450	Positive
	refr-multi_lat-2697	14_270178_222	14_080	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_270178	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen , p18	Chemiluminescent Assay		IgG	362	U/mL	Positive
	refr-multi_lat-2698	14_270178_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_270178	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2699	14_270178_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_270178	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2700	14_270178_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_270178	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2701	14_270178_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_270178	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2702	14_278647_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_278647	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	2.017	COI450	Positive
	refr-multi_lat-2703	14_285169_222	14_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_285169	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	2.7	U/mL	Positive
	refr-multi_lat-2704	14_285169_222	14_080	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_285169	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen , p18	Chemiluminescent Assay		IgG	494	U/mL	Positive
	refr-multi_lat-2705	14_286779_222	14_080	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_286779	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen , p18	Chemiluminescent Assay		IgG	600	U/mL	Positive
	refr-multi_lat-2706	14_286779_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_286779	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2707	14_286779_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_286779	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2708	14_286779_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_286779	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2709	14_286779_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_286779	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2710	14_287186_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_287186	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	2.49	COI450	Positive
	refr-multi_lat-2711	14_301926_222	14_080	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_301926	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen , p18	Chemiluminescent Assay		IgG	600	U/mL	Positive
	refr-multi_lat-2712	14_304474_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_304474	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	2.052	COI450	Positive
	refr-multi_lat-2713	14_304492_222	14_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_304492	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	9.4	U/mL	Positive
	refr-multi_lat-2714	14_304492_222	14_080	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_304492	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen , p18	Chemiluminescent Assay		IgG	600	U/mL	Positive
	refr-multi_lat-2715	14_304492_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_304492	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2716	14_304492_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_304492	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2717	14_304492_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_304492	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2718	14_304492_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_304492	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2719	14_306348_222	14_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_306348	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	6.5	U/mL	Positive
	refr-multi_lat-2720	14_306348_222	14_080	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_306348	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen , p18	Chemiluminescent Assay		IgG	378	U/mL	Positive
	refr-multi_lat-2721	14_306348_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_306348	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2722	14_306348_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_306348	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2723	14_306348_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_306348	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2724	14_306348_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_306348	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2725	14_311544_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_311544	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	5.503	COI450	Positive
	refr-multi_lat-2726	14_311544_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_311544	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	2.12	S/CO	Positive
	refr-multi_lat-2727	14_313928_222	14_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_313928	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	5.7	U/mL	Positive
	refr-multi_lat-2728	14_313928_222	14_080	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_313928	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen , p18	Chemiluminescent Assay		IgG	600	U/mL	Positive
	refr-multi_lat-2729	14_322676_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_322676	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	1.25	COI450	Positive
	refr-multi_lat-2730	14_324493_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_324493	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	3.03	COI450	Positive
	refr-multi_lat-2731	14_327086_222	14_080	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_327086	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen , p18	Chemiluminescent Assay		IgG	172	U/mL	Positive
	refr-multi_lat-2732	14_334077_222	14_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_334077	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	1.5	U/mL	Positive
	refr-multi_lat-2733	14_334077_222	14_080	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_334077	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen , p18	Chemiluminescent Assay		IgG	286	U/mL	Positive
	refr-multi_lat-2734	14_339154_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_339154	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	1.156	COI450	Positive
	refr-multi_lat-2735	14_339339_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_339339	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	0.878	COI450	Positive
	refr-multi_lat-2736	14_339739_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_339739	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	3.833	COI450	Positive
	refr-multi_lat-2737	14_348651_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_348651	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	2.624	COI450	Positive
	refr-multi_lat-2738	14_348651_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_348651	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	1.13	S/CO	Positive
	refr-multi_lat-2739	14_361741_222	14_080	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_361741	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen , p18	Chemiluminescent Assay		IgG	600	U/mL	Positive
	refr-multi_lat-2740	14_361741_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_361741	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2741	14_361741_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_361741	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2742	14_361741_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_361741	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2743	14_362791_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_362791	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	0.784	COI450	Positive
	refr-multi_lat-2744	14_362791_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_362791	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	2.85	S/CO	Positive
	refr-multi_lat-2745	14_367355_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_367355	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	4.148	COI450	Positive
	refr-multi_lat-2746	14_368073_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_368073	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	5.312	COI450	Positive
	refr-multi_lat-2747	14_368073_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_368073	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	1.31	S/CO	Positive
	refr-multi_lat-2748	14_373975_222	14_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_373975	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	10	U/mL	Positive
	refr-multi_lat-2749	14_373975_222	14_080	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_373975	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen , p18	Chemiluminescent Assay		IgG	119	U/mL	Positive
	refr-multi_lat-2750	14_373975_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_373975	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2751	14_373975_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_373975	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2752	14_373975_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_373975	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2753	14_373975_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_373975	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2754	14_374212_222	14_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_374212	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	1.3	U/mL	Positive
	refr-multi_lat-2755	14_374212_222	14_080	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_374212	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen , p18	Chemiluminescent Assay		IgG	600	U/mL	Positive
	refr-multi_lat-2756	14_379363_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_379363	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	2.078	COI450	Positive
	refr-multi_lat-2757	14_382861_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_382861	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	2.97	COI450	Positive
	refr-multi_lat-2758	14_382861_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_382861	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	1.39	S/CO	Positive
	refr-multi_lat-2759	14_384727_222	14_080	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_384727	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen , p18	Chemiluminescent Assay		IgG	600	U/mL	Positive
	refr-multi_lat-2760	14_384727_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_384727	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2761	14_384727_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_384727	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2762	14_384727_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_384727	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2763	14_384727_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_384727	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2764	14_385063_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_385063	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	0.909	COI450	Positive
	refr-multi_lat-2765	14_391735_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_391735	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	1.96	COI450	Positive
	refr-multi_lat-2766	14_392122_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_392122	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2767	14_392122_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_392122	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2768	14_392122_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_392122	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2769	14_392122_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_392122	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2770	14_399432_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_399432	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	1.251	COI450	Positive
	refr-multi_lat-2771	14_403358_222	14_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_403358	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	1.8	U/mL	Positive
	refr-multi_lat-2772	14_403358_222	14_080	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_403358	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen , p18	Chemiluminescent Assay		IgG	600	U/mL	Positive
	refr-multi_lat-2773	14_403358_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_403358	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2774	14_403358_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_403358	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2775	14_403358_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_403358	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2776	14_403358_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_403358	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2777	14_404768_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_404768	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	3.619	COI450	Positive
	refr-multi_lat-2778	14_408074_222	14_080	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_408074	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen , p18	Chemiluminescent Assay		IgG	104	U/mL	Positive
	refr-multi_lat-2779	14_409279_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_409279	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	3.253	COI450	Positive
	refr-multi_lat-2780	14_409279_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_409279	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	1.39	S/CO	Positive
	refr-multi_lat-2781	14_410477_222	14_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_410477	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	10	U/mL	Positive
	refr-multi_lat-2782	14_410477_222	14_080	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_410477	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen , p18	Chemiluminescent Assay		IgG	600	U/mL	Positive
	refr-multi_lat-2783	14_410477_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_410477	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2784	14_410477_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_410477	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2785	14_410477_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_410477	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2786	14_410477_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_410477	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2787	14_412766_222	14_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_412766	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	10	U/mL	Positive
	refr-multi_lat-2788	14_412766_222	14_080	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_412766	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen , p18	Chemiluminescent Assay		IgG	49	U/mL	Positive
	refr-multi_lat-2789	14_412766_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_412766	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2790	14_412766_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_412766	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2791	14_412766_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_412766	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2792	14_412766_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_412766	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2793	14_413507_222	14_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_413507	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	2.5	U/mL	Positive
	refr-multi_lat-2794	14_413507_222	14_080	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_413507	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen , p18	Chemiluminescent Assay		IgG	174	U/mL	Positive
	refr-multi_lat-2795	14_413507_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_413507	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2796	14_413507_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_413507	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2797	14_413507_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_413507	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2798	14_413507_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_413507	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2799	14_420792_222	14_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_420792	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	4.3	U/mL	Positive
	refr-multi_lat-2800	14_420792_222	14_080	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_420792	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen , p18	Chemiluminescent Assay		IgG	167	U/mL	Positive
	refr-multi_lat-2801	14_420792_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_420792	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2802	14_420792_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_420792	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2803	14_420792_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_420792	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2804	14_420792_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_420792	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2805	14_427801_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_427801	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	1.554	COI450	Positive
	refr-multi_lat-2806	14_427801_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_427801	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	6.63	S/CO	Positive
	refr-multi_lat-2807	14_428897_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_428897	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	1.63	COI450	Positive
	refr-multi_lat-2808	14_428897_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_428897	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	13.98	S/CO	Positive
	refr-multi_lat-2809	14_429588_222	14_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_429588	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	7.2	U/mL	Positive
	refr-multi_lat-2810	14_429588_222	14_080	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_429588	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen , p18	Chemiluminescent Assay		IgG	117	U/mL	Positive
	refr-multi_lat-2811	14_429588_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_429588	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2812	14_429588_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_429588	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2813	14_429588_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_429588	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2814	14_429588_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_429588	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2815	14_437688_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_437688	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	1.816	COI450	Positive
	refr-multi_lat-2816	14_439218_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_439218	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	2.956	COI450	Positive
	refr-multi_lat-2817	14_439218_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_439218	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	4.13	S/CO	Positive
	refr-multi_lat-2818	14_444128_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_444128	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	1.533	COI450	Positive
	refr-multi_lat-2819	14_444128_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_444128	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	1.11	S/CO	Positive
	refr-multi_lat-2820	14_446374_222	14_080	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_446374	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen , p18	Chemiluminescent Assay		IgG	600	U/mL	Positive
	refr-multi_lat-2821	14_453592_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_453592	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	1.923	COI450	Positive
	refr-multi_lat-2822	14_453592_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_453592	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	1.29	S/CO	Positive
	refr-multi_lat-2823	14_456907_222	14_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_456907	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	2.7	U/mL	Positive
	refr-multi_lat-2824	14_456907_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_456907	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2825	14_456907_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_456907	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2826	14_456907_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_456907	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2827	14_456907_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_456907	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2828	14_464837_222	14_080	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_464837	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen , p18	Chemiluminescent Assay		IgG	600	U/mL	Positive
	refr-multi_lat-2829	14_464837_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_464837	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2830	14_464837_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_464837	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2831	14_464837_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_464837	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2832	14_464837_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_464837	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2833	14_471327_222	14_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_471327	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	4.5	U/mL	Positive
	refr-multi_lat-2834	14_471327_222	14_080	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_471327	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen , p18	Chemiluminescent Assay		IgG	159	U/mL	Positive
	refr-multi_lat-2835	14_471327_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_471327	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2836	14_471327_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_471327	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2837	14_471327_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_471327	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2838	14_471327_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_471327	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2839	14_482383_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_482383	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	2.348	COI450	Positive
	refr-multi_lat-2840	14_483903_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_483903	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	2.411	COI450	Positive
	refr-multi_lat-2841	14_491531_222	14_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_491531	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	1.7	U/mL	Positive
	refr-multi_lat-2842	14_491531_222	14_080	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_491531	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen , p18	Chemiluminescent Assay		IgG	600	U/mL	Positive
	refr-multi_lat-2843	14_491531_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_491531	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2844	14_491531_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_491531	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2845	14_491531_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_491531	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2846	14_491531_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_491531	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2847	14_491696_222	14_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_491696	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	3.4	U/mL	Positive
	refr-multi_lat-2848	14_491696_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_491696	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2849	14_491696_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_491696	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2850	14_491696_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_491696	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2851	14_491696_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_491696	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2852	14_493466_222	14_080	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_493466	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen , p18	Chemiluminescent Assay		IgG	600	U/mL	Positive
	refr-multi_lat-2853	14_495208_222	14_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_495208	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	10	U/mL	Positive
	refr-multi_lat-2854	14_495208_222	14_080	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_495208	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen , p18	Chemiluminescent Assay		IgG	30.8	U/mL	Positive
	refr-multi_lat-2855	14_499594_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_499594	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	3.407	COI450	Positive
	refr-multi_lat-2856	14_500745_222	14_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_500745	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	10	U/mL	Positive
	refr-multi_lat-2857	14_500745_222	14_080	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_500745	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen , p18	Chemiluminescent Assay		IgG	600	U/mL	Positive
	refr-multi_lat-2858	14_507701_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_507701	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	3.245	COI450	Positive
	refr-multi_lat-2859	14_507701_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_507701	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	1.37	S/CO	Positive
	refr-multi_lat-2860	14_512561_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_512561	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	3.674	COI450	Positive
	refr-multi_lat-2861	14_513053_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_513053	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	2.75	COI450	Positive
	refr-multi_lat-2862	14_528185_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_528185	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	2.757	COI450	Positive
	refr-multi_lat-2863	14_529422_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_529422	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	2.858	COI450	Positive
	refr-multi_lat-2864	14_533782_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_533782	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	1.504	COI450	Positive
	refr-multi_lat-2865	14_536104_222	14_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_536104	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	10	U/mL	Positive
	refr-multi_lat-2866	14_536104_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_536104	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2867	14_536104_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_536104	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2868	14_536104_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_536104	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2869	14_536104_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_536104	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2870	14_541069_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_541069	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	0.829	COI450	Positive
	refr-multi_lat-2871	14_541069_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_541069	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	2.24	S/CO	Positive
	refr-multi_lat-2872	14_562035_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_562035	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	4.543	COI450	Positive
	refr-multi_lat-2873	14_562891_222	14_080	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_562891	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen , p18	Chemiluminescent Assay		IgG	200	U/mL	Positive
	refr-multi_lat-2874	14_562891_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_562891	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2875	14_562891_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_562891	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2876	14_562891_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_562891	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2877	14_562891_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_562891	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2878	14_563092_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_563092	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	2.339	COI450	Positive
	refr-multi_lat-2879	14_568176_222	14_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_568176	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	4.4	U/mL	Positive
	refr-multi_lat-2880	14_568176_222	14_080	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_568176	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen , p18	Chemiluminescent Assay		IgG	600	U/mL	Positive
	refr-multi_lat-2881	14_569615_222	14_080	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_569615	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen , p18	Chemiluminescent Assay		IgG	30.4	U/mL	Positive
	refr-multi_lat-2882	14_571359_222	14_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_571359	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	1.1	U/mL	Positive
	refr-multi_lat-2883	14_571359_222	14_080	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_571359	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen , p18	Chemiluminescent Assay		IgG	152	U/mL	Positive
	refr-multi_lat-2884	14_573413_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_573413	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	2.932	COI450	Positive
	refr-multi_lat-2885	14_582321_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_582321	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	1.453	COI450	Positive
	refr-multi_lat-2886	14_587174_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_587174	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	2.011	COI450	Positive
	refr-multi_lat-2887	14_587174_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_587174	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	1.07	S/CO	Positive
	refr-multi_lat-2888	14_588864_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_588864	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	1.408	COI450	Positive
	refr-multi_lat-2889	14_591664_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_591664	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	0.8	COI450	Positive
	refr-multi_lat-2890	14_594272_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_594272	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	1.94	COI450	Positive
	refr-multi_lat-2891	14_597395_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_597395	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	2.758	COI450	Positive
	refr-multi_lat-2892	14_603328_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_603328	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	4.627	COI450	Positive
	refr-multi_lat-2893	14_603328_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_603328	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	14.75	S/CO	Positive
	refr-multi_lat-2894	14_607014_222	14_080	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_607014	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen , p18	Chemiluminescent Assay		IgG	600	U/mL	Positive
	refr-multi_lat-2895	14_616772_222	14_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_616772	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	1.1	U/mL	Positive
	refr-multi_lat-2896	14_616772_222	14_080	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_616772	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen , p18	Chemiluminescent Assay		IgG	216	U/mL	Positive
	refr-multi_lat-2897	14_616772_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_616772	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2898	14_616772_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_616772	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2899	14_616772_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_616772	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2900	14_616772_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_616772	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2901	14_620328_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_620328	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	1.574	COI450	Positive
	refr-multi_lat-2902	14_628758_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_628758	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	3.832	COI450	Positive
	refr-multi_lat-2903	14_629929_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_629929	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	1.029	COI450	Positive
	refr-multi_lat-2904	14_629929_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_629929	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	1.91	S/CO	Positive
	refr-multi_lat-2905	14_636569_222	14_080	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_636569	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen , p18	Chemiluminescent Assay		IgG	478	U/mL	Positive
	refr-multi_lat-2906	14_636569_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_636569	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2907	14_636569_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_636569	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2908	14_636569_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_636569	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2909	14_636569_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_636569	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2910	14_639229_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_639229	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	2.549	COI450	Positive
	refr-multi_lat-2911	14_639229_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_639229	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	1.32	S/CO	Positive
	refr-multi_lat-2912	14_639824_222	14_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_639824	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.75	U/mL	Positive
	refr-multi_lat-2913	14_639824_222	14_080	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_639824	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen , p18	Chemiluminescent Assay		IgG	311	U/mL	Positive
	refr-multi_lat-2914	14_639824_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_639824	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2915	14_639824_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_639824	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2916	14_639824_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_639824	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2917	14_639824_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_639824	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2918	14_647441_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_647441	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	2.294	COI450	Positive
	refr-multi_lat-2919	14_647441_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_647441	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	1.63	S/CO	Positive
	refr-multi_lat-2920	14_649515_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_649515	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	1.643	COI450	Positive
	refr-multi_lat-2921	14_653364_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_653364	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	3.625	COI450	Positive
	refr-multi_lat-2922	14_654254_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_654254	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	3.25	COI450	Positive
	refr-multi_lat-2923	14_654254_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_654254	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	2.54	S/CO	Positive
	refr-multi_lat-2924	14_658367_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_658367	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	1.493	COI450	Positive
	refr-multi_lat-2925	14_670351_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_670351	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	1.502	COI450	Positive
	refr-multi_lat-2926	14_672894_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_672894	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	0.908	COI450	Positive
	refr-multi_lat-2927	14_675231_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_675231	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	1.194	COI450	Positive
	refr-multi_lat-2928	14_683717_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_683717	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	1.99	COI450	Positive
	refr-multi_lat-2929	14_683717_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_683717	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	1.64	S/CO	Positive
	refr-multi_lat-2930	14_685588_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_685588	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	1.409	COI450	Positive
	refr-multi_lat-2931	14_693608_222	14_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_693608	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	10	U/mL	Positive
	refr-multi_lat-2932	14_693608_222	14_080	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_693608	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen , p18	Chemiluminescent Assay		IgG	242	U/mL	Positive
	refr-multi_lat-2933	14_693608_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_693608	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2934	14_693608_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_693608	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2935	14_693608_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_693608	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2936	14_693608_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_693608	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2937	14_698954_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_698954	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	4.775	COI450	Positive
	refr-multi_lat-2938	14_705478_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_705478	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	3.924	COI450	Positive
	refr-multi_lat-2939	14_705478_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_705478	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	7.61	S/CO	Positive
	refr-multi_lat-2940	14_713146_222	14_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_713146	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	8.7	U/mL	Positive
	refr-multi_lat-2941	14_713146_222	14_080	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_713146	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen , p18	Chemiluminescent Assay		IgG	600	U/mL	Positive
	refr-multi_lat-2942	14_719447_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_719447	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	0.918	COI450	Positive
	refr-multi_lat-2943	14_720781_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_720781	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	2.308	COI450	Positive
	refr-multi_lat-2944	14_722081_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_722081	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	3.505	COI450	Positive
	refr-multi_lat-2945	14_724174_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_724174	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	2.592	COI450	Positive
	refr-multi_lat-2946	14_741906_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_741906	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	2.34	COI450	Positive
	refr-multi_lat-2947	14_743991_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_743991	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	2.3	COI450	Positive
	refr-multi_lat-2948	14_747586_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_747586	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	1.957	COI450	Positive
	refr-multi_lat-2949	14_747586_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_747586	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	2.38	S/CO	Positive
	refr-multi_lat-2950	14_752797_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_752797	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	1.343	COI450	Positive
	refr-multi_lat-2951	14_753466_222	14_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_753466	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	10	U/mL	Positive
	refr-multi_lat-2952	14_753466_222	14_080	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_753466	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen , p18	Chemiluminescent Assay		IgG	600	U/mL	Positive
	refr-multi_lat-2953	14_754797_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_754797	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	1	COI450	Positive
	refr-multi_lat-2954	14_758241_222	14_080	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_758241	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen , p18	Chemiluminescent Assay		IgG	35	U/mL	Positive
	refr-multi_lat-2955	14_758241_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_758241	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2956	14_758241_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_758241	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2957	14_758241_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_758241	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2958	14_758241_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_758241	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2959	14_761696_222	14_080	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_761696	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen , p18	Chemiluminescent Assay		IgG	352	U/mL	Positive
	refr-multi_lat-2960	14_761696_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_761696	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2961	14_761696_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_761696	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2962	14_761696_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_761696	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2963	14_761696_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_761696	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2964	14_776628_222	14_080	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_776628	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen , p18	Chemiluminescent Assay		IgG	600	U/mL	Positive
	refr-multi_lat-2965	14_776628_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_776628	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2966	14_776628_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_776628	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2967	14_776628_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_776628	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2968	14_776628_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_776628	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2969	14_779347_222	14_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_779347	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	6.5	U/mL	Positive
	refr-multi_lat-2970	14_779347_222	14_080	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_779347	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen , p18	Chemiluminescent Assay		IgG	600	U/mL	Positive
	refr-multi_lat-2971	14_795323_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_795323	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	1.226	COI450	Positive
	refr-multi_lat-2972	14_809758_222	14_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_809758	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	1.3	U/mL	Positive
	refr-multi_lat-2973	14_809758_222	14_080	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_809758	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen , p18	Chemiluminescent Assay		IgG	600	U/mL	Positive
	refr-multi_lat-2974	14_811101_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_811101	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	0.869	COI450	Positive
	refr-multi_lat-2975	14_811101_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_811101	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	1.49	S/CO	Positive
	refr-multi_lat-2976	14_820803_222	14_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_820803	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	7.2	U/mL	Positive
	refr-multi_lat-2977	14_820803_222	14_080	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_820803	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen , p18	Chemiluminescent Assay		IgG	115	U/mL	Positive
	refr-multi_lat-2978	14_820803_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_820803	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2979	14_820803_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_820803	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2980	14_820803_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_820803	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2981	14_820803_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_820803	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2982	14_831542_222	14_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_831542	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	10	U/mL	Positive
	refr-multi_lat-2983	14_831542_222	14_080	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_831542	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen , p18	Chemiluminescent Assay		IgG	600	U/mL	Positive
	refr-multi_lat-2984	14_833094_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_833094	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	5.067	COI450	Positive
	refr-multi_lat-2985	14_833094_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_833094	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	1.73	S/CO	Positive
	refr-multi_lat-2986	14_836565_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_836565	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	1.495	COI450	Positive
	refr-multi_lat-2987	14_841836_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_841836	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	3.813	COI450	Positive
	refr-multi_lat-2988	14_845339_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_845339	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	2.869	COI450	Positive
	refr-multi_lat-2989	14_852274_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_852274	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	2.805	COI450	Positive
	refr-multi_lat-2990	14_852274_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_852274	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	1.16	S/CO	Positive
	refr-multi_lat-2991	14_860194_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_860194	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	1.998	COI450	Positive
	refr-multi_lat-2992	14_860194_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_860194	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	3.05	S/CO	Positive
	refr-multi_lat-2993	14_860417_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_860417	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	2.473	COI450	Positive
	refr-multi_lat-2994	14_861721_222	14_080	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_861721	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen , p18	Chemiluminescent Assay		IgG	600	U/mL	Positive
	refr-multi_lat-2995	14_861721_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_861721	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2996	14_861721_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_861721	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2997	14_861721_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_861721	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2998	14_861721_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_861721	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-2999	14_873075_222	14_080	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_873075	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen , p18	Chemiluminescent Assay		IgG	277	U/mL	Positive
	refr-multi_lat-3000	14_873075_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_873075	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-3001	14_873075_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_873075	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-3002	14_873075_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_873075	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-3003	14_873075_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_873075	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-3004	14_873517_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_873517	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	2.621	COI450	Positive
	refr-multi_lat-3005	14_873517_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_873517	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	1.52	S/CO	Positive
	refr-multi_lat-3006	14_875077_222	14_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_875077	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	2	U/mL	Positive
	refr-multi_lat-3007	14_875077_222	14_080	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_875077	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen , p18	Chemiluminescent Assay		IgG	600	U/mL	Positive
	refr-multi_lat-3008	14_881576_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_881576	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	3.272	COI450	Positive
	refr-multi_lat-3009	14_884177_222	14_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_884177	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	10	U/mL	Positive
	refr-multi_lat-3010	14_884177_222	14_080	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_884177	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen , p18	Chemiluminescent Assay		IgG	600	U/mL	Positive
	refr-multi_lat-3011	14_884177_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_884177	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-3012	14_884177_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_884177	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-3013	14_884177_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_884177	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-3014	14_884177_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_884177	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-3015	14_896884_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_896884	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	1	COI450	Positive
	refr-multi_lat-3016	14_900776_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_900776	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	3.09	COI450	Positive
	refr-multi_lat-3017	14_906595_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_906595	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	1.546	COI450	Positive
	refr-multi_lat-3018	14_910475_222	14_080	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_910475	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen , p18	Chemiluminescent Assay		IgG	510	U/mL	Positive
	refr-multi_lat-3019	14_910475_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_910475	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-3020	14_910475_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_910475	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-3021	14_910475_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_910475	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-3022	14_910475_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_910475	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-3023	14_918413_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_918413	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	1.837	COI450	Positive
	refr-multi_lat-3024	14_931124_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_931124	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	3.595	COI450	Positive
	refr-multi_lat-3025	14_931124_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_931124	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	1.6	S/CO	Positive
	refr-multi_lat-3026	14_949379_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_949379	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	2.022	COI450	Positive
	refr-multi_lat-3027	14_949379_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_949379	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	1.9	S/CO	Positive
	refr-multi_lat-3028	14_950845_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_950845	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	4.163	COI450	Positive
	refr-multi_lat-3029	14_950845_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_950845	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	1.12	S/CO	Positive
	refr-multi_lat-3030	14_967972_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_967972	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	1.114	COI450	Positive
	refr-multi_lat-3031	14_973416_222	14_080	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_973416	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen , p18	Chemiluminescent Assay		IgG	600	U/mL	Positive
	refr-multi_lat-3032	14_973416_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_973416	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-3033	14_973416_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_973416	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-3034	14_973416_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_973416	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-3035	14_973416_222	14_090	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_973416	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	NA	Not Specified	Positive
	refr-multi_lat-3036	14_974137_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_974137	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	1.476	COI450	Positive
	refr-multi_lat-3037	14_981447_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_981447	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	3.917	COI450	Positive
	refr-multi_lat-3038	14_988602_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_988602	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	2.276	COI450	Positive
	refr-multi_lat-3039	14_988602_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_988602	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	3.55	S/CO	Positive
	refr-multi_lat-3040	14_991643_222	14_080	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_991643	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen , p18	Chemiluminescent Assay		IgG	131	U/mL	Positive
	refr-multi_lat-3041	14_994521_222	14_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_994521	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	5.6	U/mL	Positive
	refr-multi_lat-3042	14_994521_222	14_080	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_994521	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen , p18	Chemiluminescent Assay		IgG	85.3	U/mL	Positive
	refr-multi_lat-3043	14_994827_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_994827	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	3.773	COI450	Positive
	refr-multi_lat-3044	14_999724_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_999724	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	1.356	COI450	Positive
	refr-multi_lat-3045	14_999724_222	14_020	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_999724	SeroNet_Reference_Study_visit-01									Abbott Alinity m SARS-CoV-2 Assay	SARS-CoV-2 Virus, Spike	Chemiluminescent Assay		IgM	4.1	S/CO	Positive
	refr-multi_lat-3046	27_100002_200	27_505	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100002	SeroNet_Reference_Study_visit-01									BioPlex 2200 EBV IgG Assay	Epstein-Barr Virus, Viral Capsid Antigen 	Multiplex Immunoassay		IgG	8	AI	Positive
	refr-multi_lat-3047	27_100002_200	27_511	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100002	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	1.2	OD	Positive
	refr-multi_lat-3048	27_100002_200	27_511	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100002	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	2.4	OD	Positive
	refr-multi_lat-3049	27_100002_200	27_511	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100002	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	2.5	OD	Positive
	refr-multi_lat-3050	27_100003_200	27_504	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100003	SeroNet_Reference_Study_visit-01									BioPlex 2200 ToRC IgM Kit	Cytomegalovirus, CMV antigens	Multiplex Immunoassay		IgG	8	AI	Positive
	refr-multi_lat-3051	27_100003_200	27_505	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100003	SeroNet_Reference_Study_visit-01									BioPlex 2200 EBV IgG Assay	Epstein-Barr Virus, Viral Capsid Antigen 	Multiplex Immunoassay		IgG	8	AI	Positive
	refr-multi_lat-3052	27_100003_200	27_511	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100003	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	1.2	OD	Positive
	refr-multi_lat-3053	27_100003_200	27_511	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100003	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	1.9	OD	Positive
	refr-multi_lat-3054	27_100003_200	27_511	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100003	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	1.8	OD	Positive
	refr-multi_lat-3055	27_100004_200	27_501	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100004	SeroNet_Reference_Study_visit-01									Elecsys Anti-SARS-CoV-2 S Immunoassay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		Total	250	U/mL	Positive
	refr-multi_lat-3056	27_100004_200	27_502	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100004	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgG Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgG	6400	titer	Positive
	refr-multi_lat-3057	27_100005_200	27_501	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100005	SeroNet_Reference_Study_visit-01									Elecsys Anti-SARS-CoV-2 S Immunoassay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		Total	16.15	U/mL	Positive
	refr-multi_lat-3058	27_100005_200	27_502	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100005	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgG Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgG	800	titer	Positive
	refr-multi_lat-3059	27_100006_200	27_501	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100006	SeroNet_Reference_Study_visit-01									Elecsys Anti-SARS-CoV-2 S Immunoassay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		Total	250	U/mL	Positive
	refr-multi_lat-3060	27_100006_200	27_502	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100006	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgG Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgG	6400	titer	Positive
	refr-multi_lat-3061	27_100006_200	27_503	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100006	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgM Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgM	200	titer	Positive
	refr-multi_lat-3062	27_100007_200	27_501	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100007	SeroNet_Reference_Study_visit-01									Elecsys Anti-SARS-CoV-2 S Immunoassay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		Total	62.39	U/mL	Positive
	refr-multi_lat-3063	27_100007_200	27_502	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100007	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgG Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgG	800	titer	Positive
	refr-multi_lat-3064	27_100008_200	27_504	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100008	SeroNet_Reference_Study_visit-01									BioPlex 2200 ToRC IgM Kit	Cytomegalovirus, CMV antigens	Multiplex Immunoassay		IgG	8	AI	Positive
	refr-multi_lat-3065	27_100008_200	27_505	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100008	SeroNet_Reference_Study_visit-01									BioPlex 2200 EBV IgG Assay	Epstein-Barr Virus, Viral Capsid Antigen 	Multiplex Immunoassay		IgG	7.1	AI	Positive
	refr-multi_lat-3066	27_100008_200	27_511	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100008	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	0.6	OD	Positive
	refr-multi_lat-3067	27_100008_200	27_511	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100008	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	1.7	OD	Positive
	refr-multi_lat-3068	27_100008_200	27_511	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100008	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	1	OD	Positive
	refr-multi_lat-3069	27_100009_200	27_501	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100009	SeroNet_Reference_Study_visit-01									Elecsys Anti-SARS-CoV-2 S Immunoassay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		Total	17.65	U/mL	Positive
	refr-multi_lat-3070	27_100009_200	27_502	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100009	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgG Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgG	800	titer	Positive
	refr-multi_lat-3071	27_100010_200	27_501	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100010	SeroNet_Reference_Study_visit-01									Elecsys Anti-SARS-CoV-2 S Immunoassay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		Total	250	U/mL	Positive
	refr-multi_lat-3072	27_100010_200	27_502	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100010	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgG Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgG	3200	titer	Positive
	refr-multi_lat-3073	27_100011_200	27_501	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100011	SeroNet_Reference_Study_visit-01									Elecsys Anti-SARS-CoV-2 S Immunoassay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		Total	50.08	U/mL	Positive
	refr-multi_lat-3074	27_100011_200	27_502	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100011	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgG Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgG	1600	titer	Positive
	refr-multi_lat-3075	27_100011_200	27_503	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100011	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgM Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgM	400	titer	Positive
	refr-multi_lat-3076	27_100012_200	27_504	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100012	SeroNet_Reference_Study_visit-01									BioPlex 2200 ToRC IgM Kit	Cytomegalovirus, CMV antigens	Multiplex Immunoassay		IgG	6.9	AI	Positive
	refr-multi_lat-3077	27_100012_200	27_505	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100012	SeroNet_Reference_Study_visit-01									BioPlex 2200 EBV IgG Assay	Epstein-Barr Virus, Viral Capsid Antigen 	Multiplex Immunoassay		IgG	8	AI	Positive
	refr-multi_lat-3078	27_100012_200	27_511	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100012	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	0.6	OD	Positive
	refr-multi_lat-3079	27_100012_200	27_511	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100012	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	1.9	OD	Positive
	refr-multi_lat-3080	27_100012_200	27_511	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100012	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	1.5	OD	Positive
	refr-multi_lat-3081	27_100013_200	27_504	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100013	SeroNet_Reference_Study_visit-01									BioPlex 2200 ToRC IgM Kit	Cytomegalovirus, CMV antigens	Multiplex Immunoassay		IgG	8	AI	Positive
	refr-multi_lat-3082	27_100013_200	27_505	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100013	SeroNet_Reference_Study_visit-01									BioPlex 2200 EBV IgG Assay	Epstein-Barr Virus, Viral Capsid Antigen 	Multiplex Immunoassay		IgG	6.9	AI	Positive
	refr-multi_lat-3083	27_100013_200	27_511	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100013	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	1.7	OD	Positive
	refr-multi_lat-3084	27_100013_200	27_511	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100013	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	2.1	OD	Positive
	refr-multi_lat-3085	27_100013_200	27_511	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100013	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	0.9	OD	Positive
	refr-multi_lat-3086	27_100015_200	27_501	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100015	SeroNet_Reference_Study_visit-01									Elecsys Anti-SARS-CoV-2 S Immunoassay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		Total	175.3	U/mL	Positive
	refr-multi_lat-3087	27_100015_200	27_502	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100015	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgG Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgG	800	titer	Positive
	refr-multi_lat-3088	27_100016_200	27_504	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100016	SeroNet_Reference_Study_visit-01									BioPlex 2200 ToRC IgM Kit	Cytomegalovirus, CMV antigens	Multiplex Immunoassay		IgG	6.1	AI	Positive
	refr-multi_lat-3089	27_100016_200	27_505	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100016	SeroNet_Reference_Study_visit-01									BioPlex 2200 EBV IgG Assay	Epstein-Barr Virus, Viral Capsid Antigen 	Multiplex Immunoassay		IgG	4.6	AI	Positive
	refr-multi_lat-3090	27_100016_200	27_511	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100016	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	1.4	OD	Positive
	refr-multi_lat-3091	27_100016_200	27_511	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100016	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	2.2	OD	Positive
	refr-multi_lat-3092	27_100016_200	27_511	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100016	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	1.5	OD	Positive
	refr-multi_lat-3093	27_100017_200	27_505	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100017	SeroNet_Reference_Study_visit-01									BioPlex 2200 EBV IgG Assay	Epstein-Barr Virus, Viral Capsid Antigen 	Multiplex Immunoassay		IgG	6.9	AI	Positive
	refr-multi_lat-3094	27_100017_200	27_511	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100017	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	1.1	OD	Positive
	refr-multi_lat-3095	27_100017_200	27_511	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100017	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	2.2	OD	Positive
	refr-multi_lat-3096	27_100017_200	27_511	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100017	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	1.8	OD	Positive
	refr-multi_lat-3097	27_100018_200	27_504	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100018	SeroNet_Reference_Study_visit-01									BioPlex 2200 ToRC IgM Kit	Cytomegalovirus, CMV antigens	Multiplex Immunoassay		IgG	6.8	AI	Positive
	refr-multi_lat-3098	27_100018_200	27_505	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100018	SeroNet_Reference_Study_visit-01									BioPlex 2200 EBV IgG Assay	Epstein-Barr Virus, Viral Capsid Antigen 	Multiplex Immunoassay		IgG	7.2	AI	Positive
	refr-multi_lat-3099	27_100018_200	27_511	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100018	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	0.5	OD	Positive
	refr-multi_lat-3100	27_100018_200	27_511	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100018	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	1.7	OD	Positive
	refr-multi_lat-3101	27_100018_200	27_511	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100018	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	0.5	OD	Positive
	refr-multi_lat-3102	27_100019_200	27_501	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100019	SeroNet_Reference_Study_visit-01									Elecsys Anti-SARS-CoV-2 S Immunoassay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		Total	250	U/mL	Positive
	refr-multi_lat-3103	27_100019_200	27_502	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100019	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgG Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgG	3200	titer	Positive
	refr-multi_lat-3104	27_100019_200	27_503	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100019	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgM Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgM	200	titer	Positive
	refr-multi_lat-3105	27_100020_200	27_505	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100020	SeroNet_Reference_Study_visit-01									BioPlex 2200 EBV IgG Assay	Epstein-Barr Virus, Viral Capsid Antigen 	Multiplex Immunoassay		IgG	5.9	AI	Positive
	refr-multi_lat-3106	27_100020_200	27_511	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100020	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	1.5	OD	Positive
	refr-multi_lat-3107	27_100020_200	27_511	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100020	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	2	OD	Positive
	refr-multi_lat-3108	27_100020_200	27_511	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100020	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	1.8	OD	Positive
	refr-multi_lat-3109	27_100021_200	27_501	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100021	SeroNet_Reference_Study_visit-01									Elecsys Anti-SARS-CoV-2 S Immunoassay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		Total	33.41	U/mL	Positive
	refr-multi_lat-3110	27_100021_200	27_502	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100021	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgG Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgG	200	titer	Positive
	refr-multi_lat-3111	27_100021_200	27_503	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100021	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgM Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgM	200	titer	Positive
	refr-multi_lat-3112	27_100022_200	27_501	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100022	SeroNet_Reference_Study_visit-01									Elecsys Anti-SARS-CoV-2 S Immunoassay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		Total	250	U/mL	Positive
	refr-multi_lat-3113	27_100022_200	27_502	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100022	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgG Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgG	1600	titer	Positive
	refr-multi_lat-3114	27_100022_200	27_503	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100022	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgM Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgM	400	titer	Positive
	refr-multi_lat-3115	27_100023_200	27_501	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100023	SeroNet_Reference_Study_visit-01									Elecsys Anti-SARS-CoV-2 S Immunoassay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		Total	64.4	U/mL	Positive
	refr-multi_lat-3116	27_100023_200	27_502	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100023	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgG Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgG	800	titer	Positive
	refr-multi_lat-3117	27_100023_200	27_503	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100023	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgM Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgM	400	titer	Positive
	refr-multi_lat-3118	27_100024_200	27_501	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100024	SeroNet_Reference_Study_visit-01									Elecsys Anti-SARS-CoV-2 S Immunoassay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		Total	69	U/mL	Positive
	refr-multi_lat-3119	27_100024_200	27_502	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100024	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgG Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgG	200	titer	Positive
	refr-multi_lat-3120	27_100025_200	27_501	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100025	SeroNet_Reference_Study_visit-01									Elecsys Anti-SARS-CoV-2 S Immunoassay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		Total	159	U/mL	Positive
	refr-multi_lat-3121	27_100025_200	27_502	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100025	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgG Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgG	800	titer	Positive
	refr-multi_lat-3122	27_100025_200	27_503	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100025	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgM Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgM	800	titer	Positive
	refr-multi_lat-3123	27_100026_200	27_501	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100026	SeroNet_Reference_Study_visit-01									Elecsys Anti-SARS-CoV-2 S Immunoassay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		Total	250	U/mL	Positive
	refr-multi_lat-3124	27_100026_200	27_502	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100026	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgG Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgG	800	titer	Positive
	refr-multi_lat-3125	27_100027_200	27_501	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100027	SeroNet_Reference_Study_visit-01									Elecsys Anti-SARS-CoV-2 S Immunoassay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		Total	77.79	U/mL	Positive
	refr-multi_lat-3126	27_100027_200	27_502	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100027	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgG Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgG	6400	titer	Positive
	refr-multi_lat-3127	27_100027_200	27_503	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100027	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgM Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgM	800	titer	Positive
	refr-multi_lat-3128	27_100028_200	27_501	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100028	SeroNet_Reference_Study_visit-01									Elecsys Anti-SARS-CoV-2 S Immunoassay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		Total	250	U/mL	Positive
	refr-multi_lat-3129	27_100028_200	27_502	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100028	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgG Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgG	800	titer	Positive
	refr-multi_lat-3130	27_100029_200	27_501	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100029	SeroNet_Reference_Study_visit-01									Elecsys Anti-SARS-CoV-2 S Immunoassay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		Total	108.2	U/mL	Positive
	refr-multi_lat-3131	27_100029_200	27_502	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100029	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgG Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgG	1600	titer	Positive
	refr-multi_lat-3132	27_100030_200	27_501	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100030	SeroNet_Reference_Study_visit-01									Elecsys Anti-SARS-CoV-2 S Immunoassay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		Total	229	U/mL	Positive
	refr-multi_lat-3133	27_100030_200	27_502	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100030	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgG Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgG	12800	titer	Positive
	refr-multi_lat-3134	27_100030_200	27_503	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100030	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgM Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgM	400	titer	Positive
	refr-multi_lat-3135	27_100031_200	27_501	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100031	SeroNet_Reference_Study_visit-01									Elecsys Anti-SARS-CoV-2 S Immunoassay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		Total	118.4	U/mL	Positive
	refr-multi_lat-3136	27_100031_200	27_502	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100031	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgG Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgG	400	titer	Positive
	refr-multi_lat-3137	27_100032_200	27_501	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100032	SeroNet_Reference_Study_visit-01									Elecsys Anti-SARS-CoV-2 S Immunoassay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		Total	250	U/mL	Positive
	refr-multi_lat-3138	27_100032_200	27_502	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100032	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgG Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgG	1600	titer	Positive
	refr-multi_lat-3139	27_100033_200	27_501	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100033	SeroNet_Reference_Study_visit-01									Elecsys Anti-SARS-CoV-2 S Immunoassay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		Total	114.3	U/mL	Positive
	refr-multi_lat-3140	27_100033_200	27_502	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100033	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgG Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgG	400	titer	Positive
	refr-multi_lat-3141	27_100034_200	27_501	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100034	SeroNet_Reference_Study_visit-01									Elecsys Anti-SARS-CoV-2 S Immunoassay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		Total	4340	U/mL	Positive
	refr-multi_lat-3142	27_100034_200	27_502	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100034	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgG Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgG	6400	titer	Positive
	refr-multi_lat-3143	27_100034_200	27_503	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100034	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgM Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgM	200	titer	Positive
	refr-multi_lat-3144	27_100035_200	27_505	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100035	SeroNet_Reference_Study_visit-01									BioPlex 2200 EBV IgG Assay	Epstein-Barr Virus, Viral Capsid Antigen 	Multiplex Immunoassay		IgG	7.1	AI	Positive
	refr-multi_lat-3145	27_100035_200	27_511	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100035	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	0.5	OD	Positive
	refr-multi_lat-3146	27_100035_200	27_511	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100035	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	2.2	OD	Positive
	refr-multi_lat-3147	27_100035_200	27_511	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100035	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	2.4	OD	Positive
	refr-multi_lat-3148	27_100036_200	27_501	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100036	SeroNet_Reference_Study_visit-01									Elecsys Anti-SARS-CoV-2 S Immunoassay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		Total	494	U/mL	Positive
	refr-multi_lat-3149	27_100036_200	27_502	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100036	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgG Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgG	51200	titer	Positive
	refr-multi_lat-3150	27_100036_200	27_503	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100036	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgM Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgM	400	titer	Positive
	refr-multi_lat-3151	27_100038_200	27_501	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100038	SeroNet_Reference_Study_visit-01									Elecsys Anti-SARS-CoV-2 S Immunoassay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		Total	250	U/mL	Positive
	refr-multi_lat-3152	27_100038_200	27_502	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100038	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgG Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgG	12800	titer	Positive
	refr-multi_lat-3153	27_100038_200	27_503	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100038	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgM Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgM	200	titer	Positive
	refr-multi_lat-3154	27_100039_200	27_501	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100039	SeroNet_Reference_Study_visit-01									Elecsys Anti-SARS-CoV-2 S Immunoassay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		Total	786.2	U/mL	Positive
	refr-multi_lat-3155	27_100039_200	27_502	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100039	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgG Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgG	12800	titer	Positive
	refr-multi_lat-3156	27_100039_200	27_503	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100039	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgM Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgM	800	titer	Positive
	refr-multi_lat-3157	27_100040_200	27_501	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100040	SeroNet_Reference_Study_visit-01									Elecsys Anti-SARS-CoV-2 S Immunoassay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		Total	22.63	U/mL	Positive
	refr-multi_lat-3158	27_100040_200	27_502	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100040	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgG Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgG	800	titer	Positive
	refr-multi_lat-3159	27_100040_200	27_503	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100040	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgM Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgM	6400	titer	Positive
	refr-multi_lat-3160	27_100041_200	27_501	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100041	SeroNet_Reference_Study_visit-01									Elecsys Anti-SARS-CoV-2 S Immunoassay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		Total	250	U/mL	Positive
	refr-multi_lat-3161	27_100041_200	27_502	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100041	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgG Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgG	25600	titer	Positive
	refr-multi_lat-3162	27_100041_200	27_503	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100041	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgM Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgM	1600	titer	Positive
	refr-multi_lat-3163	27_100042_200	27_501	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100042	SeroNet_Reference_Study_visit-01									Elecsys Anti-SARS-CoV-2 S Immunoassay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		Total	7.08	U/mL	Positive
	refr-multi_lat-3164	27_100042_200	27_502	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100042	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgG Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgG	400	titer	Positive
	refr-multi_lat-3165	27_100043_200	27_501	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100043	SeroNet_Reference_Study_visit-01									Elecsys Anti-SARS-CoV-2 S Immunoassay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		Total	191	U/mL	Positive
	refr-multi_lat-3166	27_100043_200	27_502	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100043	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgG Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgG	6400	titer	Positive
	refr-multi_lat-3167	27_100043_200	27_503	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100043	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgM Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgM	400	titer	Positive
	refr-multi_lat-3168	27_100045_100	27_505	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100045	SeroNet_Reference_Study_visit-01									BioPlex 2200 EBV IgG Assay	Epstein-Barr Virus, Viral Capsid Antigen 	Multiplex Immunoassay		IgG	4	AI	Positive
	refr-multi_lat-3169	27_100045_100	27_511	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100045	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	1.6	OD	Positive
	refr-multi_lat-3170	27_100045_100	27_511	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100045	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	2.3	OD	Positive
	refr-multi_lat-3171	27_100045_100	27_511	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100045	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	1.6	OD	Positive
	refr-multi_lat-3172	27_100046_200	27_504	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100046	SeroNet_Reference_Study_visit-01									BioPlex 2200 ToRC IgM Kit	Cytomegalovirus, CMV antigens	Multiplex Immunoassay		IgG	8	AI	Positive
	refr-multi_lat-3173	27_100046_200	27_505	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100046	SeroNet_Reference_Study_visit-01									BioPlex 2200 EBV IgG Assay	Epstein-Barr Virus, Viral Capsid Antigen 	Multiplex Immunoassay		IgG	6.9	AI	Positive
	refr-multi_lat-3174	27_100046_200	27_511	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100046	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	1.1	OD	Positive
	refr-multi_lat-3175	27_100046_200	27_511	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100046	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	2.3	OD	Positive
	refr-multi_lat-3176	27_100046_200	27_511	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100046	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	1.4	OD	Positive
	refr-multi_lat-3177	27_100047_200	27_505	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100047	SeroNet_Reference_Study_visit-01									BioPlex 2200 EBV IgG Assay	Epstein-Barr Virus, Viral Capsid Antigen 	Multiplex Immunoassay		IgG	7.1	AI	Positive
	refr-multi_lat-3178	27_100047_200	27_511	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100047	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	0.6	OD	Positive
	refr-multi_lat-3179	27_100047_200	27_511	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100047	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	1.5	OD	Positive
	refr-multi_lat-3180	27_100047_200	27_511	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100047	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	1.9	OD	Positive
	refr-multi_lat-3181	27_100048_200	27_504	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100048	SeroNet_Reference_Study_visit-01									BioPlex 2200 ToRC IgM Kit	Cytomegalovirus, CMV antigens	Multiplex Immunoassay		IgG	8	AI	Positive
	refr-multi_lat-3182	27_100048_200	27_505	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100048	SeroNet_Reference_Study_visit-01									BioPlex 2200 EBV IgG Assay	Epstein-Barr Virus, Viral Capsid Antigen 	Multiplex Immunoassay		IgG	3.4	AI	Positive
	refr-multi_lat-3183	27_100048_200	27_511	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100048	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	0.5	OD	Positive
	refr-multi_lat-3184	27_100048_200	27_511	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100048	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	1.7	OD	Positive
	refr-multi_lat-3185	27_100048_200	27_511	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100048	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	0.9	OD	Positive
	refr-multi_lat-3186	27_100049_200	27_509	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100049	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-3187	27_100049_200	27_510	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100049	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	10	U/mL	Positive
	refr-multi_lat-3188	27_100049_200	27_511	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100049	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	0.5	OD	Positive
	refr-multi_lat-3189	27_100049_200	27_511	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100049	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	1.6	OD	Positive
	refr-multi_lat-3190	27_100049_200	27_511	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100049	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	1.1	OD	Positive
	refr-multi_lat-3191	27_100051_200	27_509	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100051	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	314	U/mL	Positive
	refr-multi_lat-3192	27_100051_200	27_511	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100051	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	0.6	OD	Positive
	refr-multi_lat-3193	27_100051_200	27_511	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100051	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	1.4	OD	Positive
	refr-multi_lat-3194	27_100051_200	27_511	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100051	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	0.4	OD	Positive
	refr-multi_lat-3195	27_100052_200	27_509	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100052	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	384	U/mL	Positive
	refr-multi_lat-3196	27_100052_200	27_511	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100052	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	1.3	OD	Positive
	refr-multi_lat-3197	27_100052_200	27_511	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100052	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	1.7	OD	Positive
	refr-multi_lat-3198	27_100052_200	27_511	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100052	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	2.4	OD	Positive
	refr-multi_lat-3199	27_100053_200	27_509	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100053	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	153	U/mL	Positive
	refr-multi_lat-3200	27_100053_200	27_511	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100053	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	1.1	OD	Positive
	refr-multi_lat-3201	27_100053_200	27_511	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100053	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	2.3	OD	Positive
	refr-multi_lat-3202	27_100053_200	27_511	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100053	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	1.7	OD	Positive
	refr-multi_lat-3203	27_100056_200	27_501	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100056	SeroNet_Reference_Study_visit-01									Elecsys Anti-SARS-CoV-2 S Immunoassay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		Total	172	U/mL	Positive
	refr-multi_lat-3204	27_100056_200	27_502	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100056	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgG Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgG	1600	titer	Positive
	refr-multi_lat-3205	27_100056_200	27_503	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100056	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgM Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgM	400	titer	Positive
	refr-multi_lat-3206	27_100061_200	27_501	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100061	SeroNet_Reference_Study_visit-01									Elecsys Anti-SARS-CoV-2 S Immunoassay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		Total	419	U/mL	Positive
	refr-multi_lat-3207	27_100061_200	27_502	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100061	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgG Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgG	12800	titer	Positive
	refr-multi_lat-3208	27_100061_200	27_503	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100061	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgM Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgM	200	titer	Positive
	refr-multi_lat-3209	27_100077_200	27_501	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100077	SeroNet_Reference_Study_visit-01									Elecsys Anti-SARS-CoV-2 S Immunoassay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		Total	239	U/mL	Positive
	refr-multi_lat-3210	27_100077_200	27_502	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100077	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgG Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgG	25600	titer	Positive
	refr-multi_lat-3211	27_100077_200	27_503	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100077	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgM Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgM	200	titer	Positive
	refr-multi_lat-3212	27_100078_200	27_501	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100078	SeroNet_Reference_Study_visit-01									Elecsys Anti-SARS-CoV-2 S Immunoassay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		Total	2330	U/mL	Positive
	refr-multi_lat-3213	27_100078_200	27_502	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100078	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgG Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgG	51200	titer	Positive
	refr-multi_lat-3214	27_100078_200	27_503	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100078	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgM Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgM	1600	titer	Positive
	refr-multi_lat-3215	27_100079_200	27_501	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100079	SeroNet_Reference_Study_visit-01									Elecsys Anti-SARS-CoV-2 S Immunoassay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		Total	9.94	U/mL	Positive
	refr-multi_lat-3216	27_100079_200	27_502	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100079	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgG Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgG	200	titer	Positive
	refr-multi_lat-3217	27_100088_200	27_501	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100088	SeroNet_Reference_Study_visit-01									Elecsys Anti-SARS-CoV-2 S Immunoassay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		Total	386	U/mL	Positive
	refr-multi_lat-3218	27_100088_200	27_502	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100088	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgG Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgG	3200	titer	Positive
	refr-multi_lat-3219	27_100090_200	27_501	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100090	SeroNet_Reference_Study_visit-01									Elecsys Anti-SARS-CoV-2 S Immunoassay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		Total	250	U/mL	Positive
	refr-multi_lat-3220	27_100090_200	27_502	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100090	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgG Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgG	6400	titer	Positive
	refr-multi_lat-3221	27_100090_200	27_503	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100090	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgM Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgM	400	titer	Positive
	refr-multi_lat-3222	27_100091_200	27_501	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100091	SeroNet_Reference_Study_visit-01									Elecsys Anti-SARS-CoV-2 S Immunoassay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		Total	171	U/mL	Positive
	refr-multi_lat-3223	27_100091_200	27_502	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100091	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgG Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgG	6400	titer	Positive
	refr-multi_lat-3224	27_100091_200	27_503	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100091	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgM Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgM	400	titer	Positive
	refr-multi_lat-3225	27_100092_200	27_501	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100092	SeroNet_Reference_Study_visit-01									Elecsys Anti-SARS-CoV-2 S Immunoassay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		Total	5.05	U/mL	Positive
	refr-multi_lat-3226	27_100092_200	27_503	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100092	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgM Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgM	200	titer	Positive
	refr-multi_lat-3227	27_100093_200	27_504	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100093	SeroNet_Reference_Study_visit-01									BioPlex 2200 ToRC IgM Kit	Cytomegalovirus, CMV antigens	Multiplex Immunoassay		IgG	8	AI	Positive
	refr-multi_lat-3228	27_100093_200	27_505	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100093	SeroNet_Reference_Study_visit-01									BioPlex 2200 EBV IgG Assay	Epstein-Barr Virus, Viral Capsid Antigen 	Multiplex Immunoassay		IgG	8	AI	Positive
	refr-multi_lat-3229	27_100093_200	27_511	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100093	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	1.8	OD	Positive
	refr-multi_lat-3230	27_100093_200	27_511	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100093	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	2.2	OD	Positive
	refr-multi_lat-3231	27_100093_200	27_511	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100093	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	2.1	OD	Positive
	refr-multi_lat-3232	27_100101_200	27_501	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100101	SeroNet_Reference_Study_visit-01									Elecsys Anti-SARS-CoV-2 S Immunoassay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		Total	98.2	U/mL	Positive
	refr-multi_lat-3233	27_100101_200	27_502	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100101	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgG Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgG	800	titer	Positive
	refr-multi_lat-3234	27_100104_200	27_501	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100104	SeroNet_Reference_Study_visit-01									Elecsys Anti-SARS-CoV-2 S Immunoassay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		Total	48.6	U/mL	Positive
	refr-multi_lat-3235	27_100104_200	27_502	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100104	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgG Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgG	1600	titer	Positive
	refr-multi_lat-3236	27_100104_200	27_503	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100104	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgM Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgM	200	titer	Positive
	refr-multi_lat-3237	27_100107_200	27_501	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100107	SeroNet_Reference_Study_visit-01									Elecsys Anti-SARS-CoV-2 S Immunoassay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		Total	45.5	U/mL	Positive
	refr-multi_lat-3238	27_100107_200	27_502	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100107	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgG Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgG	400	titer	Positive
	refr-multi_lat-3239	27_100107_200	27_503	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100107	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgM Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgM	200	titer	Positive
	refr-multi_lat-3240	27_100112_200	27_504	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100112	SeroNet_Reference_Study_visit-01									BioPlex 2200 ToRC IgM Kit	Cytomegalovirus, CMV antigens	Multiplex Immunoassay		IgG	8	AI	Positive
	refr-multi_lat-3241	27_100112_200	27_505	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100112	SeroNet_Reference_Study_visit-01									BioPlex 2200 EBV IgG Assay	Epstein-Barr Virus, Viral Capsid Antigen 	Multiplex Immunoassay		IgG	8	AI	Positive
	refr-multi_lat-3242	27_100112_200	27_511	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100112	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	1.2	OD	Positive
	refr-multi_lat-3243	27_100112_200	27_511	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100112	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	2.3	OD	Positive
	refr-multi_lat-3244	27_100112_200	27_511	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100112	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, Spike, RBD	ELISA		IgG	1.1	OD	Positive
	refr-multi_lat-3245	27_100130_200	27_501	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100130	SeroNet_Reference_Study_visit-01									Elecsys Anti-SARS-CoV-2 S Immunoassay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		Total	2500	U/mL	Positive
	refr-multi_lat-3246	27_100130_200	27_502	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100130	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgG Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgG	12800	titer	Positive
	refr-multi_lat-3247	27_100130_200	27_503	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100130	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgM Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgM	200	titer	Positive
	refr-multi_lat-3248	27_100132_200	27_501	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100132	SeroNet_Reference_Study_visit-01									Elecsys Anti-SARS-CoV-2 S Immunoassay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		Total	98.3	U/mL	Positive
	refr-multi_lat-3249	27_100132_200	27_502	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100132	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgG Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgG	200	titer	Positive
	refr-multi_lat-3250	27_100133_200	27_501	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100133	SeroNet_Reference_Study_visit-01									Elecsys Anti-SARS-CoV-2 S Immunoassay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		Total	328	U/mL	Positive
	refr-multi_lat-3251	27_100133_200	27_502	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100133	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgG Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgG	3200	titer	Positive
	refr-multi_lat-3252	27_100133_200	27_503	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100133	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgM Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgM	200	titer	Positive
	refr-multi_lat-3253	27_100134_200	27_501	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100134	SeroNet_Reference_Study_visit-01									Elecsys Anti-SARS-CoV-2 S Immunoassay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		Total	883	U/mL	Positive
	refr-multi_lat-3254	27_100134_200	27_502	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100134	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgG Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgG	3200	titer	Positive
	refr-multi_lat-3255	27_100135_200	27_501	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100135	SeroNet_Reference_Study_visit-01									Elecsys Anti-SARS-CoV-2 S Immunoassay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		Total	939	U/mL	Positive
	refr-multi_lat-3256	27_100135_200	27_502	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100135	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgG Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgG	800	titer	Positive
	refr-multi_lat-3257	27_100136_200	27_501	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100136	SeroNet_Reference_Study_visit-01									Elecsys Anti-SARS-CoV-2 S Immunoassay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		Total	527	U/mL	Positive
	refr-multi_lat-3258	27_100136_200	27_502	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100136	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgG Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgG	1600	titer	Positive
	refr-multi_lat-3259	27_100137_200	27_501	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100137	SeroNet_Reference_Study_visit-01									Elecsys Anti-SARS-CoV-2 S Immunoassay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		Total	2291	U/mL	Positive
	refr-multi_lat-3260	27_100137_200	27_502	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100137	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgG Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgG	12800	titer	Positive
	refr-multi_lat-3261	27_100137_200	27_503	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100137	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgM Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgM	400	titer	Positive
	refr-multi_lat-3262	27_100139_200	27_501	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100139	SeroNet_Reference_Study_visit-01									Elecsys Anti-SARS-CoV-2 S Immunoassay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		Total	618	U/mL	Positive
	refr-multi_lat-3263	27_100139_200	27_502	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100139	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgG Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgG	25600	titer	Positive
	refr-multi_lat-3264	27_100139_200	27_503	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100139	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgM Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgM	3200	titer	Positive
	refr-multi_lat-3265	27_100140_200	27_501	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100140	SeroNet_Reference_Study_visit-01									Elecsys Anti-SARS-CoV-2 S Immunoassay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		Total	6.3	U/mL	Positive
	refr-multi_lat-3266	27_100140_200	27_502	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100140	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgG Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgG	200	titer	Positive
	refr-multi_lat-3267	27_100140_200	27_503	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100140	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgM Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgM	200	titer	Positive
	refr-multi_lat-3268	27_100141_200	27_501	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100141	SeroNet_Reference_Study_visit-01									Elecsys Anti-SARS-CoV-2 S Immunoassay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		Total	137	U/mL	Positive
	refr-multi_lat-3269	27_100141_200	27_502	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100141	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgG Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgG	800	titer	Positive
	refr-multi_lat-3270	27_100141_200	27_503	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100141	SeroNet_Reference_Study_visit-01									SARS-CoV-2 Spike IgM Assay	SARS-CoV-2 Virus, Spike, RBD	ELISA		IgM	200	titer	Positive
	refr-multi_lat-3271	32_111001_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_111001	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3272	32_111007_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_111007	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3273	32_111019_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_111019	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3274	32_111023_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_111023	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3275	32_111024_301	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_111024	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3276	32_111025_301	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_111025	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Positive
	refr-multi_lat-3277	32_111025_301	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_111025	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3278	32_111026_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_111026	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3279	32_111027_301	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_111027	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Positive
	refr-multi_lat-3280	32_111027_301	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_111027	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3281	32_111030_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_111030	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3282	32_111031_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_111031	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3283	32_111032_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_111032	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3284	32_111033_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_111033	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3285	32_111035_301	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_111035	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3286	32_111044_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_111044	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Positive
	refr-multi_lat-3287	32_111044_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_111044	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3288	32_111047_301	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_111047	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3289	32_551015_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551015	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Positive
	refr-multi_lat-3290	32_551015_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551015	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3291	32_551020_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551020	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3292	32_551022_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551022	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Positive
	refr-multi_lat-3293	32_551022_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551022	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3294	32_551028_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551028	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3295	32_551033_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551033	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Positive
	refr-multi_lat-3296	32_551034_101	32_035	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551034	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3297	32_551037_101	32_060	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551037	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, Nucleocapsid	ELISA		IgG	1.3	OD	Positive
	refr-multi_lat-3298	32_551037_101	32_065	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551037	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-HKU1, Nucleocapsid	ELISA		IgG	0.7	OD	Positive
	refr-multi_lat-3299	32_551037_101	32_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551037	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-NL63, Nucleocapsid	ELISA		IgG	0.6	OD	Positive
	refr-multi_lat-3300	32_551037_101	32_075	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551037	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-OC43, Nucleocapsid	ELISA		IgG	0.4	OD	Positive
	refr-multi_lat-3301	32_551045_101	32_060	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551045	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, Nucleocapsid	ELISA		IgG	1.3	OD	Positive
	refr-multi_lat-3302	32_551045_101	32_065	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551045	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-HKU1, Nucleocapsid	ELISA		IgG	1.3	OD	Positive
	refr-multi_lat-3303	32_551045_101	32_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551045	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-NL63, Nucleocapsid	ELISA		IgG	1.4	OD	Positive
	refr-multi_lat-3304	32_551045_101	32_075	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551045	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-OC43, Nucleocapsid	ELISA		IgG	1.1	OD	Positive
	refr-multi_lat-3305	32_551049_101	32_035	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551049	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3306	32_551051_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551051	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Positive
	refr-multi_lat-3307	32_551051_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551051	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3308	32_551054_101	32_060	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551054	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, Nucleocapsid	ELISA		IgG	1.3	OD	Positive
	refr-multi_lat-3309	32_551054_101	32_065	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551054	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-HKU1, Nucleocapsid	ELISA		IgG	0.5	OD	Positive
	refr-multi_lat-3310	32_551054_101	32_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551054	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-NL63, Nucleocapsid	ELISA		IgG	1.1	OD	Positive
	refr-multi_lat-3311	32_551054_101	32_075	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551054	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-OC43, Nucleocapsid	ELISA		IgG	0.6	OD	Positive
	refr-multi_lat-3312	32_551056_101	32_060	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551056	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, Nucleocapsid	ELISA		IgG	1.9	OD	Positive
	refr-multi_lat-3313	32_551056_101	32_065	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551056	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-HKU1, Nucleocapsid	ELISA		IgG	0.4	OD	Positive
	refr-multi_lat-3314	32_551056_101	32_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551056	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-NL63, Nucleocapsid	ELISA		IgG	0.9	OD	Positive
	refr-multi_lat-3315	32_551056_101	32_075	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551056	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-OC43, Nucleocapsid	ELISA		IgG	1.6	OD	Positive
	refr-multi_lat-3316	32_551058_101	32_035	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551058	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3317	32_551060_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551060	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Positive
	refr-multi_lat-3318	32_551060_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551060	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3319	32_551061_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551061	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3320	32_551064_101	32_060	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551064	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, Nucleocapsid	ELISA		IgG	0.8	OD	Positive
	refr-multi_lat-3321	32_551064_101	32_065	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551064	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-HKU1, Nucleocapsid	ELISA		IgG	0.5	OD	Positive
	refr-multi_lat-3322	32_551064_101	32_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551064	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-NL63, Nucleocapsid	ELISA		IgG	1.1	OD	Positive
	refr-multi_lat-3323	32_551064_101	32_075	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551064	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-OC43, Nucleocapsid	ELISA		IgG	0.5	OD	Positive
	refr-multi_lat-3324	32_551065_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551065	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3325	32_551068_101	32_060	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551068	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, Nucleocapsid	ELISA		IgG	1.6	OD	Positive
	refr-multi_lat-3326	32_551068_101	32_065	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551068	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-HKU1, Nucleocapsid	ELISA		IgG	1.5	OD	Positive
	refr-multi_lat-3327	32_551068_101	32_075	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551068	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-OC43, Nucleocapsid	ELISA		IgG	1	OD	Positive
	refr-multi_lat-3328	32_551069_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551069	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Positive
	refr-multi_lat-3329	32_551069_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551069	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3330	32_551071_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551071	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Positive
	refr-multi_lat-3331	32_551071_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551071	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3332	32_551072_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551072	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Positive
	refr-multi_lat-3333	32_551072_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551072	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3334	32_551074_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551074	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Positive
	refr-multi_lat-3335	32_551074_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551074	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3336	32_551075_101	32_060	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551075	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, Nucleocapsid	ELISA		IgG	1.5	OD	Positive
	refr-multi_lat-3337	32_551075_101	32_065	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551075	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-HKU1, Nucleocapsid	ELISA		IgG	0.5	OD	Positive
	refr-multi_lat-3338	32_551075_101	32_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551075	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-NL63, Nucleocapsid	ELISA		IgG	1.7	OD	Positive
	refr-multi_lat-3339	32_551075_101	32_075	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551075	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-OC43, Nucleocapsid	ELISA		IgG	1.4	OD	Positive
	refr-multi_lat-3340	32_551079_101	32_060	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551079	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, Nucleocapsid	ELISA		IgG	0.6	OD	Positive
	refr-multi_lat-3341	32_551079_101	32_065	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551079	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-HKU1, Nucleocapsid	ELISA		IgG	0.7	OD	Positive
	refr-multi_lat-3342	32_551079_101	32_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551079	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-NL63, Nucleocapsid	ELISA		IgG	1.2	OD	Positive
	refr-multi_lat-3343	32_551079_101	32_075	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551079	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-OC43, Nucleocapsid	ELISA		IgG	0.8	OD	Positive
	refr-multi_lat-3344	32_551080_101	32_060	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551080	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, Nucleocapsid	ELISA		IgG	1.4	OD	Positive
	refr-multi_lat-3345	32_551080_101	32_065	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551080	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-HKU1, Nucleocapsid	ELISA		IgG	0.8	OD	Positive
	refr-multi_lat-3346	32_551080_101	32_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551080	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-NL63, Nucleocapsid	ELISA		IgG	1.5	OD	Positive
	refr-multi_lat-3347	32_551080_101	32_075	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551080	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-OC43, Nucleocapsid	ELISA		IgG	0.5	OD	Positive
	refr-multi_lat-3348	32_551081_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551081	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3349	32_551082_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551082	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3350	32_551084_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551084	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Positive
	refr-multi_lat-3351	32_551084_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551084	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3352	32_551093_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551093	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3353	32_551094_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551094	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3354	32_551095_101	32_047	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551095	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgM	NA	Not Specified	Positive
	refr-multi_lat-3355	32_551095_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551095	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3356	32_551110_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551110	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3357	32_551116_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551116	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3358	32_551132_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551132	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3359	32_551133_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551133	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3360	32_551134_101	32_060	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551134	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, Nucleocapsid	ELISA		IgG	1.4	OD	Positive
	refr-multi_lat-3361	32_551134_101	32_065	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551134	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-HKU1, Nucleocapsid	ELISA		IgG	1.6	OD	Positive
	refr-multi_lat-3362	32_551134_101	32_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551134	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-NL63, Nucleocapsid	ELISA		IgG	1.9	OD	Positive
	refr-multi_lat-3363	32_551134_101	32_075	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551134	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-OC43, Nucleocapsid	ELISA		IgG	2.1	OD	Positive
	refr-multi_lat-3364	32_551135_101	32_060	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551135	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, Nucleocapsid	ELISA		IgG	1.4	OD	Positive
	refr-multi_lat-3365	32_551135_101	32_065	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551135	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-HKU1, Nucleocapsid	ELISA		IgG	1.8	OD	Positive
	refr-multi_lat-3366	32_551135_101	32_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551135	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-NL63, Nucleocapsid	ELISA		IgG	1.6	OD	Positive
	refr-multi_lat-3367	32_551135_101	32_075	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551135	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-OC43, Nucleocapsid	ELISA		IgG	0.9	OD	Positive
	refr-multi_lat-3368	32_551136_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551136	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3369	32_551139_101	32_060	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551139	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, Nucleocapsid	ELISA		IgG	0.9	OD	Positive
	refr-multi_lat-3370	32_551139_101	32_065	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551139	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-HKU1, Nucleocapsid	ELISA		IgG	2.4	OD	Positive
	refr-multi_lat-3371	32_551139_101	32_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551139	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-NL63, Nucleocapsid	ELISA		IgG	1.6	OD	Positive
	refr-multi_lat-3372	32_551139_101	32_075	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551139	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-OC43, Nucleocapsid	ELISA		IgG	1.8	OD	Positive
	refr-multi_lat-3373	32_551152_101	32_060	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551152	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, Nucleocapsid	ELISA		IgG	0.8	OD	Positive
	refr-multi_lat-3374	32_551152_101	32_065	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551152	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-HKU1, Nucleocapsid	ELISA		IgG	0.6	OD	Positive
	refr-multi_lat-3375	32_551152_101	32_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551152	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-NL63, Nucleocapsid	ELISA		IgG	1.2	OD	Positive
	refr-multi_lat-3376	32_551152_101	32_075	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551152	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-OC43, Nucleocapsid	ELISA		IgG	1.3	OD	Positive
	refr-multi_lat-3377	32_551168_101	32_060	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551168	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, Nucleocapsid	ELISA		IgG	1.9	OD	Positive
	refr-multi_lat-3378	32_551168_101	32_065	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551168	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-HKU1, Nucleocapsid	ELISA		IgG	2.1	OD	Positive
	refr-multi_lat-3379	32_551168_101	32_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551168	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-NL63, Nucleocapsid	ELISA		IgG	1.7	OD	Positive
	refr-multi_lat-3380	32_551168_101	32_075	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551168	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-OC43, Nucleocapsid	ELISA		IgG	2.1	OD	Positive
	refr-multi_lat-3381	32_551169_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551169	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3382	32_551170_101	32_035	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551170	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3383	32_551171_101	32_040	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551171	SeroNet_Reference_Study_visit-01									BioPlex 2200 EBV IgG Assay	Epstein-Barr Virus, Early Antigen Diffuse, Viral Capsid Antigen, Nuclear antigen - 1	Multiplex Immunoassay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3384	32_551172_101	32_035	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551172	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3385	32_551173_101	32_035	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551173	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3386	32_551174_101	32_040	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551174	SeroNet_Reference_Study_visit-01									BioPlex 2200 EBV IgG Assay	Epstein-Barr Virus, Early Antigen Diffuse, Viral Capsid Antigen, Nuclear antigen - 1	Multiplex Immunoassay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3387	32_551176_101	32_040	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551176	SeroNet_Reference_Study_visit-01									BioPlex 2200 EBV IgG Assay	Epstein-Barr Virus, Early Antigen Diffuse, Viral Capsid Antigen, Nuclear antigen - 1	Multiplex Immunoassay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3388	32_551177_101	32_060	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551177	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, Nucleocapsid	ELISA		IgG	1.2	OD	Positive
	refr-multi_lat-3389	32_551177_101	32_065	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551177	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-HKU1, Nucleocapsid	ELISA		IgG	0.6	OD	Positive
	refr-multi_lat-3390	32_551177_101	32_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551177	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-NL63, Nucleocapsid	ELISA		IgG	1.6	OD	Positive
	refr-multi_lat-3391	32_551177_101	32_075	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551177	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-OC43, Nucleocapsid	ELISA		IgG	0.8	OD	Positive
	refr-multi_lat-3392	32_551178_101	32_060	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551178	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, Nucleocapsid	ELISA		IgG	1	OD	Positive
	refr-multi_lat-3393	32_551178_101	32_065	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551178	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-HKU1, Nucleocapsid	ELISA		IgG	1	OD	Positive
	refr-multi_lat-3394	32_551178_101	32_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551178	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-NL63, Nucleocapsid	ELISA		IgG	1.2	OD	Positive
	refr-multi_lat-3395	32_551178_101	32_075	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551178	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-OC43, Nucleocapsid	ELISA		IgG	0.8	OD	Positive
	refr-multi_lat-3396	32_551179_101	32_035	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551179	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3397	32_551180_101	32_060	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551180	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, Nucleocapsid	ELISA		IgG	0.9	OD	Positive
	refr-multi_lat-3398	32_551180_101	32_065	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551180	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-HKU1, Nucleocapsid	ELISA		IgG	1.4	OD	Positive
	refr-multi_lat-3399	32_551180_101	32_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551180	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-NL63, Nucleocapsid	ELISA		IgG	1.7	OD	Positive
	refr-multi_lat-3400	32_551180_101	32_075	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551180	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-OC43, Nucleocapsid	ELISA		IgG	1.6	OD	Positive
	refr-multi_lat-3401	32_551182_101	32_040	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551182	SeroNet_Reference_Study_visit-01									BioPlex 2200 EBV IgG Assay	Epstein-Barr Virus, Early Antigen Diffuse, Viral Capsid Antigen, Nuclear antigen - 1	Multiplex Immunoassay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3402	32_551183_101	32_040	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551183	SeroNet_Reference_Study_visit-01									BioPlex 2200 EBV IgG Assay	Epstein-Barr Virus, Early Antigen Diffuse, Viral Capsid Antigen, Nuclear antigen - 1	Multiplex Immunoassay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3403	32_551184_101	32_040	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551184	SeroNet_Reference_Study_visit-01									BioPlex 2200 EBV IgG Assay	Epstein-Barr Virus, Early Antigen Diffuse, Viral Capsid Antigen, Nuclear antigen - 1	Multiplex Immunoassay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3404	32_551185_101	32_060	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551185	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, Nucleocapsid	ELISA		IgG	1.3	OD	Positive
	refr-multi_lat-3405	32_551185_101	32_065	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551185	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-HKU1, Nucleocapsid	ELISA		IgG	1.7	OD	Positive
	refr-multi_lat-3406	32_551185_101	32_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551185	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-NL63, Nucleocapsid	ELISA		IgG	2	OD	Positive
	refr-multi_lat-3407	32_551185_101	32_075	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551185	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-OC43, Nucleocapsid	ELISA		IgG	1.3	OD	Positive
	refr-multi_lat-3408	32_551186_101	32_040	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551186	SeroNet_Reference_Study_visit-01									BioPlex 2200 EBV IgG Assay	Epstein-Barr Virus, Early Antigen Diffuse, Viral Capsid Antigen, Nuclear antigen - 1	Multiplex Immunoassay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3409	32_551187_101	32_060	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551187	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, Nucleocapsid	ELISA		IgG	1.2	OD	Positive
	refr-multi_lat-3410	32_551187_101	32_065	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551187	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-HKU1, Nucleocapsid	ELISA		IgG	0.9	OD	Positive
	refr-multi_lat-3411	32_551187_101	32_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551187	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-NL63, Nucleocapsid	ELISA		IgG	1.3	OD	Positive
	refr-multi_lat-3412	32_551187_101	32_075	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551187	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-OC43, Nucleocapsid	ELISA		IgG	0.9	OD	Positive
	refr-multi_lat-3413	32_551188_101	32_040	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551188	SeroNet_Reference_Study_visit-01									BioPlex 2200 EBV IgG Assay	Epstein-Barr Virus, Early Antigen Diffuse, Viral Capsid Antigen, Nuclear antigen - 1	Multiplex Immunoassay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3414	32_551189_101	32_040	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551189	SeroNet_Reference_Study_visit-01									BioPlex 2200 EBV IgG Assay	Epstein-Barr Virus, Early Antigen Diffuse, Viral Capsid Antigen, Nuclear antigen - 1	Multiplex Immunoassay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3415	32_551190_101	32_040	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551190	SeroNet_Reference_Study_visit-01									BioPlex 2200 EBV IgG Assay	Epstein-Barr Virus, Early Antigen Diffuse, Viral Capsid Antigen, Nuclear antigen - 1	Multiplex Immunoassay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3416	32_551191_101	32_040	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551191	SeroNet_Reference_Study_visit-01									BioPlex 2200 EBV IgG Assay	Epstein-Barr Virus, Early Antigen Diffuse, Viral Capsid Antigen, Nuclear antigen - 1	Multiplex Immunoassay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3417	32_551192_101	32_035	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551192	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3418	32_551193_101	32_060	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551193	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, Nucleocapsid	ELISA		IgG	1.6	OD	Positive
	refr-multi_lat-3419	32_551193_101	32_065	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551193	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-HKU1, Nucleocapsid	ELISA		IgG	1.9	OD	Positive
	refr-multi_lat-3420	32_551193_101	32_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551193	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-NL63, Nucleocapsid	ELISA		IgG	1.9	OD	Positive
	refr-multi_lat-3421	32_551193_101	32_075	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551193	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-OC43, Nucleocapsid	ELISA		IgG	1.5	OD	Positive
	refr-multi_lat-3422	32_551194_101	32_040	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551194	SeroNet_Reference_Study_visit-01									BioPlex 2200 EBV IgG Assay	Epstein-Barr Virus, Early Antigen Diffuse, Viral Capsid Antigen, Nuclear antigen - 1	Multiplex Immunoassay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3423	32_551195_101	32_035	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551195	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3424	32_551196_101	32_040	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551196	SeroNet_Reference_Study_visit-01									BioPlex 2200 EBV IgG Assay	Epstein-Barr Virus, Early Antigen Diffuse, Viral Capsid Antigen, Nuclear antigen - 1	Multiplex Immunoassay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3425	32_551197_101	32_060	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551197	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, Nucleocapsid	ELISA		IgG	1.5	OD	Positive
	refr-multi_lat-3426	32_551197_101	32_065	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551197	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-HKU1, Nucleocapsid	ELISA		IgG	2.2	OD	Positive
	refr-multi_lat-3427	32_551197_101	32_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551197	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-NL63, Nucleocapsid	ELISA		IgG	1.9	OD	Positive
	refr-multi_lat-3428	32_551197_101	32_075	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551197	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-OC43, Nucleocapsid	ELISA		IgG	2	OD	Positive
	refr-multi_lat-3429	32_551198_101	32_040	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551198	SeroNet_Reference_Study_visit-01									BioPlex 2200 EBV IgG Assay	Epstein-Barr Virus, Early Antigen Diffuse, Viral Capsid Antigen, Nuclear antigen - 1	Multiplex Immunoassay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3430	32_551201_101	32_040	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551201	SeroNet_Reference_Study_visit-01									BioPlex 2200 EBV IgG Assay	Epstein-Barr Virus, Early Antigen Diffuse, Viral Capsid Antigen, Nuclear antigen - 1	Multiplex Immunoassay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3431	32_551202_101	32_040	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551202	SeroNet_Reference_Study_visit-01									BioPlex 2200 EBV IgG Assay	Epstein-Barr Virus, Early Antigen Diffuse, Viral Capsid Antigen, Nuclear antigen - 1	Multiplex Immunoassay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3432	32_551204_101	32_040	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551204	SeroNet_Reference_Study_visit-01									BioPlex 2200 EBV IgG Assay	Epstein-Barr Virus, Early Antigen Diffuse, Viral Capsid Antigen, Nuclear antigen - 1	Multiplex Immunoassay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3433	32_551206_101	32_060	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551206	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, Nucleocapsid	ELISA		IgG	1.2	OD	Positive
	refr-multi_lat-3434	32_551206_101	32_065	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551206	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-HKU1, Nucleocapsid	ELISA		IgG	1.6	OD	Positive
	refr-multi_lat-3435	32_551206_101	32_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551206	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-NL63, Nucleocapsid	ELISA		IgG	2	OD	Positive
	refr-multi_lat-3436	32_551206_101	32_075	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551206	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-OC43, Nucleocapsid	ELISA		IgG	0.8	OD	Positive
	refr-multi_lat-3437	32_551207_101	32_040	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551207	SeroNet_Reference_Study_visit-01									BioPlex 2200 EBV IgG Assay	Epstein-Barr Virus, Early Antigen Diffuse, Viral Capsid Antigen, Nuclear antigen - 1	Multiplex Immunoassay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3438	32_551208_101	32_040	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551208	SeroNet_Reference_Study_visit-01									BioPlex 2200 EBV IgG Assay	Epstein-Barr Virus, Early Antigen Diffuse, Viral Capsid Antigen, Nuclear antigen - 1	Multiplex Immunoassay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3439	32_551209_101	32_040	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551209	SeroNet_Reference_Study_visit-01									BioPlex 2200 EBV IgG Assay	Epstein-Barr Virus, Early Antigen Diffuse, Viral Capsid Antigen, Nuclear antigen - 1	Multiplex Immunoassay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3440	32_551210_101	32_040	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551210	SeroNet_Reference_Study_visit-01									BioPlex 2200 EBV IgG Assay	Epstein-Barr Virus, Early Antigen Diffuse, Viral Capsid Antigen, Nuclear antigen - 1	Multiplex Immunoassay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3441	32_551211_101	32_060	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551211	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, Nucleocapsid	ELISA		IgG	0.8	OD	Positive
	refr-multi_lat-3442	32_551211_101	32_065	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551211	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-HKU1, Nucleocapsid	ELISA		IgG	0.5	OD	Positive
	refr-multi_lat-3443	32_551211_101	32_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551211	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-NL63, Nucleocapsid	ELISA		IgG	1.7	OD	Positive
	refr-multi_lat-3444	32_551211_101	32_075	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551211	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-OC43, Nucleocapsid	ELISA		IgG	0.6	OD	Positive
	refr-multi_lat-3445	32_551212_101	32_035	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551212	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3446	32_551213_101	32_040	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551213	SeroNet_Reference_Study_visit-01									BioPlex 2200 EBV IgG Assay	Epstein-Barr Virus, Early Antigen Diffuse, Viral Capsid Antigen, Nuclear antigen - 1	Multiplex Immunoassay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3447	32_551214_101	32_040	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551214	SeroNet_Reference_Study_visit-01									BioPlex 2200 EBV IgG Assay	Epstein-Barr Virus, Early Antigen Diffuse, Viral Capsid Antigen, Nuclear antigen - 1	Multiplex Immunoassay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3448	32_551215_101	32_040	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551215	SeroNet_Reference_Study_visit-01									BioPlex 2200 EBV IgG Assay	Epstein-Barr Virus, Early Antigen Diffuse, Viral Capsid Antigen, Nuclear antigen - 1	Multiplex Immunoassay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3449	32_551216_101	32_035	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551216	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3450	32_551217_101	32_040	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551217	SeroNet_Reference_Study_visit-01									BioPlex 2200 EBV IgG Assay	Epstein-Barr Virus, Early Antigen Diffuse, Viral Capsid Antigen, Nuclear antigen - 1	Multiplex Immunoassay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3451	32_551219_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551219	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3452	32_551220_101	32_060	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551220	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, Nucleocapsid	ELISA		IgG	0.5	OD	Positive
	refr-multi_lat-3453	32_551220_101	32_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551220	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-NL63, Nucleocapsid	ELISA		IgG	1	OD	Positive
	refr-multi_lat-3454	32_551220_101	32_075	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551220	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-OC43, Nucleocapsid	ELISA		IgG	0.7	OD	Positive
	refr-multi_lat-3455	32_551221_101	32_048	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551221	SeroNet_Reference_Study_visit-01									ACCESS SARS -CoV-2 IgG Assay	SARS-CoV-2 Virus, Spike, RBD	Chemiluminescent Assay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3456	32_551222_101	32_060	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551222	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, Nucleocapsid	ELISA		IgG	1.1	OD	Positive
	refr-multi_lat-3457	32_551222_101	32_065	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551222	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-HKU1, Nucleocapsid	ELISA		IgG	1.7	OD	Positive
	refr-multi_lat-3458	32_551222_101	32_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551222	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-NL63, Nucleocapsid	ELISA		IgG	2	OD	Positive
	refr-multi_lat-3459	32_551222_101	32_075	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551222	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-OC43, Nucleocapsid	ELISA		IgG	2.4	OD	Positive
	refr-multi_lat-3460	32_551223_101	32_060	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551223	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, Nucleocapsid	ELISA		IgG	0.9	OD	Positive
	refr-multi_lat-3461	32_551223_101	32_065	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551223	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-HKU1, Nucleocapsid	ELISA		IgG	1.6	OD	Positive
	refr-multi_lat-3462	32_551223_101	32_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551223	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-NL63, Nucleocapsid	ELISA		IgG	1.7	OD	Positive
	refr-multi_lat-3463	32_551223_101	32_075	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551223	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-OC43, Nucleocapsid	ELISA		IgG	1.4	OD	Positive
	refr-multi_lat-3464	32_551224_101	32_060	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551224	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, Nucleocapsid	ELISA		IgG	1	OD	Positive
	refr-multi_lat-3465	32_551224_101	32_065	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551224	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-HKU1, Nucleocapsid	ELISA		IgG	1.7	OD	Positive
	refr-multi_lat-3466	32_551224_101	32_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551224	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-NL63, Nucleocapsid	ELISA		IgG	1.7	OD	Positive
	refr-multi_lat-3467	32_551224_101	32_075	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551224	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-OC43, Nucleocapsid	ELISA		IgG	1.7	OD	Positive
	refr-multi_lat-3468	32_551225_101	32_060	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551225	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, Nucleocapsid	ELISA		IgG	1.2	OD	Positive
	refr-multi_lat-3469	32_551225_101	32_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551225	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-NL63, Nucleocapsid	ELISA		IgG	1.9	OD	Positive
	refr-multi_lat-3470	32_551225_101	32_075	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551225	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-OC43, Nucleocapsid	ELISA		IgG	1.4	OD	Positive
	refr-multi_lat-3471	32_551226_101	32_060	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551226	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, Nucleocapsid	ELISA		IgG	1.4	OD	Positive
	refr-multi_lat-3472	32_551226_101	32_065	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551226	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-HKU1, Nucleocapsid	ELISA		IgG	1.7	OD	Positive
	refr-multi_lat-3473	32_551226_101	32_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551226	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-NL63, Nucleocapsid	ELISA		IgG	2.2	OD	Positive
	refr-multi_lat-3474	32_551226_101	32_075	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551226	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-OC43, Nucleocapsid	ELISA		IgG	1.8	OD	Positive
	refr-multi_lat-3475	32_551227_101	32_060	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551227	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, Nucleocapsid	ELISA		IgG	0.7	OD	Positive
	refr-multi_lat-3476	32_551227_101	32_065	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551227	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-HKU1, Nucleocapsid	ELISA		IgG	0.9	OD	Positive
	refr-multi_lat-3477	32_551227_101	32_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551227	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-NL63, Nucleocapsid	ELISA		IgG	1.6	OD	Positive
	refr-multi_lat-3478	32_551227_101	32_075	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551227	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-OC43, Nucleocapsid	ELISA		IgG	1.5	OD	Positive
	refr-multi_lat-3479	32_551228_101	32_060	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551228	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, Nucleocapsid	ELISA		IgG	1.7	OD	Positive
	refr-multi_lat-3480	32_551228_101	32_065	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551228	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-HKU1, Nucleocapsid	ELISA		IgG	1.2	OD	Positive
	refr-multi_lat-3481	32_551228_101	32_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551228	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-NL63, Nucleocapsid	ELISA		IgG	2	OD	Positive
	refr-multi_lat-3482	32_551228_101	32_075	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551228	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-OC43, Nucleocapsid	ELISA		IgG	0.8	OD	Positive
	refr-multi_lat-3483	32_551229_101	32_035	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551229	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3484	32_551230_101	32_060	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551230	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, Nucleocapsid	ELISA		IgG	1.2	OD	Positive
	refr-multi_lat-3485	32_551230_101	32_065	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551230	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-HKU1, Nucleocapsid	ELISA		IgG	1.3	OD	Positive
	refr-multi_lat-3486	32_551230_101	32_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551230	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-NL63, Nucleocapsid	ELISA		IgG	1	OD	Positive
	refr-multi_lat-3487	32_551230_101	32_075	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551230	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-OC43, Nucleocapsid	ELISA		IgG	1.1	OD	Positive
	refr-multi_lat-3488	32_551231_101	32_060	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551231	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, Nucleocapsid	ELISA		IgG	0.5	OD	Positive
	refr-multi_lat-3489	32_551231_101	32_065	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551231	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-HKU1, Nucleocapsid	ELISA		IgG	0.8	OD	Positive
	refr-multi_lat-3490	32_551231_101	32_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551231	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-NL63, Nucleocapsid	ELISA		IgG	0.8	OD	Positive
	refr-multi_lat-3491	32_551231_101	32_075	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551231	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-OC43, Nucleocapsid	ELISA		IgG	0.9	OD	Positive
	refr-multi_lat-3492	32_551232_101	32_035	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551232	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3493	32_551234_101	32_035	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551234	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3494	32_551237_101	32_035	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551237	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3495	32_551238_101	32_040	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551238	SeroNet_Reference_Study_visit-01									BioPlex 2200 EBV IgG Assay	Epstein-Barr Virus, Early Antigen Diffuse, Viral Capsid Antigen, Nuclear antigen - 1	Multiplex Immunoassay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3496	32_551239_101	32_040	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551239	SeroNet_Reference_Study_visit-01									BioPlex 2200 EBV IgG Assay	Epstein-Barr Virus, Early Antigen Diffuse, Viral Capsid Antigen, Nuclear antigen - 1	Multiplex Immunoassay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3497	32_551240_101	32_040	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551240	SeroNet_Reference_Study_visit-01									BioPlex 2200 EBV IgG Assay	Epstein-Barr Virus, Early Antigen Diffuse, Viral Capsid Antigen, Nuclear antigen - 1	Multiplex Immunoassay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3498	32_551241_101	32_040	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551241	SeroNet_Reference_Study_visit-01									BioPlex 2200 EBV IgG Assay	Epstein-Barr Virus, Early Antigen Diffuse, Viral Capsid Antigen, Nuclear antigen - 1	Multiplex Immunoassay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3499	32_551242_101	32_040	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551242	SeroNet_Reference_Study_visit-01									BioPlex 2200 EBV IgG Assay	Epstein-Barr Virus, Early Antigen Diffuse, Viral Capsid Antigen, Nuclear antigen - 1	Multiplex Immunoassay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3500	32_551258_101	32_040	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551258	SeroNet_Reference_Study_visit-01									BioPlex 2200 EBV IgG Assay	Epstein-Barr Virus, Early Antigen Diffuse, Viral Capsid Antigen, Nuclear antigen - 1	Multiplex Immunoassay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3501	32_551259_101	32_040	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551259	SeroNet_Reference_Study_visit-01									BioPlex 2200 EBV IgG Assay	Epstein-Barr Virus, Early Antigen Diffuse, Viral Capsid Antigen, Nuclear antigen - 1	Multiplex Immunoassay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3502	32_551261_101	32_040	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551261	SeroNet_Reference_Study_visit-01									BioPlex 2200 EBV IgG Assay	Epstein-Barr Virus, Early Antigen Diffuse, Viral Capsid Antigen, Nuclear antigen - 1	Multiplex Immunoassay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3503	32_551261_101	32_060	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551261	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, Nucleocapsid	ELISA		IgG	2	OD	Positive
	refr-multi_lat-3504	32_551261_101	32_065	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551261	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-HKU1, Nucleocapsid	ELISA		IgG	1	OD	Positive
	refr-multi_lat-3505	32_551261_101	32_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551261	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-NL63, Nucleocapsid	ELISA		IgG	1.7	OD	Positive
	refr-multi_lat-3506	32_551261_101	32_075	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551261	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-OC43, Nucleocapsid	ELISA		IgG	1.8	OD	Positive
	refr-multi_lat-3507	32_551290_101	32_040	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551290	SeroNet_Reference_Study_visit-01									BioPlex 2200 EBV IgG Assay	Epstein-Barr Virus, Early Antigen Diffuse, Viral Capsid Antigen, Nuclear antigen - 1	Multiplex Immunoassay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3508	32_551290_101	32_060	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551290	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, Nucleocapsid	ELISA		IgG	2.1	OD	Positive
	refr-multi_lat-3509	32_551290_101	32_065	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551290	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-HKU1, Nucleocapsid	ELISA		IgG	0.7	OD	Positive
	refr-multi_lat-3510	32_551290_101	32_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551290	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-NL63, Nucleocapsid	ELISA		IgG	0.9	OD	Positive
	refr-multi_lat-3511	32_551290_101	32_075	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551290	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-OC43, Nucleocapsid	ELISA		IgG	0.6	OD	Positive
	refr-multi_lat-3512	32_551294_101	32_040	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551294	SeroNet_Reference_Study_visit-01									BioPlex 2200 EBV IgG Assay	Epstein-Barr Virus, Early Antigen Diffuse, Viral Capsid Antigen, Nuclear antigen - 1	Multiplex Immunoassay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3513	32_551294_101	32_060	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551294	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, Nucleocapsid	ELISA		IgG	1.2	OD	Positive
	refr-multi_lat-3514	32_551294_101	32_065	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551294	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-HKU1, Nucleocapsid	ELISA		IgG	1.2	OD	Positive
	refr-multi_lat-3515	32_551294_101	32_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551294	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-NL63, Nucleocapsid	ELISA		IgG	0.8	OD	Positive
	refr-multi_lat-3516	32_551294_101	32_075	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551294	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-OC43, Nucleocapsid	ELISA		IgG	1.6	OD	Positive
	refr-multi_lat-3517	32_551295_101	32_040	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551295	SeroNet_Reference_Study_visit-01									BioPlex 2200 EBV IgG Assay	Epstein-Barr Virus, Early Antigen Diffuse, Viral Capsid Antigen, Nuclear antigen - 1	Multiplex Immunoassay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3518	32_551295_101	32_060	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551295	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, Nucleocapsid	ELISA		IgG	1.6	OD	Positive
	refr-multi_lat-3519	32_551295_101	32_065	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551295	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-HKU1, Nucleocapsid	ELISA		IgG	2	OD	Positive
	refr-multi_lat-3520	32_551295_101	32_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551295	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-NL63, Nucleocapsid	ELISA		IgG	1.4	OD	Positive
	refr-multi_lat-3521	32_551295_101	32_075	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551295	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-OC43, Nucleocapsid	ELISA		IgG	2.4	OD	Positive
	refr-multi_lat-3522	32_551296_101	32_060	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551296	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, Nucleocapsid	ELISA		IgG	1.8	OD	Positive
	refr-multi_lat-3523	32_551296_101	32_065	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551296	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-HKU1, Nucleocapsid	ELISA		IgG	0.8	OD	Positive
	refr-multi_lat-3524	32_551296_101	32_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551296	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-NL63, Nucleocapsid	ELISA		IgG	1.3	OD	Positive
	refr-multi_lat-3525	32_551296_101	32_075	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551296	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-OC43, Nucleocapsid	ELISA		IgG	2	OD	Positive
	refr-multi_lat-3526	32_551299_101	32_040	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551299	SeroNet_Reference_Study_visit-01									BioPlex 2200 EBV IgG Assay	Epstein-Barr Virus, Early Antigen Diffuse, Viral Capsid Antigen, Nuclear antigen - 1	Multiplex Immunoassay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3527	32_551299_101	32_060	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551299	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, Nucleocapsid	ELISA		IgG	0.8	OD	Positive
	refr-multi_lat-3528	32_551299_101	32_065	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551299	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-HKU1, Nucleocapsid	ELISA		IgG	0.5	OD	Positive
	refr-multi_lat-3529	32_551299_101	32_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551299	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-NL63, Nucleocapsid	ELISA		IgG	0.7	OD	Positive
	refr-multi_lat-3530	32_551299_101	32_075	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551299	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-OC43, Nucleocapsid	ELISA		IgG	0.9	OD	Positive
	refr-multi_lat-3531	32_551300_101	32_040	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551300	SeroNet_Reference_Study_visit-01									BioPlex 2200 EBV IgG Assay	Epstein-Barr Virus, Early Antigen Diffuse, Viral Capsid Antigen, Nuclear antigen - 1	Multiplex Immunoassay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3532	32_551300_101	32_060	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551300	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, Nucleocapsid	ELISA		IgG	1.4	OD	Positive
	refr-multi_lat-3533	32_551300_101	32_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551300	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-NL63, Nucleocapsid	ELISA		IgG	1.1	OD	Positive
	refr-multi_lat-3534	32_551300_101	32_075	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551300	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-OC43, Nucleocapsid	ELISA		IgG	0.8	OD	Positive
	refr-multi_lat-3535	32_551301_101	32_040	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551301	SeroNet_Reference_Study_visit-01									BioPlex 2200 EBV IgG Assay	Epstein-Barr Virus, Early Antigen Diffuse, Viral Capsid Antigen, Nuclear antigen - 1	Multiplex Immunoassay		IgG	NA	Not Specified	Positive
	refr-multi_lat-3536	32_551301_101	32_060	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551301	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, Nucleocapsid	ELISA		IgG	1.9	OD	Positive
	refr-multi_lat-3537	32_551301_101	32_065	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551301	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-HKU1, Nucleocapsid	ELISA		IgG	0.4	OD	Positive
	refr-multi_lat-3538	32_551301_101	32_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551301	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-NL63, Nucleocapsid	ELISA		IgG	1.5	OD	Positive
	refr-multi_lat-3539	32_551301_101	32_075	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551301	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-OC43, Nucleocapsid	ELISA		IgG	2.4	OD	Positive
	refr-multi_lat-3540	32_551302_103	32_060	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551302	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, Nucleocapsid	ELISA		IgG	2	OD	Positive
	refr-multi_lat-3541	32_551302_103	32_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551302	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-NL63, Nucleocapsid	ELISA		IgG	1.5	OD	Positive
	refr-multi_lat-3542	32_551302_103	32_075	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551302	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-OC43, Nucleocapsid	ELISA		IgG	0.8	OD	Positive
	refr-multi_lat-3543	32_551303_103	32_060	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551303	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, Nucleocapsid	ELISA		IgG	1.2	OD	Positive
	refr-multi_lat-3544	32_551303_103	32_065	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551303	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-HKU1, Nucleocapsid	ELISA		IgG	0.7	OD	Positive
	refr-multi_lat-3545	32_551303_103	32_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551303	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-NL63, Nucleocapsid	ELISA		IgG	0.7	OD	Positive
	refr-multi_lat-3546	32_551303_103	32_075	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551303	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-OC43, Nucleocapsid	ELISA		IgG	1	OD	Positive
	refr-multi_lat-3547	32_551305_103	32_060	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551305	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, Nucleocapsid	ELISA		IgG	2.2	OD	Positive
	refr-multi_lat-3548	32_551305_103	32_065	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551305	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-HKU1, Nucleocapsid	ELISA		IgG	0.5	OD	Positive
	refr-multi_lat-3549	32_551305_103	32_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551305	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-NL63, Nucleocapsid	ELISA		IgG	0.8	OD	Positive
	refr-multi_lat-3550	32_551305_103	32_075	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551305	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-OC43, Nucleocapsid	ELISA		IgG	1.7	OD	Positive
	refr-multi_lat-3551	32_551307_103	32_060	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551307	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, Nucleocapsid	ELISA		IgG	1.6	OD	Positive
	refr-multi_lat-3552	32_551307_103	32_065	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551307	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-HKU1, Nucleocapsid	ELISA		IgG	0.6	OD	Positive
	refr-multi_lat-3553	32_551307_103	32_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551307	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-NL63, Nucleocapsid	ELISA		IgG	1.5	OD	Positive
	refr-multi_lat-3554	32_551307_103	32_075	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551307	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-OC43, Nucleocapsid	ELISA		IgG	2.4	OD	Positive
	refr-multi_lat-3555	32_551308_103	32_060	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551308	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, Nucleocapsid	ELISA		IgG	1.7	OD	Positive
	refr-multi_lat-3556	32_551308_103	32_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551308	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-NL63, Nucleocapsid	ELISA		IgG	0.7	OD	Positive
	refr-multi_lat-3557	32_551308_103	32_075	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551308	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-OC43, Nucleocapsid	ELISA		IgG	1.1	OD	Positive
	refr-multi_lat-3558	32_551309_103	32_060	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551309	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, Nucleocapsid	ELISA		IgG	2	OD	Positive
	refr-multi_lat-3559	32_551309_103	32_065	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551309	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-HKU1, Nucleocapsid	ELISA		IgG	0.7	OD	Positive
	refr-multi_lat-3560	32_551309_103	32_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551309	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-NL63, Nucleocapsid	ELISA		IgG	0.9	OD	Positive
	refr-multi_lat-3561	32_551309_103	32_075	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551309	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-OC43, Nucleocapsid	ELISA		IgG	1.8	OD	Positive
	refr-multi_lat-3562	32_551310_103	32_060	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551310	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, Nucleocapsid	ELISA		IgG	1.7	OD	Positive
	refr-multi_lat-3563	32_551310_103	32_065	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551310	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-HKU1, Nucleocapsid	ELISA		IgG	1.9	OD	Positive
	refr-multi_lat-3564	32_551310_103	32_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551310	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-NL63, Nucleocapsid	ELISA		IgG	1.1	OD	Positive
	refr-multi_lat-3565	32_551310_103	32_075	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551310	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-OC43, Nucleocapsid	ELISA		IgG	1.6	OD	Positive
	refr-multi_lat-3566	32_551313_103	32_060	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551313	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, Nucleocapsid	ELISA		IgG	1.2	OD	Positive
	refr-multi_lat-3567	32_551313_103	32_065	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551313	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-HKU1, Nucleocapsid	ELISA		IgG	1.8	OD	Positive
	refr-multi_lat-3568	32_551313_103	32_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551313	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-NL63, Nucleocapsid	ELISA		IgG	0.7	OD	Positive
	refr-multi_lat-3569	32_551313_103	32_075	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551313	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-OC43, Nucleocapsid	ELISA		IgG	0.8	OD	Positive
	refr-multi_lat-3570	32_551315_103	32_060	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551315	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, Nucleocapsid	ELISA		IgG	1.2	OD	Positive
	refr-multi_lat-3571	32_551315_103	32_065	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551315	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-HKU1, Nucleocapsid	ELISA		IgG	1.9	OD	Positive
	refr-multi_lat-3572	32_551315_103	32_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551315	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-NL63, Nucleocapsid	ELISA		IgG	0.8	OD	Positive
	refr-multi_lat-3573	32_551315_103	32_075	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551315	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-OC43, Nucleocapsid	ELISA		IgG	2	OD	Positive
	refr-multi_lat-3574	32_551316_103	32_060	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551316	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, Nucleocapsid	ELISA		IgG	1.8	OD	Positive
	refr-multi_lat-3575	32_551316_103	32_065	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551316	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-HKU1, Nucleocapsid	ELISA		IgG	1.3	OD	Positive
	refr-multi_lat-3576	32_551316_103	32_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551316	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-NL63, Nucleocapsid	ELISA		IgG	1.6	OD	Positive
	refr-multi_lat-3577	32_551316_103	32_075	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551316	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-OC43, Nucleocapsid	ELISA		IgG	2.6	OD	Positive
	refr-multi_lat-3578	32_551319_103	32_060	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551319	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, Nucleocapsid	ELISA		IgG	1.8	OD	Positive
	refr-multi_lat-3579	32_551319_103	32_065	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551319	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-HKU1, Nucleocapsid	ELISA		IgG	1.5	OD	Positive
	refr-multi_lat-3580	32_551319_103	32_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551319	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-NL63, Nucleocapsid	ELISA		IgG	1.6	OD	Positive
	refr-multi_lat-3581	32_551319_103	32_075	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551319	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-OC43, Nucleocapsid	ELISA		IgG	1.1	OD	Positive
	refr-multi_lat-3582	32_551320_103	32_060	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551320	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, Nucleocapsid	ELISA		IgG	2	OD	Positive
	refr-multi_lat-3583	32_551320_103	32_075	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551320	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-OC43, Nucleocapsid	ELISA		IgG	1.2	OD	Positive
	refr-multi_lat-3584	32_551321_103	32_060	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551321	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, Nucleocapsid	ELISA		IgG	1.3	OD	Positive
	refr-multi_lat-3585	32_551321_103	32_065	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551321	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-HKU1, Nucleocapsid	ELISA		IgG	1.3	OD	Positive
	refr-multi_lat-3586	32_551321_103	32_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551321	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-NL63, Nucleocapsid	ELISA		IgG	0.6	OD	Positive
	refr-multi_lat-3587	32_551321_103	32_075	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551321	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-OC43, Nucleocapsid	ELISA		IgG	1.7	OD	Positive
	refr-multi_lat-3588	32_551322_103	32_060	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551322	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, Nucleocapsid	ELISA		IgG	1.3	OD	Positive
	refr-multi_lat-3589	32_551322_103	32_065	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551322	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-HKU1, Nucleocapsid	ELISA		IgG	0.6	OD	Positive
	refr-multi_lat-3590	32_551322_103	32_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551322	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-NL63, Nucleocapsid	ELISA		IgG	0.9	OD	Positive
	refr-multi_lat-3591	32_551322_103	32_075	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551322	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-OC43, Nucleocapsid	ELISA		IgG	2	OD	Positive
	refr-multi_lat-3592	32_551323_103	32_060	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551323	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, Nucleocapsid	ELISA		IgG	1.9	OD	Positive
	refr-multi_lat-3593	32_551323_103	32_065	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551323	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-HKU1, Nucleocapsid	ELISA		IgG	0.7	OD	Positive
	refr-multi_lat-3594	32_551323_103	32_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551323	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-NL63, Nucleocapsid	ELISA		IgG	0.5	OD	Positive
	refr-multi_lat-3595	32_551323_103	32_075	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551323	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-OC43, Nucleocapsid	ELISA		IgG	1.1	OD	Positive
	refr-multi_lat-3596	32_551324_101	32_060	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551324	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, Nucleocapsid	ELISA		IgG	2	OD	Positive
	refr-multi_lat-3597	32_551324_101	32_065	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551324	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-HKU1, Nucleocapsid	ELISA		IgG	1.2	OD	Positive
	refr-multi_lat-3598	32_551324_101	32_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551324	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-NL63, Nucleocapsid	ELISA		IgG	1.4	OD	Positive
	refr-multi_lat-3599	32_551324_101	32_075	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551324	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-OC43, Nucleocapsid	ELISA		IgG	2	OD	Positive
	refr-multi_lat-3600	32_551325_101	32_060	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551325	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, Nucleocapsid	ELISA		IgG	1.5	OD	Positive
	refr-multi_lat-3601	32_551325_101	32_065	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551325	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-HKU1, Nucleocapsid	ELISA		IgG	1.3	OD	Positive
	refr-multi_lat-3602	32_551325_101	32_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551325	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-NL63, Nucleocapsid	ELISA		IgG	1	OD	Positive
	refr-multi_lat-3603	32_551325_101	32_075	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551325	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-OC43, Nucleocapsid	ELISA		IgG	1.9	OD	Positive
	refr-multi_lat-3604	32_551326_101	32_060	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551326	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, Nucleocapsid	ELISA		IgG	1	OD	Positive
	refr-multi_lat-3605	32_551326_101	32_065	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551326	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-HKU1, Nucleocapsid	ELISA		IgG	1.4	OD	Positive
	refr-multi_lat-3606	32_551326_101	32_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551326	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-NL63, Nucleocapsid	ELISA		IgG	1.3	OD	Positive
	refr-multi_lat-3607	32_551326_101	32_075	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551326	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-OC43, Nucleocapsid	ELISA		IgG	1.6	OD	Positive
	refr-multi_lat-3608	32_551328_103	32_060	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551328	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, Nucleocapsid	ELISA		IgG	2.2	OD	Positive
	refr-multi_lat-3609	32_551328_103	32_065	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551328	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-HKU1, Nucleocapsid	ELISA		IgG	1.3	OD	Positive
	refr-multi_lat-3610	32_551328_103	32_070	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551328	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-NL63, Nucleocapsid	ELISA		IgG	2.1	OD	Positive
	refr-multi_lat-3611	32_551328_103	32_075	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	32_551328	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-OC43, Nucleocapsid	ELISA		IgG	2.5	OD	Positive
	refr-multi_lat-3612	41_100009_100	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100009	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	6.6	U/mL	Positive
	refr-multi_lat-3613	41_100009_100	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100009	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-3614	41_100009_100	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100009	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	500	U/mL	Positive
	refr-multi_lat-3615	41_100009_100	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100009	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	109	AU/mL	Positive
	refr-multi_lat-3616	41_100009_100	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100009	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	28.2	Index	Positive
	refr-multi_lat-3617	41_100011_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100011	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-3618	41_100011_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100011	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	15	U/mL	Positive
	refr-multi_lat-3619	41_100011_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100011	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	332	U/mL	Positive
	refr-multi_lat-3620	41_100012_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100012	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	10	U/mL	Positive
	refr-multi_lat-3621	41_100012_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100012	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	44.3	U/mL	Positive
	refr-multi_lat-3622	41_100012_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100012	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	474	U/mL	Positive
	refr-multi_lat-3623	41_100012_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100012	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	342	U/mL	Positive
	refr-multi_lat-3624	41_100014_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100014	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	183	U/mL	Positive
	refr-multi_lat-3625	41_100014_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100014	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	150	U/mL	Positive
	refr-multi_lat-3626	41_100014_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100014	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	81.4	U/mL	Positive
	refr-multi_lat-3627	41_100015_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100015	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-3628	41_100015_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100015	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	394	U/mL	Positive
	refr-multi_lat-3629	41_100021_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100021	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	10	U/mL	Positive
	refr-multi_lat-3630	41_100021_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100021	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	395	U/mL	Positive
	refr-multi_lat-3631	41_100021_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100021	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	584	U/mL	Positive
	refr-multi_lat-3632	41_100033_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100033	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	4.8	U/mL	Positive
	refr-multi_lat-3633	41_100033_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100033	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	123	U/mL	Positive
	refr-multi_lat-3634	41_100033_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100033	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	110	AU/mL	Positive
	refr-multi_lat-3635	41_100057_102	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100057	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	102	U/mL	Positive
	refr-multi_lat-3636	41_100057_102	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100057	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	260	U/mL	Positive
	refr-multi_lat-3637	41_100059_100	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100059	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	124	U/mL	Positive
	refr-multi_lat-3638	41_100059_100	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100059	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	263	U/mL	Positive
	refr-multi_lat-3639	41_100062_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100062	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	10	U/mL	Positive
	refr-multi_lat-3640	41_100062_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100062	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-3641	41_100062_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100062	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	112	U/mL	Positive
	refr-multi_lat-3642	41_100062_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100062	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	96.5	U/mL	Positive
	refr-multi_lat-3643	41_100063_100	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100063	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	5.9	U/mL	Positive
	refr-multi_lat-3644	41_100063_100	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100063	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	150	U/mL	Positive
	refr-multi_lat-3645	41_100063_100	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100063	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	413	U/mL	Positive
	refr-multi_lat-3646	41_100064_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100064	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-3647	41_100064_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100064	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	528	U/mL	Positive
	refr-multi_lat-3648	41_100066_100	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100066	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	45.2	U/mL	Positive
	refr-multi_lat-3649	41_100066_100	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100066	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	600	U/mL	Positive
	refr-multi_lat-3650	41_100069_100	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100069	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	10	U/mL	Positive
	refr-multi_lat-3651	41_100069_100	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100069	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	33.2	U/mL	Positive
	refr-multi_lat-3652	41_100071_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100071	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	119	U/mL	Positive
	refr-multi_lat-3653	41_100071_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100071	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	360	U/mL	Positive
	refr-multi_lat-3654	41_100072_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100072	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-3655	41_100072_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100072	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	565	U/mL	Positive
	refr-multi_lat-3656	41_100074_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100074	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	10	U/mL	Positive
	refr-multi_lat-3657	41_100074_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100074	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	209	U/mL	Positive
	refr-multi_lat-3658	41_100074_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100074	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	59.1	U/mL	Positive
	refr-multi_lat-3659	41_100076_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100076	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	160	U/mL	Positive
	refr-multi_lat-3660	41_100076_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100076	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-3661	41_100076_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100076	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	600	U/mL	Positive
	refr-multi_lat-3662	41_100077_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100077	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	507	U/mL	Positive
	refr-multi_lat-3663	41_100077_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100077	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	361	U/mL	Positive
	refr-multi_lat-3664	41_100078_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100078	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-3665	41_100078_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100078	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	92.7	U/mL	Positive
	refr-multi_lat-3666	41_100078_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100078	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	600	U/mL	Positive
	refr-multi_lat-3667	41_100079_100	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100079	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	324	U/mL	Positive
	refr-multi_lat-3668	41_100079_100	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100079	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	100	U/mL	Positive
	refr-multi_lat-3669	41_100079_100	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100079	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	600	U/mL	Positive
	refr-multi_lat-3670	41_100080_100	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100080	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	3.5	U/mL	Positive
	refr-multi_lat-3671	41_100080_100	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100080	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	50.7	U/mL	Positive
	refr-multi_lat-3672	41_100080_100	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100080	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	578	U/mL	Positive
	refr-multi_lat-3673	41_100081_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100081	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	26.8	U/mL	Positive
	refr-multi_lat-3674	41_100083_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100083	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	28.9	U/mL	Positive
	refr-multi_lat-3675	41_100083_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100083	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	497	U/mL	Positive
	refr-multi_lat-3676	41_100085_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100085	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-3677	41_100085_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100085	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	406	U/mL	Positive
	refr-multi_lat-3678	41_100090_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100090	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	10	U/mL	Positive
	refr-multi_lat-3679	41_100090_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100090	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	305	U/mL	Positive
	refr-multi_lat-3680	41_100090_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100090	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	19.9	U/mL	Positive
	refr-multi_lat-3681	41_100090_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100090	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	21.5	AU/mL	Positive
	refr-multi_lat-3682	41_100090_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100090	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	1.96	Index	Positive
	refr-multi_lat-3683	41_100091_102	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100091	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	47.7	U/mL	Positive
	refr-multi_lat-3684	41_100091_102	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100091	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	345	U/mL	Positive
	refr-multi_lat-3685	41_100091_102	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100091	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	0.6861	OD	Positive
	refr-multi_lat-3686	41_100091_102	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100091	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	0.4111	OD	Positive
	refr-multi_lat-3687	41_100091_102	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100091	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.1578	OD	Positive
	refr-multi_lat-3688	41_100091_102	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100091	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.4761	OD	Positive
	refr-multi_lat-3689	41_100092_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100092	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	4.33	Index	Positive
	refr-multi_lat-3690	41_100093_100	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100093	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-3691	41_100093_100	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100093	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	21.7	AU/mL	Positive
	refr-multi_lat-3692	41_100093_100	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100093	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	2.8	Index	Positive
	refr-multi_lat-3693	41_100096_100	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100096	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	50.7	U/mL	Positive
	refr-multi_lat-3694	41_100096_100	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100096	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	380	U/mL	Positive
	refr-multi_lat-3695	41_100096_100	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100096	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	54.5	U/mL	Positive
	refr-multi_lat-3696	41_100096_100	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100096	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	226	U/mL	Positive
	refr-multi_lat-3697	41_100097_100	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100097	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	6.4	U/mL	Positive
	refr-multi_lat-3698	41_100097_100	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100097	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	71.8	U/mL	Positive
	refr-multi_lat-3699	41_100097_100	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100097	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	20	U/mL	Positive
	refr-multi_lat-3700	41_100097_100	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100097	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	457	U/mL	Positive
	refr-multi_lat-3701	41_100098_100	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100098	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	160	U/mL	Positive
	refr-multi_lat-3702	41_100098_100	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100098	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	87.4	U/mL	Positive
	refr-multi_lat-3703	41_100098_100	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100098	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	141	U/mL	Positive
	refr-multi_lat-3704	41_100099_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100099	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-3705	41_100099_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100099	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	15.1	U/mL	Positive
	refr-multi_lat-3706	41_100099_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100099	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	63.8	U/mL	Positive
	refr-multi_lat-3707	41_100100_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100100	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	161	U/mL	Positive
	refr-multi_lat-3708	41_100100_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100100	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	32	U/mL	Positive
	refr-multi_lat-3709	41_100101_100	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100101	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	5.5	U/mL	Positive
	refr-multi_lat-3710	41_100101_100	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100101	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	197	U/mL	Positive
	refr-multi_lat-3711	41_100101_100	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100101	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	12	U/mL	Positive
	refr-multi_lat-3712	41_100101_100	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100101	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	40.3	U/mL	Positive
	refr-multi_lat-3713	41_100102_100	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100102	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	315	U/mL	Positive
	refr-multi_lat-3714	41_100102_100	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100102	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	100	U/mL	Positive
	refr-multi_lat-3715	41_100104_100	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100104	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-3716	41_100104_100	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100104	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	150	U/mL	Positive
	refr-multi_lat-3717	41_100104_100	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100104	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	384	U/mL	Positive
	refr-multi_lat-3718	41_100105_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100105	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	382	U/mL	Positive
	refr-multi_lat-3719	41_100105_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100105	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	150	U/mL	Positive
	refr-multi_lat-3720	41_100105_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100105	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	199	U/mL	Positive
	refr-multi_lat-3721	41_100105_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100105	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	15.3	AU/mL	Positive
	refr-multi_lat-3722	41_100105_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100105	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	14.4	Index	Positive
	refr-multi_lat-3723	41_100106_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100106	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	8.8	U/mL	Positive
	refr-multi_lat-3724	41_100106_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100106	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	62.3	U/mL	Positive
	refr-multi_lat-3725	41_100106_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100106	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	20.7	U/mL	Positive
	refr-multi_lat-3726	41_100106_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100106	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	600	U/mL	Positive
	refr-multi_lat-3727	41_100107_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100107	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	7	U/mL	Positive
	refr-multi_lat-3728	41_100107_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100107	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	32.9	U/mL	Positive
	refr-multi_lat-3729	41_100107_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100107	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	362	U/mL	Positive
	refr-multi_lat-3730	41_100108_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100108	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	7.1	U/mL	Positive
	refr-multi_lat-3731	41_100108_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100108	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-3732	41_100108_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100108	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	118	U/mL	Positive
	refr-multi_lat-3733	41_100109_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100109	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	1.1	U/mL	Positive
	refr-multi_lat-3734	41_100109_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100109	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	182	U/mL	Positive
	refr-multi_lat-3735	41_100109_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100109	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	22	U/mL	Positive
	refr-multi_lat-3736	41_100110_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100110	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	10	U/mL	Positive
	refr-multi_lat-3737	41_100110_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100110	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-3738	41_100110_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100110	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	150	U/mL	Positive
	refr-multi_lat-3739	41_100110_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100110	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	600	U/mL	Positive
	refr-multi_lat-3740	41_100111_100	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100111	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-3741	41_100111_100	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100111	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	600	U/mL	Positive
	refr-multi_lat-3742	41_100112_100	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100112	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	8.4	U/mL	Positive
	refr-multi_lat-3743	41_100112_100	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100112	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	339	U/mL	Positive
	refr-multi_lat-3744	41_100112_100	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100112	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	26.6	U/mL	Positive
	refr-multi_lat-3745	41_100114_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100114	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-3746	41_100114_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100114	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	88	U/mL	Positive
	refr-multi_lat-3747	41_100114_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100114	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	600	U/mL	Positive
	refr-multi_lat-3748	41_100115_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100115	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	57.1	U/mL	Positive
	refr-multi_lat-3749	41_100115_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100115	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	600	U/mL	Positive
	refr-multi_lat-3750	41_100115_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100115	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	1.34	Index	Positive
	refr-multi_lat-3751	41_100116_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100116	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	5.3	U/mL	Positive
	refr-multi_lat-3752	41_100116_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100116	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	504	U/mL	Positive
	refr-multi_lat-3753	41_100116_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100116	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	35.3	U/mL	Positive
	refr-multi_lat-3754	41_100116_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100116	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	404	U/mL	Positive
	refr-multi_lat-3755	41_100119_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100119	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	0.84	U/mL	Positive
	refr-multi_lat-3756	41_100119_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100119	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-3757	41_100119_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100119	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	442	U/mL	Positive
	refr-multi_lat-3758	41_100120_100	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100120	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	4.5	U/mL	Positive
	refr-multi_lat-3759	41_100120_100	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100120	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-3760	41_100120_100	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100120	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	28.5	U/mL	Positive
	refr-multi_lat-3761	41_100120_100	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100120	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	150	U/mL	Positive
	refr-multi_lat-3762	41_100120_100	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100120	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	29.8	AU/mL	Positive
	refr-multi_lat-3763	41_100122_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100122	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-3764	41_100122_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100122	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	507	U/mL	Positive
	refr-multi_lat-3765	41_100123_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100123	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	9.6	U/mL	Positive
	refr-multi_lat-3766	41_100123_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100123	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	391	U/mL	Positive
	refr-multi_lat-3767	41_100123_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100123	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	67.2	U/mL	Positive
	refr-multi_lat-3768	41_100123_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100123	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	305	U/mL	Positive
	refr-multi_lat-3769	41_100124_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100124	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-3770	41_100124_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100124	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	109	U/mL	Positive
	refr-multi_lat-3771	41_100125_100	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100125	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-3772	41_100125_100	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100125	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	26.8	U/mL	Positive
	refr-multi_lat-3773	41_100126_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100126	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	69	U/mL	Positive
	refr-multi_lat-3774	41_100126_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100126	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	168	U/mL	Positive
	refr-multi_lat-3775	41_100126_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100126	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	34.4	U/mL	Positive
	refr-multi_lat-3776	41_100126_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100126	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	294	U/mL	Positive
	refr-multi_lat-3777	41_100126_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100126	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	2.06	Index	Positive
	refr-multi_lat-3778	41_100127_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100127	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-3779	41_100127_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100127	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	135	U/mL	Positive
	refr-multi_lat-3780	41_100127_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100127	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	22	AU/mL	Positive
	refr-multi_lat-3781	41_100127_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100127	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	5.55	Index	Positive
	refr-multi_lat-3782	41_100128_100	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100128	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-3783	41_100128_100	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100128	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	150	U/mL	Positive
	refr-multi_lat-3784	41_100128_100	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100128	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	331	U/mL	Positive
	refr-multi_lat-3785	41_100132_100	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100132	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	68.6	U/mL	Positive
	refr-multi_lat-3786	41_100133_100	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100133	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-3787	41_100133_100	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100133	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	318	U/mL	Positive
	refr-multi_lat-3788	41_100135_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100135	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	69.7	U/mL	Positive
	refr-multi_lat-3789	41_100135_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100135	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	238	U/mL	Positive
	refr-multi_lat-3790	41_100136_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100136	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	271	U/mL	Positive
	refr-multi_lat-3791	41_100136_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100136	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	150	U/mL	Positive
	refr-multi_lat-3792	41_100136_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100136	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	321	U/mL	Positive
	refr-multi_lat-3793	41_100138_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100138	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	4.8	U/mL	Positive
	refr-multi_lat-3794	41_100138_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100138	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	354	U/mL	Positive
	refr-multi_lat-3795	41_100138_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100138	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	600	U/mL	Positive
	refr-multi_lat-3796	41_100138_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100138	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	81.1	AU/mL	Positive
	refr-multi_lat-3797	41_100139_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100139	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	126	U/mL	Positive
	refr-multi_lat-3798	41_100139_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100139	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	33.4	U/mL	Positive
	refr-multi_lat-3799	41_100139_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100139	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	414	U/mL	Positive
	refr-multi_lat-3800	41_100140_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100140	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	63.7	U/mL	Positive
	refr-multi_lat-3801	41_100140_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100140	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	436	U/mL	Positive
	refr-multi_lat-3802	41_100144_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100144	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-3803	41_100144_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100144	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	226	U/mL	Positive
	refr-multi_lat-3804	41_100144_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100144	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	92.2	AU/mL	Positive
	refr-multi_lat-3805	41_100145_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100145	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	542	U/mL	Positive
	refr-multi_lat-3806	41_100145_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100145	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	340	U/mL	Positive
	refr-multi_lat-3807	41_100147_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100147	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	349	U/mL	Positive
	refr-multi_lat-3808	41_100147_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100147	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	11.9	U/mL	Positive
	refr-multi_lat-3809	41_100147_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100147	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	325	U/mL	Positive
	refr-multi_lat-3810	41_100148_100	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100148	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	6.2	U/mL	Positive
	refr-multi_lat-3811	41_100148_100	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100148	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-3812	41_100148_100	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100148	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	600	U/mL	Positive
	refr-multi_lat-3813	41_100149_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100149	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	277	U/mL	Positive
	refr-multi_lat-3814	41_100150_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100150	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-3815	41_100150_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100150	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	150	U/mL	Positive
	refr-multi_lat-3816	41_100150_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100150	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	369	U/mL	Positive
	refr-multi_lat-3817	41_100151_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100151	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	171	U/mL	Positive
	refr-multi_lat-3818	41_100151_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100151	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	117	U/mL	Positive
	refr-multi_lat-3819	41_100152_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100152	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	617	U/mL	Positive
	refr-multi_lat-3820	41_100152_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100152	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	26.6	U/mL	Positive
	refr-multi_lat-3821	41_100152_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100152	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	525	U/mL	Positive
	refr-multi_lat-3822	41_100153_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100153	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	668	U/mL	Positive
	refr-multi_lat-3823	41_100153_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100153	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	150	U/mL	Positive
	refr-multi_lat-3824	41_100153_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100153	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	600	U/mL	Positive
	refr-multi_lat-3825	41_100154_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100154	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	2.6	U/mL	Positive
	refr-multi_lat-3826	41_100154_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100154	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-3827	41_100154_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100154	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	383	U/mL	Positive
	refr-multi_lat-3828	41_100155_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100155	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-3829	41_100155_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100155	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	27.1	U/mL	Positive
	refr-multi_lat-3830	41_100158_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100158	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-3831	41_100158_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100158	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	573	U/mL	Positive
	refr-multi_lat-3832	41_100164_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100164	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	539	U/mL	Positive
	refr-multi_lat-3833	41_100164_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100164	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	199	U/mL	Positive
	refr-multi_lat-3834	41_100164_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100164	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	57.2	AU/mL	Positive
	refr-multi_lat-3835	41_100167_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100167	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	49.7	U/mL	Positive
	refr-multi_lat-3836	41_100168_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100168	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	6.2	U/mL	Positive
	refr-multi_lat-3837	41_100168_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100168	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-3838	41_100168_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100168	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	422	U/mL	Positive
	refr-multi_lat-3839	41_100168_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100168	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	225	AU/mL	Positive
	refr-multi_lat-3840	41_100168_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100168	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	12.6	Index	Positive
	refr-multi_lat-3841	41_100169_100	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100169	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	523	U/mL	Positive
	refr-multi_lat-3842	41_100169_100	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100169	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	600	U/mL	Positive
	refr-multi_lat-3843	41_100169_100	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100169	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	15.9	AU/mL	Positive
	refr-multi_lat-3844	41_100170_100	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100170	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	8.4	U/mL	Positive
	refr-multi_lat-3845	41_100170_100	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100170	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	543	U/mL	Positive
	refr-multi_lat-3846	41_100170_100	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100170	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	393	U/mL	Positive
	refr-multi_lat-3847	41_100171_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100171	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	433	U/mL	Positive
	refr-multi_lat-3848	41_100171_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100171	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	398	U/mL	Positive
	refr-multi_lat-3849	41_100172_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100172	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	6.4	U/mL	Positive
	refr-multi_lat-3850	41_100172_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100172	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-3851	41_100172_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100172	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	600	U/mL	Positive
	refr-multi_lat-3852	41_100172_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100172	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	17.2	AU/mL	Positive
	refr-multi_lat-3853	41_100175_100	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100175	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-3854	41_100175_100	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100175	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	582	U/mL	Positive
	refr-multi_lat-3855	41_100176_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100176	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	384	U/mL	Positive
	refr-multi_lat-3856	41_100176_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100176	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	327	U/mL	Positive
	refr-multi_lat-3857	41_100178_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100178	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	114	U/mL	Positive
	refr-multi_lat-3858	41_100178_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100178	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	158	U/mL	Positive
	refr-multi_lat-3859	41_100178_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100178	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	45.4	AU/mL	Positive
	refr-multi_lat-3860	41_100179_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100179	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	160	U/mL	Positive
	refr-multi_lat-3861	41_100179_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100179	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	276	U/mL	Positive
	refr-multi_lat-3862	41_100181_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100181	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	10	U/mL	Positive
	refr-multi_lat-3863	41_100181_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100181	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	217	U/mL	Positive
	refr-multi_lat-3864	41_100181_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100181	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	564	U/mL	Positive
	refr-multi_lat-3865	41_100184_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100184	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	5.8	U/mL	Positive
	refr-multi_lat-3866	41_100184_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100184	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-3867	41_100184_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100184	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	360	U/mL	Positive
	refr-multi_lat-3868	41_100185_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100185	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	378	U/mL	Positive
	refr-multi_lat-3869	41_100185_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100185	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	11.8	U/mL	Positive
	refr-multi_lat-3870	41_100185_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100185	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	475	U/mL	Positive
	refr-multi_lat-3871	41_100185_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100185	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	43.7	AU/mL	Positive
	refr-multi_lat-3872	41_100189_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100189	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-3873	41_100189_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100189	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	428	U/mL	Positive
	refr-multi_lat-3874	41_100190_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100190	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-3875	41_100190_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100190	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	27.8	U/mL	Positive
	refr-multi_lat-3876	41_100190_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100190	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	466	U/mL	Positive
	refr-multi_lat-3877	41_100194_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100194	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	5	U/mL	Positive
	refr-multi_lat-3878	41_100195_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100195	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	9.9	U/mL	Positive
	refr-multi_lat-3879	41_100195_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100195	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-3880	41_100195_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100195	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	228	U/mL	Positive
	refr-multi_lat-3881	41_100195_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100195	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	77.1	AU/mL	Positive
	refr-multi_lat-3882	41_100196_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100196	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	5.7	U/mL	Positive
	refr-multi_lat-3883	41_100196_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100196	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-3884	41_100196_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100196	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	384	U/mL	Positive
	refr-multi_lat-3885	41_100196_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100196	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	159	AU/mL	Positive
	refr-multi_lat-3886	41_100197_100	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100197	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	6.2	U/mL	Positive
	refr-multi_lat-3887	41_100197_100	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100197	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-3888	41_100197_100	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100197	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	333	U/mL	Positive
	refr-multi_lat-3889	41_100197_100	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100197	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	88.1	AU/mL	Positive
	refr-multi_lat-3890	41_100198_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100198	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	7.5	U/mL	Positive
	refr-multi_lat-3891	41_100198_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100198	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	293	U/mL	Positive
	refr-multi_lat-3892	41_100198_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100198	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	309	U/mL	Positive
	refr-multi_lat-3893	41_100198_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100198	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	29.4	AU/mL	Positive
	refr-multi_lat-3894	41_100202_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100202	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	254	U/mL	Positive
	refr-multi_lat-3895	41_100202_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100202	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	434	U/mL	Positive
	refr-multi_lat-3896	41_100203_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100203	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	19.8	AU/mL	Positive
	refr-multi_lat-3897	41_100207_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100207	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	134	U/mL	Positive
	refr-multi_lat-3898	41_100207_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100207	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	189	U/mL	Positive
	refr-multi_lat-3899	41_100207_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100207	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.3881	OD	Positive
	refr-multi_lat-3900	41_100207_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100207	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.6323	OD	Positive
	refr-multi_lat-3901	41_100207_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100207	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	2.0309	OD	Positive
	refr-multi_lat-3902	41_100207_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100207	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	0.9268	OD	Positive
	refr-multi_lat-3903	41_100208_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100208	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	275	U/mL	Positive
	refr-multi_lat-3904	41_100208_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100208	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	244	U/mL	Positive
	refr-multi_lat-3905	41_100208_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100208	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	48.8	AU/mL	Positive
	refr-multi_lat-3906	41_100209_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100209	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	10	U/mL	Positive
	refr-multi_lat-3907	41_100209_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100209	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-3908	41_100209_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100209	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	150	U/mL	Positive
	refr-multi_lat-3909	41_100209_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100209	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	554	U/mL	Positive
	refr-multi_lat-3910	41_100211_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100211	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	26	AU/mL	Positive
	refr-multi_lat-3911	41_100211_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100211	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	7.75	Index	Positive
	refr-multi_lat-3912	41_100212_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100212	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	548	U/mL	Positive
	refr-multi_lat-3913	41_100212_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100212	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	529	U/mL	Positive
	refr-multi_lat-3914	41_100212_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100212	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	79.8	AU/mL	Positive
	refr-multi_lat-3915	41_100212_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100212	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	1.44	Index	Positive
	refr-multi_lat-3916	41_100214_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100214	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-3917	41_100214_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100214	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	600	U/mL	Positive
	refr-multi_lat-3918	41_100214_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100214	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	20.6	AU/mL	Positive
	refr-multi_lat-3919	41_100216_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100216	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	8	U/mL	Positive
	refr-multi_lat-3920	41_100216_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100216	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-3921	41_100216_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100216	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	150	U/mL	Positive
	refr-multi_lat-3922	41_100216_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100216	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	148	U/mL	Positive
	refr-multi_lat-3923	41_100216_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100216	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	95.4	AU/mL	Positive
	refr-multi_lat-3924	41_100216_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100216	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	7.84	Index	Positive
	refr-multi_lat-3925	41_100218_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100218	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	10	U/mL	Positive
	refr-multi_lat-3926	41_100218_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100218	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-3927	41_100218_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100218	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	600	U/mL	Positive
	refr-multi_lat-3928	41_100218_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100218	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	37.9	AU/mL	Positive
	refr-multi_lat-3929	41_100218_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100218	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	1.47	Index	Positive
	refr-multi_lat-3930	41_100222_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100222	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-3931	41_100222_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100222	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	515	U/mL	Positive
	refr-multi_lat-3932	41_100222_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100222	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.8284	OD	Positive
	refr-multi_lat-3933	41_100222_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100222	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	2.1261	OD	Positive
	refr-multi_lat-3934	41_100222_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100222	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	2.1084	OD	Positive
	refr-multi_lat-3935	41_100222_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100222	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.9749	OD	Positive
	refr-multi_lat-3936	41_100228_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100228	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	6.9	U/mL	Positive
	refr-multi_lat-3937	41_100228_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100228	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	102	U/mL	Positive
	refr-multi_lat-3938	41_100228_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100228	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	105	U/mL	Positive
	refr-multi_lat-3939	41_100228_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100228	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	256	AU/mL	Positive
	refr-multi_lat-3940	41_100228_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100228	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	1.76	Index	Positive
	refr-multi_lat-3941	41_100230_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100230	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	339	U/mL	Positive
	refr-multi_lat-3942	41_100230_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100230	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	532	U/mL	Positive
	refr-multi_lat-3943	41_100230_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100230	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	154	AU/mL	Positive
	refr-multi_lat-3944	41_100230_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100230	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	25.2	Index	Positive
	refr-multi_lat-3945	41_100239_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100239	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	1.2	U/mL	Positive
	refr-multi_lat-3946	41_100239_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100239	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	365	U/mL	Positive
	refr-multi_lat-3947	41_100239_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100239	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	32.3	AU/mL	Positive
	refr-multi_lat-3948	41_100240_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100240	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-3949	41_100240_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100240	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	465	U/mL	Positive
	refr-multi_lat-3950	41_100240_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100240	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	65.9	AU/mL	Positive
	refr-multi_lat-3951	41_100240_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100240	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	4.99	Index	Positive
	refr-multi_lat-3952	41_100241_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100241	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-3953	41_100241_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100241	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	470	U/mL	Positive
	refr-multi_lat-3954	41_100241_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100241	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	53.1	AU/mL	Positive
	refr-multi_lat-3955	41_100242_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100242	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	10	U/mL	Positive
	refr-multi_lat-3956	41_100242_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100242	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-3957	41_100242_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100242	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	14.7	U/mL	Positive
	refr-multi_lat-3958	41_100242_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100242	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	600	U/mL	Positive
	refr-multi_lat-3959	41_100242_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100242	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.5614	OD	Positive
	refr-multi_lat-3960	41_100242_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100242	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	0.8492	OD	Positive
	refr-multi_lat-3961	41_100242_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100242	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	2.0268	OD	Positive
	refr-multi_lat-3962	41_100242_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100242	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	0.68	OD	Positive
	refr-multi_lat-3963	41_100246_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100246	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	1.2	U/mL	Positive
	refr-multi_lat-3964	41_100246_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100246	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	68.2	U/mL	Positive
	refr-multi_lat-3965	41_100246_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100246	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	61.3	U/mL	Positive
	refr-multi_lat-3966	41_100246_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100246	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	28.9	AU/mL	Positive
	refr-multi_lat-3967	41_100246_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100246	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	2.05	Index	Positive
	refr-multi_lat-3968	41_100249_100	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100249	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	302	U/mL	Positive
	refr-multi_lat-3969	41_100249_100	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100249	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	236	U/mL	Positive
	refr-multi_lat-3970	41_100249_100	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100249	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	20	AU/mL	Positive
	refr-multi_lat-3971	41_100250_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100250	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	9.2	U/mL	Positive
	refr-multi_lat-3972	41_100250_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100250	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	745	U/mL	Positive
	refr-multi_lat-3973	41_100250_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100250	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	153	U/mL	Positive
	refr-multi_lat-3974	41_100250_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100250	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	73.7	AU/mL	Positive
	refr-multi_lat-3975	41_100250_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100250	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	2.41	Index	Positive
	refr-multi_lat-3976	41_100251_100	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100251	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	8.2	U/mL	Positive
	refr-multi_lat-3977	41_100251_100	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100251	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	56.7	U/mL	Positive
	refr-multi_lat-3978	41_100251_100	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100251	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	360	U/mL	Positive
	refr-multi_lat-3979	41_100253_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100253	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	46	U/mL	Positive
	refr-multi_lat-3980	41_100253_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100253	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	25.5	U/mL	Positive
	refr-multi_lat-3981	41_100253_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100253	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	1.88	Index	Positive
	refr-multi_lat-3982	41_100254_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100254	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-3983	41_100254_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100254	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	24.1	U/mL	Positive
	refr-multi_lat-3984	41_100254_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100254	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	529	U/mL	Positive
	refr-multi_lat-3985	41_100254_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100254	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	37.9	AU/mL	Positive
	refr-multi_lat-3986	41_100254_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100254	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	4.77	Index	Positive
	refr-multi_lat-3987	41_100255_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100255	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	7.3	U/mL	Positive
	refr-multi_lat-3988	41_100255_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100255	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	44.3	U/mL	Positive
	refr-multi_lat-3989	41_100255_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100255	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	101	U/mL	Positive
	refr-multi_lat-3990	41_100255_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100255	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	48.3	AU/mL	Positive
	refr-multi_lat-3991	41_100257_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100257	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	10	U/mL	Positive
	refr-multi_lat-3992	41_100257_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100257	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	28	U/mL	Positive
	refr-multi_lat-3993	41_100257_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100257	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	12.2	U/mL	Positive
	refr-multi_lat-3994	41_100257_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100257	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	25.9	U/mL	Positive
	refr-multi_lat-3995	41_100257_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100257	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	400	AU/mL	Positive
	refr-multi_lat-3996	41_100258_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100258	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	115	U/mL	Positive
	refr-multi_lat-3997	41_100258_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100258	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	47.5	U/mL	Positive
	refr-multi_lat-3998	41_100258_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100258	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	28.7	AU/mL	Positive
	refr-multi_lat-3999	41_100258_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100258	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	7.74	Index	Positive
	refr-multi_lat-4000	41_100259_100	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100259	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-4001	41_100259_100	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100259	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	234	U/mL	Positive
	refr-multi_lat-4002	41_100263_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100263	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	5.5	U/mL	Positive
	refr-multi_lat-4003	41_100263_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100263	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	68.7	U/mL	Positive
	refr-multi_lat-4004	41_100263_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100263	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	19.6	U/mL	Positive
	refr-multi_lat-4005	41_100263_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100263	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	34.7	U/mL	Positive
	refr-multi_lat-4006	41_100263_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100263	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.2143	OD	Positive
	refr-multi_lat-4007	41_100263_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100263	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.3641	OD	Positive
	refr-multi_lat-4008	41_100263_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100263	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	2.1924	OD	Positive
	refr-multi_lat-4009	41_100263_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100263	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.7073	OD	Positive
	refr-multi_lat-4010	41_100264_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100264	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	20.4	AU/mL	Positive
	refr-multi_lat-4011	41_100270_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100270	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	2.1	U/mL	Positive
	refr-multi_lat-4012	41_100270_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100270	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	165	U/mL	Positive
	refr-multi_lat-4013	41_100270_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100270	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	46.3	U/mL	Positive
	refr-multi_lat-4014	41_100270_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100270	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	51.3	AU/mL	Positive
	refr-multi_lat-4015	41_100274_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100274	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	10	U/mL	Positive
	refr-multi_lat-4016	41_100274_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100274	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-4017	41_100274_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100274	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	150	U/mL	Positive
	refr-multi_lat-4018	41_100274_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100274	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	41.8	U/mL	Positive
	refr-multi_lat-4019	41_100274_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100274	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	90.4	AU/mL	Positive
	refr-multi_lat-4020	41_100276_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100276	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	2.4	U/mL	Positive
	refr-multi_lat-4021	41_100276_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100276	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	421	U/mL	Positive
	refr-multi_lat-4022	41_100276_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100276	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	580	U/mL	Positive
	refr-multi_lat-4023	41_100278_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100278	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	10	U/mL	Positive
	refr-multi_lat-4024	41_100278_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100278	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	111	U/mL	Positive
	refr-multi_lat-4025	41_100278_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100278	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	21.3	U/mL	Positive
	refr-multi_lat-4026	41_100278_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100278	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	160	U/mL	Positive
	refr-multi_lat-4027	41_100278_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100278	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	400	AU/mL	Positive
	refr-multi_lat-4028	41_100278_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100278	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	5.45	Index	Positive
	refr-multi_lat-4029	41_100280_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100280	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	7.7	U/mL	Positive
	refr-multi_lat-4030	41_100280_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100280	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-4031	41_100280_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100280	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	118	U/mL	Positive
	refr-multi_lat-4032	41_100285_100	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100285	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-4033	41_100285_100	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100285	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	11	U/mL	Positive
	refr-multi_lat-4034	41_100285_100	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100285	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	276	U/mL	Positive
	refr-multi_lat-4035	41_100285_100	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100285	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.0918	OD	Positive
	refr-multi_lat-4036	41_100285_100	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100285	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.1728	OD	Positive
	refr-multi_lat-4037	41_100285_100	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100285	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.8509	OD	Positive
	refr-multi_lat-4038	41_100285_100	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100285	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	0.8234	OD	Positive
	refr-multi_lat-4039	41_100292_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100292	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	138	U/mL	Positive
	refr-multi_lat-4040	41_100292_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100292	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	14.6	U/mL	Positive
	refr-multi_lat-4041	41_100292_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100292	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	105	U/mL	Positive
	refr-multi_lat-4042	41_100295_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100295	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	155	U/mL	Positive
	refr-multi_lat-4043	41_100295_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100295	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	14.9	U/mL	Positive
	refr-multi_lat-4044	41_100295_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100295	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	523	U/mL	Positive
	refr-multi_lat-4045	41_100295_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100295	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	107	AU/mL	Positive
	refr-multi_lat-4046	41_100298_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100298	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	5.4	U/mL	Positive
	refr-multi_lat-4047	41_100298_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100298	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	151	U/mL	Positive
	refr-multi_lat-4048	41_100298_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100298	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	51.9	U/mL	Positive
	refr-multi_lat-4049	41_100298_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100298	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	42.6	U/mL	Positive
	refr-multi_lat-4050	41_100298_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100298	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	44.2	AU/mL	Positive
	refr-multi_lat-4051	41_100300_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100300	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-4052	41_100300_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100300	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	600	U/mL	Positive
	refr-multi_lat-4053	41_100300_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100300	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	189	AU/mL	Positive
	refr-multi_lat-4054	41_100300_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100300	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	12.5	Index	Positive
	refr-multi_lat-4055	41_100304_100	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100304	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-4056	41_100304_100	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100304	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	106	U/mL	Positive
	refr-multi_lat-4057	41_100306_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100306	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	10	U/mL	Positive
	refr-multi_lat-4058	41_100306_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100306	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-4059	41_100306_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100306	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	150	U/mL	Positive
	refr-multi_lat-4060	41_100306_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100306	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	575	U/mL	Positive
	refr-multi_lat-4061	41_100307_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100307	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	5.4	U/mL	Positive
	refr-multi_lat-4062	41_100307_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100307	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	44.1	U/mL	Positive
	refr-multi_lat-4063	41_100307_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100307	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	0.74	OD	Positive
	refr-multi_lat-4064	41_100307_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100307	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.1903	OD	Positive
	refr-multi_lat-4065	41_100307_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100307	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.1294	OD	Positive
	refr-multi_lat-4066	41_100307_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100307	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	0.9145	OD	Positive
	refr-multi_lat-4067	41_100313_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100313	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	8.7	U/mL	Positive
	refr-multi_lat-4068	41_100313_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100313	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	595	U/mL	Positive
	refr-multi_lat-4069	41_100313_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100313	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	150	U/mL	Positive
	refr-multi_lat-4070	41_100313_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100313	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	515	U/mL	Positive
	refr-multi_lat-4071	41_100315_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100315	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	10	U/mL	Positive
	refr-multi_lat-4072	41_100315_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100315	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-4073	41_100315_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100315	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	150	U/mL	Positive
	refr-multi_lat-4074	41_100315_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100315	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	84	U/mL	Positive
	refr-multi_lat-4075	41_100320_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100320	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-4076	41_100320_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100320	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	600	U/mL	Positive
	refr-multi_lat-4077	41_100321_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100321	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	8	U/mL	Positive
	refr-multi_lat-4078	41_100321_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100321	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	411	U/mL	Positive
	refr-multi_lat-4079	41_100321_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100321	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	19.1	U/mL	Positive
	refr-multi_lat-4080	41_100321_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100321	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	91.2	U/mL	Positive
	refr-multi_lat-4081	41_100321_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100321	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	79.3	AU/mL	Positive
	refr-multi_lat-4082	41_100322_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100322	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	76.1	U/mL	Positive
	refr-multi_lat-4083	41_100322_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100322	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	515	U/mL	Positive
	refr-multi_lat-4084	41_100323_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100323	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	0.8186	OD	Positive
	refr-multi_lat-4085	41_100323_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100323	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.0461	OD	Positive
	refr-multi_lat-4086	41_100323_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100323	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	2.0382	OD	Positive
	refr-multi_lat-4087	41_100323_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100323	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.2235	OD	Positive
	refr-multi_lat-4088	41_100332_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100332	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	59.5	U/mL	Positive
	refr-multi_lat-4089	41_100332_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100332	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	148	U/mL	Positive
	refr-multi_lat-4090	41_100332_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100332	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.2232	OD	Positive
	refr-multi_lat-4091	41_100332_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100332	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.6021	OD	Positive
	refr-multi_lat-4092	41_100332_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100332	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.9725	OD	Positive
	refr-multi_lat-4093	41_100332_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100332	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	0.4952	OD	Positive
	refr-multi_lat-4094	41_100333_100	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100333	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-4095	41_100333_100	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100333	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	36.9	U/mL	Positive
	refr-multi_lat-4096	41_100333_100	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100333	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	320	U/mL	Positive
	refr-multi_lat-4097	41_100333_100	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100333	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	0.884	OD	Positive
	refr-multi_lat-4098	41_100333_100	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100333	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	0.7496	OD	Positive
	refr-multi_lat-4099	41_100333_100	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100333	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.0319	OD	Positive
	refr-multi_lat-4100	41_100333_100	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100333	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.5136	OD	Positive
	refr-multi_lat-4101	41_100336_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100336	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	2.6	U/mL	Positive
	refr-multi_lat-4102	41_100336_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100336	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-4103	41_100336_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100336	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	39.3	U/mL	Positive
	refr-multi_lat-4104	41_100336_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100336	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	600	U/mL	Positive
	refr-multi_lat-4105	41_100336_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100336	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.6798	OD	Positive
	refr-multi_lat-4106	41_100336_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100336	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.2941	OD	Positive
	refr-multi_lat-4107	41_100336_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100336	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.9388	OD	Positive
	refr-multi_lat-4108	41_100336_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100336	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.4954	OD	Positive
	refr-multi_lat-4109	41_100337_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100337	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	7.9	U/mL	Positive
	refr-multi_lat-4110	41_100337_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100337	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-4111	41_100337_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100337	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	503	U/mL	Positive
	refr-multi_lat-4112	41_100337_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100337	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.4249	OD	Positive
	refr-multi_lat-4113	41_100337_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100337	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	0.5874	OD	Positive
	refr-multi_lat-4114	41_100337_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100337	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.9239	OD	Positive
	refr-multi_lat-4115	41_100337_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100337	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.0222	OD	Positive
	refr-multi_lat-4116	41_100371_100	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100371	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	253	U/mL	Positive
	refr-multi_lat-4117	41_100371_100	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100371	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	38.2	U/mL	Positive
	refr-multi_lat-4118	41_100371_100	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100371	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	222	U/mL	Positive
	refr-multi_lat-4119	41_100371_100	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100371	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	0.9646	OD	Positive
	refr-multi_lat-4120	41_100371_100	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100371	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	0.7905	OD	Positive
	refr-multi_lat-4121	41_100371_100	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100371	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.8512	OD	Positive
	refr-multi_lat-4122	41_100371_100	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100371	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.8755	OD	Positive
	refr-multi_lat-4123	41_100396_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100396	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	8.7	U/mL	Positive
	refr-multi_lat-4124	41_100396_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100396	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	344	U/mL	Positive
	refr-multi_lat-4125	41_100396_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100396	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	600	U/mL	Positive
	refr-multi_lat-4126	41_100396_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100396	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.0788	OD	Positive
	refr-multi_lat-4127	41_100396_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100396	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	0.958	OD	Positive
	refr-multi_lat-4128	41_100396_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100396	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	2.1104	OD	Positive
	refr-multi_lat-4129	41_100396_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100396	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	0.3662	OD	Positive
	refr-multi_lat-4130	41_100399_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100399	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	2.1	U/mL	Positive
	refr-multi_lat-4131	41_100399_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100399	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	379	U/mL	Positive
	refr-multi_lat-4132	41_100399_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100399	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	177	U/mL	Positive
	refr-multi_lat-4133	41_100399_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100399	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.432	OD	Positive
	refr-multi_lat-4134	41_100399_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100399	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.3155	OD	Positive
	refr-multi_lat-4135	41_100399_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100399	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.9898	OD	Positive
	refr-multi_lat-4136	41_100399_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100399	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	2.0848	OD	Positive
	refr-multi_lat-4137	41_100409_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100409	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	576	U/mL	Positive
	refr-multi_lat-4138	41_100409_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100409	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	81	U/mL	Positive
	refr-multi_lat-4139	41_100409_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100409	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	504	U/mL	Positive
	refr-multi_lat-4140	41_100409_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100409	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	26.9	AU/mL	Positive
	refr-multi_lat-4141	41_100428_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100428	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	3.3	U/mL	Positive
	refr-multi_lat-4142	41_100428_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100428	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	47.4	U/mL	Positive
	refr-multi_lat-4143	41_100428_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100428	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	341	U/mL	Positive
	refr-multi_lat-4144	41_100428_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100428	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	500	U/mL	Positive
	refr-multi_lat-4145	41_100428_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100428	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.2346	OD	Positive
	refr-multi_lat-4146	41_100428_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100428	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	0.8187	OD	Positive
	refr-multi_lat-4147	41_100428_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100428	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.9252	OD	Positive
	refr-multi_lat-4148	41_100428_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100428	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	0.8791	OD	Positive
	refr-multi_lat-4149	41_100430_100	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100430	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	407	U/mL	Positive
	refr-multi_lat-4150	41_100430_100	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100430	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	440	U/mL	Positive
	refr-multi_lat-4151	41_100430_100	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100430	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	28.9	AU/mL	Positive
	refr-multi_lat-4152	41_100431_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100431	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	366	U/mL	Positive
	refr-multi_lat-4153	41_100431_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100431	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	23.9	U/mL	Positive
	refr-multi_lat-4154	41_100431_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100431	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.4906	OD	Positive
	refr-multi_lat-4155	41_100431_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100431	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.2926	OD	Positive
	refr-multi_lat-4156	41_100431_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100431	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	2.1282	OD	Positive
	refr-multi_lat-4157	41_100431_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100431	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	2.1288	OD	Positive
	refr-multi_lat-4158	41_100434_100	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100434	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	366	U/mL	Positive
	refr-multi_lat-4159	41_100434_100	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100434	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	48.6	U/mL	Positive
	refr-multi_lat-4160	41_100434_100	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100434	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	107	U/mL	Positive
	refr-multi_lat-4161	41_100434_100	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100434	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.5923	OD	Positive
	refr-multi_lat-4162	41_100434_100	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100434	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.1273	OD	Positive
	refr-multi_lat-4163	41_100434_100	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100434	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.7695	OD	Positive
	refr-multi_lat-4164	41_100434_100	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100434	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	2.0756	OD	Positive
	refr-multi_lat-4165	41_100437_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100437	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	313	U/mL	Positive
	refr-multi_lat-4166	41_100437_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100437	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	23.4	U/mL	Positive
	refr-multi_lat-4167	41_100437_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100437	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	543	U/mL	Positive
	refr-multi_lat-4168	41_100437_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100437	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	0.604	OD	Positive
	refr-multi_lat-4169	41_100437_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100437	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.0933	OD	Positive
	refr-multi_lat-4170	41_100437_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100437	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.7838	OD	Positive
	refr-multi_lat-4171	41_100437_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100437	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.8503	OD	Positive
	refr-multi_lat-4172	41_100438_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100438	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-4173	41_100438_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100438	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	37.5	U/mL	Positive
	refr-multi_lat-4174	41_100438_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100438	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.465	OD	Positive
	refr-multi_lat-4175	41_100438_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100438	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	2.3066	OD	Positive
	refr-multi_lat-4176	41_100438_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100438	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	2.3183	OD	Positive
	refr-multi_lat-4177	41_100438_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100438	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	2.1432	OD	Positive
	refr-multi_lat-4178	41_100439_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100439	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	201	U/mL	Positive
	refr-multi_lat-4179	41_100439_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100439	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	238	U/mL	Positive
	refr-multi_lat-4180	41_100439_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100439	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.9622	OD	Positive
	refr-multi_lat-4181	41_100439_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100439	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	0.7062	OD	Positive
	refr-multi_lat-4182	41_100439_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100439	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	2.2432	OD	Positive
	refr-multi_lat-4183	41_100439_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100439	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.9952	OD	Positive
	refr-multi_lat-4184	41_100446_100	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100446	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-4185	41_100446_100	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100446	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	150	U/mL	Positive
	refr-multi_lat-4186	41_100446_100	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100446	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	401	U/mL	Positive
	refr-multi_lat-4187	41_100446_100	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100446	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	21.4	AU/mL	Positive
	refr-multi_lat-4188	41_100447_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100447	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-4189	41_100447_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100447	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	229	U/mL	Positive
	refr-multi_lat-4190	41_100447_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100447	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.938	OD	Positive
	refr-multi_lat-4191	41_100447_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100447	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.0257	OD	Positive
	refr-multi_lat-4192	41_100447_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100447	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.8803	OD	Positive
	refr-multi_lat-4193	41_100447_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100447	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.8971	OD	Positive
	refr-multi_lat-4194	41_100450_100	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100450	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	455	U/mL	Positive
	refr-multi_lat-4195	41_100450_100	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100450	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	31.1	U/mL	Positive
	refr-multi_lat-4196	41_100450_100	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100450	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	182	AU/mL	Positive
	refr-multi_lat-4197	41_100450_100	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100450	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	2.42	Index	Positive
	refr-multi_lat-4198	41_100453_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100453	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	505	U/mL	Positive
	refr-multi_lat-4199	41_100453_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100453	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	73.3	U/mL	Positive
	refr-multi_lat-4200	41_100453_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100453	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	500	U/mL	Positive
	refr-multi_lat-4201	41_100453_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100453	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	0.5168	OD	Positive
	refr-multi_lat-4202	41_100453_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100453	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.8321	OD	Positive
	refr-multi_lat-4203	41_100453_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100453	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.8547	OD	Positive
	refr-multi_lat-4204	41_100453_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100453	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.9808	OD	Positive
	refr-multi_lat-4205	41_100457_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100457	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	1.9	U/mL	Positive
	refr-multi_lat-4206	41_100457_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100457	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	105	U/mL	Positive
	refr-multi_lat-4207	41_100457_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100457	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	481	U/mL	Positive
	refr-multi_lat-4208	41_100457_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100457	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.724	OD	Positive
	refr-multi_lat-4209	41_100457_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100457	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.7518	OD	Positive
	refr-multi_lat-4210	41_100457_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100457	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	2.0032	OD	Positive
	refr-multi_lat-4211	41_100457_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100457	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.2678	OD	Positive
	refr-multi_lat-4212	41_100458_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100458	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	162	U/mL	Positive
	refr-multi_lat-4213	41_100458_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100458	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	212	U/mL	Positive
	refr-multi_lat-4214	41_100458_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100458	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.8437	OD	Positive
	refr-multi_lat-4215	41_100458_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100458	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.7091	OD	Positive
	refr-multi_lat-4216	41_100458_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100458	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.8672	OD	Positive
	refr-multi_lat-4217	41_100458_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100458	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.7352	OD	Positive
	refr-multi_lat-4218	41_100461_100	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100461	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	5.3	U/mL	Positive
	refr-multi_lat-4219	41_100461_100	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100461	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-4220	41_100461_100	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100461	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	579	U/mL	Positive
	refr-multi_lat-4221	41_100461_100	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100461	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.025	OD	Positive
	refr-multi_lat-4222	41_100461_100	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100461	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.6062	OD	Positive
	refr-multi_lat-4223	41_100461_100	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100461	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.4001	OD	Positive
	refr-multi_lat-4224	41_100461_100	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100461	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.873	OD	Positive
	refr-multi_lat-4225	41_100462_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100462	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	4.9	U/mL	Positive
	refr-multi_lat-4226	41_100462_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100462	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	87.8	U/mL	Positive
	refr-multi_lat-4227	41_100462_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100462	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	463	U/mL	Positive
	refr-multi_lat-4228	41_100462_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100462	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	0.5421	OD	Positive
	refr-multi_lat-4229	41_100462_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100462	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	0.6141	OD	Positive
	refr-multi_lat-4230	41_100462_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100462	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.8232	OD	Positive
	refr-multi_lat-4231	41_100462_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100462	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.6481	OD	Positive
	refr-multi_lat-4232	41_100466_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100466	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	10	U/mL	Positive
	refr-multi_lat-4233	41_100466_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100466	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-4234	41_100466_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100466	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	20.1	U/mL	Positive
	refr-multi_lat-4235	41_100466_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100466	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	432	U/mL	Positive
	refr-multi_lat-4236	41_100466_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100466	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	1.86	Index	Positive
	refr-multi_lat-4237	41_100467_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100467	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	10	U/mL	Positive
	refr-multi_lat-4238	41_100467_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100467	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	200	U/mL	Positive
	refr-multi_lat-4239	41_100467_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100467	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	395	U/mL	Positive
	refr-multi_lat-4240	41_100467_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100467	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.4848	OD	Positive
	refr-multi_lat-4241	41_100467_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100467	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.2327	OD	Positive
	refr-multi_lat-4242	41_100467_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100467	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.8353	OD	Positive
	refr-multi_lat-4243	41_100467_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100467	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	0.7061	OD	Positive
	refr-multi_lat-4244	41_100468_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100468	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	107	U/mL	Positive
	refr-multi_lat-4245	41_100468_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100468	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	515	U/mL	Positive
	refr-multi_lat-4246	41_100468_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100468	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	34.3	AU/mL	Positive
	refr-multi_lat-4247	41_100468_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100468	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	4.1	Index	Positive
	refr-multi_lat-4248	41_100469_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100469	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	304	U/mL	Positive
	refr-multi_lat-4249	41_100469_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100469	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	150	U/mL	Positive
	refr-multi_lat-4250	41_100469_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100469	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	600	U/mL	Positive
	refr-multi_lat-4251	41_100469_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100469	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	67.6	AU/mL	Positive
	refr-multi_lat-4252	41_100475_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100475	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	10	U/mL	Positive
	refr-multi_lat-4253	41_100475_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100475	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-4254	41_100475_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100475	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	40.8	U/mL	Positive
	refr-multi_lat-4255	41_100475_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100475	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	293	U/mL	Positive
	refr-multi_lat-4256	41_100475_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100475	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.7323	OD	Positive
	refr-multi_lat-4257	41_100475_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100475	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.9604	OD	Positive
	refr-multi_lat-4258	41_100475_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100475	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.8694	OD	Positive
	refr-multi_lat-4259	41_100475_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100475	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	2.0503	OD	Positive
	refr-multi_lat-4260	41_100476_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100476	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	552	U/mL	Positive
	refr-multi_lat-4261	41_100476_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100476	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	507	U/mL	Positive
	refr-multi_lat-4262	41_100478_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100478	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	69.3	U/mL	Positive
	refr-multi_lat-4263	41_100478_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100478	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	31	U/mL	Positive
	refr-multi_lat-4264	41_100478_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100478	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	18.1	AU/mL	Positive
	refr-multi_lat-4265	41_100479_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100479	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	129	U/mL	Positive
	refr-multi_lat-4266	41_100479_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100479	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	238	U/mL	Positive
	refr-multi_lat-4267	41_100479_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100479	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.9268	OD	Positive
	refr-multi_lat-4268	41_100479_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100479	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.5895	OD	Positive
	refr-multi_lat-4269	41_100479_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100479	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	2.009	OD	Positive
	refr-multi_lat-4270	41_100479_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100479	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	2.0025	OD	Positive
	refr-multi_lat-4271	41_100480_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100480	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-4272	41_100480_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100480	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	150	U/mL	Positive
	refr-multi_lat-4273	41_100480_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100480	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	300	U/mL	Positive
	refr-multi_lat-4274	41_100485_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100485	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	676	U/mL	Positive
	refr-multi_lat-4275	41_100485_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100485	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	600	U/mL	Positive
	refr-multi_lat-4276	41_100485_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100485	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.0735	OD	Positive
	refr-multi_lat-4277	41_100485_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100485	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.595	OD	Positive
	refr-multi_lat-4278	41_100485_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100485	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.9329	OD	Positive
	refr-multi_lat-4279	41_100485_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100485	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.8509	OD	Positive
	refr-multi_lat-4280	41_100486_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100486	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	600	U/mL	Positive
	refr-multi_lat-4281	41_100486_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100486	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.0885	OD	Positive
	refr-multi_lat-4282	41_100486_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100486	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	0.5528	OD	Positive
	refr-multi_lat-4283	41_100486_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100486	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.5884	OD	Positive
	refr-multi_lat-4284	41_100486_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100486	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.3151	OD	Positive
	refr-multi_lat-4285	41_100487_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100487	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	7.6	U/mL	Positive
	refr-multi_lat-4286	41_100487_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100487	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	184	U/mL	Positive
	refr-multi_lat-4287	41_100487_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100487	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	88.7	U/mL	Positive
	refr-multi_lat-4288	41_100487_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100487	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	54.3	U/mL	Positive
	refr-multi_lat-4289	41_100487_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100487	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	119	AU/mL	Positive
	refr-multi_lat-4290	41_100487_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100487	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	1.54	Index	Positive
	refr-multi_lat-4291	41_100488_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100488	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-4292	41_100488_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100488	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	167	U/mL	Positive
	refr-multi_lat-4293	41_100488_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100488	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.7105	OD	Positive
	refr-multi_lat-4294	41_100488_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100488	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	0.884	OD	Positive
	refr-multi_lat-4295	41_100488_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100488	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	2.0436	OD	Positive
	refr-multi_lat-4296	41_100488_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100488	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.0753	OD	Positive
	refr-multi_lat-4297	41_100490_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100490	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-4298	41_100490_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100490	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	93	U/mL	Positive
	refr-multi_lat-4299	41_100490_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100490	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	386	U/mL	Positive
	refr-multi_lat-4300	41_100490_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100490	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	21.3	AU/mL	Positive
	refr-multi_lat-4301	41_100491_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100491	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	146	U/mL	Positive
	refr-multi_lat-4302	41_100491_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100491	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	490	U/mL	Positive
	refr-multi_lat-4303	41_100491_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100491	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	140	AU/mL	Positive
	refr-multi_lat-4304	41_100492_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100492	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	10	U/mL	Positive
	refr-multi_lat-4305	41_100492_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100492	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-4306	41_100492_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100492	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	150	U/mL	Positive
	refr-multi_lat-4307	41_100492_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100492	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	171	U/mL	Positive
	refr-multi_lat-4308	41_100492_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100492	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	0.7013	OD	Positive
	refr-multi_lat-4309	41_100492_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100492	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	0.8242	OD	Positive
	refr-multi_lat-4310	41_100492_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100492	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.8052	OD	Positive
	refr-multi_lat-4311	41_100492_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100492	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	2.1849	OD	Positive
	refr-multi_lat-4312	41_100493_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100493	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.8023	OD	Positive
	refr-multi_lat-4313	41_100493_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100493	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.0897	OD	Positive
	refr-multi_lat-4314	41_100493_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100493	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.871	OD	Positive
	refr-multi_lat-4315	41_100493_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100493	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.6478	OD	Positive
	refr-multi_lat-4316	41_100494_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100494	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	71.1	U/mL	Positive
	refr-multi_lat-4317	41_100494_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100494	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	418	U/mL	Positive
	refr-multi_lat-4318	41_100494_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100494	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	85.1	AU/mL	Positive
	refr-multi_lat-4319	41_100495_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100495	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	8.7	U/mL	Positive
	refr-multi_lat-4320	41_100495_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100495	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-4321	41_100495_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100495	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	150	U/mL	Positive
	refr-multi_lat-4322	41_100495_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100495	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	590	U/mL	Positive
	refr-multi_lat-4323	41_100495_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100495	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.603	OD	Positive
	refr-multi_lat-4324	41_100495_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100495	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.3388	OD	Positive
	refr-multi_lat-4325	41_100495_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100495	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	2.1466	OD	Positive
	refr-multi_lat-4326	41_100495_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100495	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	2.0633	OD	Positive
	refr-multi_lat-4327	41_100496_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100496	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	10	U/mL	Positive
	refr-multi_lat-4328	41_100496_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100496	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	278	U/mL	Positive
	refr-multi_lat-4329	41_100496_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100496	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	23.9	U/mL	Positive
	refr-multi_lat-4330	41_100496_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100496	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	381	U/mL	Positive
	refr-multi_lat-4331	41_100496_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100496	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.7916	OD	Positive
	refr-multi_lat-4332	41_100496_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100496	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.1072	OD	Positive
	refr-multi_lat-4333	41_100496_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100496	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	2.1799	OD	Positive
	refr-multi_lat-4334	41_100496_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100496	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	2.4451	OD	Positive
	refr-multi_lat-4335	41_100497_100	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100497	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	10	U/mL	Positive
	refr-multi_lat-4336	41_100497_100	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100497	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	290	U/mL	Positive
	refr-multi_lat-4337	41_100497_100	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100497	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	422	U/mL	Positive
	refr-multi_lat-4338	41_100498_100	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100498	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	1.3	U/mL	Positive
	refr-multi_lat-4339	41_100498_100	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100498	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	137	U/mL	Positive
	refr-multi_lat-4340	41_100498_100	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100498	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	31.2	U/mL	Positive
	refr-multi_lat-4341	41_100498_100	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100498	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	185	U/mL	Positive
	refr-multi_lat-4342	41_100499_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100499	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	122	U/mL	Positive
	refr-multi_lat-4343	41_100499_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100499	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	500	U/mL	Positive
	refr-multi_lat-4344	41_100499_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100499	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	17.6	AU/mL	Positive
	refr-multi_lat-4345	41_100500_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100500	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	29.8	U/mL	Positive
	refr-multi_lat-4346	41_100500_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100500	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.1463	OD	Positive
	refr-multi_lat-4347	41_100500_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100500	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.5677	OD	Positive
	refr-multi_lat-4348	41_100500_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100500	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.7706	OD	Positive
	refr-multi_lat-4349	41_100500_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100500	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	2.3975	OD	Positive
	refr-multi_lat-4350	41_100501_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100501	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	10	U/mL	Positive
	refr-multi_lat-4351	41_100501_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100501	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	656	U/mL	Positive
	refr-multi_lat-4352	41_100501_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100501	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	36.5	U/mL	Positive
	refr-multi_lat-4353	41_100501_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100501	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	204	U/mL	Positive
	refr-multi_lat-4354	41_100501_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100501	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.1449	OD	Positive
	refr-multi_lat-4355	41_100501_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100501	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.788	OD	Positive
	refr-multi_lat-4356	41_100501_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100501	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.7197	OD	Positive
	refr-multi_lat-4357	41_100501_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100501	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.4178	OD	Positive
	refr-multi_lat-4358	41_100503_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100503	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	10	U/mL	Positive
	refr-multi_lat-4359	41_100503_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100503	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-4360	41_100503_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100503	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	356	U/mL	Positive
	refr-multi_lat-4361	41_100505_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100505	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	8.7	U/mL	Positive
	refr-multi_lat-4362	41_100505_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100505	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	276	U/mL	Positive
	refr-multi_lat-4363	41_100505_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100505	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.7728	OD	Positive
	refr-multi_lat-4364	41_100505_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100505	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.7193	OD	Positive
	refr-multi_lat-4365	41_100505_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100505	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.8717	OD	Positive
	refr-multi_lat-4366	41_100505_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100505	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	0.8128	OD	Positive
	refr-multi_lat-4367	41_100507_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100507	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-4368	41_100507_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100507	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	501	U/mL	Positive
	refr-multi_lat-4369	41_100507_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100507	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	68.5	AU/mL	Positive
	refr-multi_lat-4370	41_100507_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100507	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	13.5	Index	Positive
	refr-multi_lat-4371	41_100510_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100510	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	66.2	U/mL	Positive
	refr-multi_lat-4372	41_100510_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100510	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	365	U/mL	Positive
	refr-multi_lat-4373	41_100510_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100510	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	0.9965	OD	Positive
	refr-multi_lat-4374	41_100510_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100510	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	0.9193	OD	Positive
	refr-multi_lat-4375	41_100510_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100510	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.7468	OD	Positive
	refr-multi_lat-4376	41_100510_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100510	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.5024	OD	Positive
	refr-multi_lat-4377	41_100511_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100511	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-4378	41_100511_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100511	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	600	U/mL	Positive
	refr-multi_lat-4379	41_100511_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100511	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	103	AU/mL	Positive
	refr-multi_lat-4380	41_100512_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100512	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	10	U/mL	Positive
	refr-multi_lat-4381	41_100512_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100512	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	368	U/mL	Positive
	refr-multi_lat-4382	41_100512_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100512	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	459	U/mL	Positive
	refr-multi_lat-4383	41_100513_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100513	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-4384	41_100513_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100513	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	34	U/mL	Positive
	refr-multi_lat-4385	41_100513_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100513	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	211	U/mL	Positive
	refr-multi_lat-4386	41_100513_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100513	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.9031	OD	Positive
	refr-multi_lat-4387	41_100513_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100513	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.3828	OD	Positive
	refr-multi_lat-4388	41_100513_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100513	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	2.0417	OD	Positive
	refr-multi_lat-4389	41_100513_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100513	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.401	OD	Positive
	refr-multi_lat-4390	41_100514_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100514	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	9.3	U/mL	Positive
	refr-multi_lat-4391	41_100514_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100514	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	244	U/mL	Positive
	refr-multi_lat-4392	41_100515_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100515	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	306	U/mL	Positive
	refr-multi_lat-4393	41_100515_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100515	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	15	U/mL	Positive
	refr-multi_lat-4394	41_100515_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100515	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	563	U/mL	Positive
	refr-multi_lat-4395	41_100535_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100535	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	3.3	U/mL	Positive
	refr-multi_lat-4396	41_100535_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100535	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	36.1	U/mL	Positive
	refr-multi_lat-4397	41_100535_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100535	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	488	U/mL	Positive
	refr-multi_lat-4398	41_100535_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100535	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	0.5657	OD	Positive
	refr-multi_lat-4399	41_100535_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100535	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.2809	OD	Positive
	refr-multi_lat-4400	41_100535_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100535	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.2634	OD	Positive
	refr-multi_lat-4401	41_100535_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100535	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.8766	OD	Positive
	refr-multi_lat-4402	41_100540_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100540	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	2.3	U/mL	Positive
	refr-multi_lat-4403	41_100540_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100540	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-4404	41_100540_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100540	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	401	U/mL	Positive
	refr-multi_lat-4405	41_100540_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100540	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	0.8832	OD	Positive
	refr-multi_lat-4406	41_100540_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100540	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	0.8606	OD	Positive
	refr-multi_lat-4407	41_100540_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100540	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	0.6709	OD	Positive
	refr-multi_lat-4408	41_100540_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100540	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	0.9588	OD	Positive
	refr-multi_lat-4409	41_100541_100	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100541	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	303	U/mL	Positive
	refr-multi_lat-4410	41_100541_100	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100541	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	19.1	U/mL	Positive
	refr-multi_lat-4411	41_100541_100	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100541	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	413	U/mL	Positive
	refr-multi_lat-4412	41_100542_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100542	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	10	U/mL	Positive
	refr-multi_lat-4413	41_100542_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100542	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	581	U/mL	Positive
	refr-multi_lat-4414	41_100542_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100542	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	15.3	U/mL	Positive
	refr-multi_lat-4415	41_100542_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100542	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	271	U/mL	Positive
	refr-multi_lat-4416	41_100542_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100542	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.0329	OD	Positive
	refr-multi_lat-4417	41_100542_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100542	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	0.6442	OD	Positive
	refr-multi_lat-4418	41_100542_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100542	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.8094	OD	Positive
	refr-multi_lat-4419	41_100542_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100542	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	2.2271	OD	Positive
	refr-multi_lat-4420	41_100544_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100544	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-4421	41_100544_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100544	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	281	U/mL	Positive
	refr-multi_lat-4422	41_100546_100	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100546	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-4423	41_100546_100	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100546	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	410	U/mL	Positive
	refr-multi_lat-4424	41_100546_100	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100546	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.0553	OD	Positive
	refr-multi_lat-4425	41_100546_100	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100546	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.4158	OD	Positive
	refr-multi_lat-4426	41_100546_100	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100546	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	2.1363	OD	Positive
	refr-multi_lat-4427	41_100546_100	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100546	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.7475	OD	Positive
	refr-multi_lat-4428	41_100547_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100547	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	5.1	U/mL	Positive
	refr-multi_lat-4429	41_100547_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100547	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	232	U/mL	Positive
	refr-multi_lat-4430	41_100547_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100547	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	406	U/mL	Positive
	refr-multi_lat-4431	41_100549_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100549	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	3.2	U/mL	Positive
	refr-multi_lat-4432	41_100549_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100549	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-4433	41_100549_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100549	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	16.4	U/mL	Positive
	refr-multi_lat-4434	41_100549_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100549	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	414	U/mL	Positive
	refr-multi_lat-4435	41_100549_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100549	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	96.9	AU/mL	Positive
	refr-multi_lat-4436	41_100549_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100549	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	2.05	Index	Positive
	refr-multi_lat-4437	41_100550_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100550	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	4.5	U/mL	Positive
	refr-multi_lat-4438	41_100550_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100550	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	39.9	U/mL	Positive
	refr-multi_lat-4439	41_100550_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100550	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	11.1	U/mL	Positive
	refr-multi_lat-4440	41_100550_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100550	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	115	U/mL	Positive
	refr-multi_lat-4441	41_100550_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100550	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	41	AU/mL	Positive
	refr-multi_lat-4442	41_100552_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100552	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	6.2	U/mL	Positive
	refr-multi_lat-4443	41_100552_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100552	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	599	U/mL	Positive
	refr-multi_lat-4444	41_100552_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100552	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	15.6	U/mL	Positive
	refr-multi_lat-4445	41_100552_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100552	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	600	U/mL	Positive
	refr-multi_lat-4446	41_100553_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100553	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	10	U/mL	Positive
	refr-multi_lat-4447	41_100553_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100553	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	125	U/mL	Positive
	refr-multi_lat-4448	41_100553_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100553	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	53.2	U/mL	Positive
	refr-multi_lat-4449	41_100559_100	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100559	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	201	U/mL	Positive
	refr-multi_lat-4450	41_100559_100	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100559	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	106	U/mL	Positive
	refr-multi_lat-4451	41_100560_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100560	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	5.4	U/mL	Positive
	refr-multi_lat-4452	41_100560_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100560	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-4453	41_100561_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100561	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-4454	41_100561_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100561	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	45.1	U/mL	Positive
	refr-multi_lat-4455	41_100561_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100561	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	282	U/mL	Positive
	refr-multi_lat-4456	41_100562_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100562	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	4.4	U/mL	Positive
	refr-multi_lat-4457	41_100562_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100562	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	135	U/mL	Positive
	refr-multi_lat-4458	41_100562_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100562	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	125	U/mL	Positive
	refr-multi_lat-4459	41_100563_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100563	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-4460	41_100563_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100563	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	57.9	U/mL	Positive
	refr-multi_lat-4461	41_100563_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100563	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	189	U/mL	Positive
	refr-multi_lat-4462	41_100564_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100564	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	296	U/mL	Positive
	refr-multi_lat-4463	41_100564_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100564	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	150	U/mL	Positive
	refr-multi_lat-4464	41_100564_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100564	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	309	U/mL	Positive
	refr-multi_lat-4465	41_100564_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100564	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.4454	OD	Positive
	refr-multi_lat-4466	41_100564_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100564	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	0.6729	OD	Positive
	refr-multi_lat-4467	41_100564_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100564	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.9512	OD	Positive
	refr-multi_lat-4468	41_100564_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100564	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.46	OD	Positive
	refr-multi_lat-4469	41_100565_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100565	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	248	U/mL	Positive
	refr-multi_lat-4470	41_100565_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100565	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	80.4	U/mL	Positive
	refr-multi_lat-4471	41_100566_100	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100566	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	67.1	U/mL	Positive
	refr-multi_lat-4472	41_100566_100	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100566	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	29.4	U/mL	Positive
	refr-multi_lat-4473	41_100566_100	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100566	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	25.5	AU/mL	Positive
	refr-multi_lat-4474	41_100567_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100567	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	10	U/mL	Positive
	refr-multi_lat-4475	41_100567_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100567	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	447	U/mL	Positive
	refr-multi_lat-4476	41_100567_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100567	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	23.9	U/mL	Positive
	refr-multi_lat-4477	41_100567_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100567	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	165	U/mL	Positive
	refr-multi_lat-4478	41_100568_100	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100568	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	10	U/mL	Positive
	refr-multi_lat-4479	41_100568_100	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100568	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	307	U/mL	Positive
	refr-multi_lat-4480	41_100568_100	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100568	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	365	U/mL	Positive
	refr-multi_lat-4481	41_100569_100	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100569	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	3.13	Index	Positive
	refr-multi_lat-4482	41_100571_100	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100571	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	10	U/mL	Positive
	refr-multi_lat-4483	41_100571_100	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100571	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-4484	41_100571_100	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100571	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	600	U/mL	Positive
	refr-multi_lat-4485	41_100571_100	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100571	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.0137	OD	Positive
	refr-multi_lat-4486	41_100571_100	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100571	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	0.9831	OD	Positive
	refr-multi_lat-4487	41_100571_100	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100571	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.6114	OD	Positive
	refr-multi_lat-4488	41_100571_100	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100571	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	0.8544	OD	Positive
	refr-multi_lat-4489	41_100572_100	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100572	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	184	U/mL	Positive
	refr-multi_lat-4490	41_100572_100	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100572	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	381	U/mL	Positive
	refr-multi_lat-4491	41_100574_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100574	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	594	U/mL	Positive
	refr-multi_lat-4492	41_100574_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100574	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	215	U/mL	Positive
	refr-multi_lat-4493	41_100579_100	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100579	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	10	U/mL	Positive
	refr-multi_lat-4494	41_100579_100	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100579	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-4495	41_100579_100	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100579	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	129	AU/mL	Positive
	refr-multi_lat-4496	41_100579_100	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100579	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	3.46	Index	Positive
	refr-multi_lat-4497	41_100580_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100580	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	10	U/mL	Positive
	refr-multi_lat-4498	41_100580_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100580	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-4499	41_100580_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100580	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	12.5	U/mL	Positive
	refr-multi_lat-4500	41_100580_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100580	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	600	U/mL	Positive
	refr-multi_lat-4501	41_100580_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100580	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	86.9	AU/mL	Positive
	refr-multi_lat-4502	41_100580_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100580	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	6.75	Index	Positive
	refr-multi_lat-4503	41_100581_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100581	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	2.3	U/mL	Positive
	refr-multi_lat-4504	41_100581_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100581	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	81.6	U/mL	Positive
	refr-multi_lat-4505	41_100581_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100581	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	51.7	AU/mL	Positive
	refr-multi_lat-4506	41_100581_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100581	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	3.72	Index	Positive
	refr-multi_lat-4507	41_100582_100	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100582	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	62.2	U/mL	Positive
	refr-multi_lat-4508	41_100582_100	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100582	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	23.8	U/mL	Positive
	refr-multi_lat-4509	41_100583_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100583	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	10	U/mL	Positive
	refr-multi_lat-4510	41_100583_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100583	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	119	U/mL	Positive
	refr-multi_lat-4511	41_100583_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100583	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	21.1	U/mL	Positive
	refr-multi_lat-4512	41_100583_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100583	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	574	U/mL	Positive
	refr-multi_lat-4513	41_100584_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100584	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-4514	41_100584_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100584	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	48.8	U/mL	Positive
	refr-multi_lat-4515	41_100585_100	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100585	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	27.3	U/mL	Positive
	refr-multi_lat-4516	41_100585_100	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100585	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	155	U/mL	Positive
	refr-multi_lat-4517	41_100586_100	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100586	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	133	U/mL	Positive
	refr-multi_lat-4518	41_100586_100	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100586	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	244	U/mL	Positive
	refr-multi_lat-4519	41_100588_100	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100588	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	9.7	U/mL	Positive
	refr-multi_lat-4520	41_100588_100	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100588	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	411	U/mL	Positive
	refr-multi_lat-4521	41_100588_100	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100588	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	99	U/mL	Positive
	refr-multi_lat-4522	41_100588_100	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100588	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	52.3	AU/mL	Positive
	refr-multi_lat-4523	41_100600_100	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100600	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-4524	41_100600_100	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100600	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	18.4	U/mL	Positive
	refr-multi_lat-4525	41_100600_100	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100600	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	598	U/mL	Positive
	refr-multi_lat-4526	41_100600_100	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100600	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	104	AU/mL	Positive
	refr-multi_lat-4527	41_100600_100	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100600	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	5.6	Index	Positive
	refr-multi_lat-4528	41_100601_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100601	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	128	U/mL	Positive
	refr-multi_lat-4529	41_100601_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100601	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	560	U/mL	Positive
	refr-multi_lat-4530	41_100602_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100602	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	9.3	U/mL	Positive
	refr-multi_lat-4531	41_100602_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100602	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-4532	41_100602_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100602	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	23.1	U/mL	Positive
	refr-multi_lat-4533	41_100602_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100602	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	445	U/mL	Positive
	refr-multi_lat-4534	41_100602_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100602	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	0.8673	OD	Positive
	refr-multi_lat-4535	41_100602_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100602	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.5184	OD	Positive
	refr-multi_lat-4536	41_100602_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100602	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.9055	OD	Positive
	refr-multi_lat-4537	41_100602_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100602	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.0093	OD	Positive
	refr-multi_lat-4538	41_100603_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100603	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	10	U/mL	Positive
	refr-multi_lat-4539	41_100603_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100603	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	414	U/mL	Positive
	refr-multi_lat-4540	41_100603_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100603	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	197	AU/mL	Positive
	refr-multi_lat-4541	41_100604_100	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100604	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	236	U/mL	Positive
	refr-multi_lat-4542	41_100604_100	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100604	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	150	U/mL	Positive
	refr-multi_lat-4543	41_100604_100	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100604	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	383	U/mL	Positive
	refr-multi_lat-4544	41_100605_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100605	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	1.3	U/mL	Positive
	refr-multi_lat-4545	41_100605_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100605	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-4546	41_100605_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100605	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	600	U/mL	Positive
	refr-multi_lat-4547	41_100605_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100605	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	42.3	AU/mL	Positive
	refr-multi_lat-4548	41_100605_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100605	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	1.28	Index	Positive
	refr-multi_lat-4549	41_100607_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100607	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	6.7	U/mL	Positive
	refr-multi_lat-4550	41_100607_101	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100607	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	54	U/mL	Positive
	refr-multi_lat-4551	41_100607_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100607	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	346	U/mL	Positive
	refr-multi_lat-4552	41_100607_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100607	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	150	U/mL	Positive
	refr-multi_lat-4553	41_100607_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100607	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	285	U/mL	Positive
	refr-multi_lat-4554	41_100607_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100607	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	246	AU/mL	Positive
	refr-multi_lat-4555	41_100607_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100607	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	50	Index	Positive
	refr-multi_lat-4556	41_100609_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100609	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	8.1	U/mL	Positive
	refr-multi_lat-4557	41_100609_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100609	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-4558	41_100609_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100609	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	17.5	U/mL	Positive
	refr-multi_lat-4559	41_100609_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100609	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	147	U/mL	Positive
	refr-multi_lat-4560	41_100610_100	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100610	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	108	U/mL	Positive
	refr-multi_lat-4561	41_100610_100	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100610	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	206	U/mL	Positive
	refr-multi_lat-4562	41_100611_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100611	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	3.7	U/mL	Positive
	refr-multi_lat-4563	41_100611_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100611	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-4564	41_100611_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100611	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	600	U/mL	Positive
	refr-multi_lat-4565	41_100611_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100611	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	113	AU/mL	Positive
	refr-multi_lat-4566	41_100612_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100612	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	7.7	U/mL	Positive
	refr-multi_lat-4567	41_100612_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100612	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-4568	41_100612_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100612	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	373	U/mL	Positive
	refr-multi_lat-4569	41_100617_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100617	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	3	U/mL	Positive
	refr-multi_lat-4570	41_100617_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100617	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	63.4	U/mL	Positive
	refr-multi_lat-4571	41_100617_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100617	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	19.8	U/mL	Positive
	refr-multi_lat-4572	41_100617_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100617	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	317	U/mL	Positive
	refr-multi_lat-4573	41_100617_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100617	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	117	AU/mL	Positive
	refr-multi_lat-4574	41_100617_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100617	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	11.1	Index	Positive
	refr-multi_lat-4575	41_100618_100	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100618	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	170	U/mL	Positive
	refr-multi_lat-4576	41_100618_100	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100618	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	20.5	U/mL	Positive
	refr-multi_lat-4577	41_100618_100	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100618	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	241	U/mL	Positive
	refr-multi_lat-4578	41_100635_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100635	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-4579	41_100635_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100635	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	600	U/mL	Positive
	refr-multi_lat-4580	41_100636_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100636	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	10	U/mL	Positive
	refr-multi_lat-4581	41_100636_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100636	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	708	U/mL	Positive
	refr-multi_lat-4582	41_100636_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100636	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	23.3	U/mL	Positive
	refr-multi_lat-4583	41_100636_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100636	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	600	U/mL	Positive
	refr-multi_lat-4584	41_100637_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100637	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	1.3	U/mL	Positive
	refr-multi_lat-4585	41_100637_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100637	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	224	U/mL	Positive
	refr-multi_lat-4586	41_100637_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100637	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	600	U/mL	Positive
	refr-multi_lat-4587	41_100638_100	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100638	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	2.2	U/mL	Positive
	refr-multi_lat-4588	41_100638_100	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100638	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	348	U/mL	Positive
	refr-multi_lat-4589	41_100638_100	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100638	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	1.47	Index	Positive
	refr-multi_lat-4590	41_100639_100	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100639	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	10	U/mL	Positive
	refr-multi_lat-4591	41_100639_100	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100639	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-4592	41_100639_100	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100639	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	348	U/mL	Positive
	refr-multi_lat-4593	41_100642_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100642	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-4594	41_100642_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100642	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	538	U/mL	Positive
	refr-multi_lat-4595	41_100642_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100642	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	17.1	AU/mL	Positive
	refr-multi_lat-4596	41_100643_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100643	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	4.6	U/mL	Positive
	refr-multi_lat-4597	41_100643_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100643	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	538	U/mL	Positive
	refr-multi_lat-4598	41_100643_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100643	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	13.1	U/mL	Positive
	refr-multi_lat-4599	41_100643_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100643	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	60.4	U/mL	Positive
	refr-multi_lat-4600	41_100644_100	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100644	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-4601	41_100644_100	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100644	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	150	U/mL	Positive
	refr-multi_lat-4602	41_100644_100	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100644	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	600	U/mL	Positive
	refr-multi_lat-4603	41_100645_100	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100645	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	164	U/mL	Positive
	refr-multi_lat-4604	41_100645_100	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100645	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	600	U/mL	Positive
	refr-multi_lat-4605	41_100656_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100656	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	6.1	U/mL	Positive
	refr-multi_lat-4606	41_100656_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100656	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-4607	41_100656_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100656	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	336	U/mL	Positive
	refr-multi_lat-4608	41_100657_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100657	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	10	U/mL	Positive
	refr-multi_lat-4609	41_100657_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100657	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-4610	41_100657_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100657	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	73.2	U/mL	Positive
	refr-multi_lat-4611	41_100657_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100657	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	221	U/mL	Positive
	refr-multi_lat-4612	41_100660_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100660	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	181	U/mL	Positive
	refr-multi_lat-4613	41_100660_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100660	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	507	U/mL	Positive
	refr-multi_lat-4614	41_100660_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100660	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	35.4	AU/mL	Positive
	refr-multi_lat-4615	41_100662_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100662	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	133	U/mL	Positive
	refr-multi_lat-4616	41_100662_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100662	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	13.6	U/mL	Positive
	refr-multi_lat-4617	41_100662_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100662	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	600	U/mL	Positive
	refr-multi_lat-4618	41_100662_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100662	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	0.7375	OD	Positive
	refr-multi_lat-4619	41_100662_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100662	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	1.341	OD	Positive
	refr-multi_lat-4620	41_100662_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100662	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	2.2128	OD	Positive
	refr-multi_lat-4621	41_100662_101	41_486	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100662	SeroNet_Reference_Study_visit-01									CBC LDT	HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, Spike, RBD	ELISA		IgG	0.8618	OD	Positive
	refr-multi_lat-4622	41_100663_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100663	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	10	U/mL	Positive
	refr-multi_lat-4623	41_100663_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100663	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	205	U/mL	Positive
	refr-multi_lat-4624	41_100663_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100663	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	25.7	U/mL	Positive
	refr-multi_lat-4625	41_100663_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100663	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	600	U/mL	Positive
	refr-multi_lat-4626	41_100663_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100663	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	27.9	AU/mL	Positive
	refr-multi_lat-4627	41_100664_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100664	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-4628	41_100664_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100664	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	150	U/mL	Positive
	refr-multi_lat-4629	41_100664_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100664	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	600	U/mL	Positive
	refr-multi_lat-4630	41_100665_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100665	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	584	U/mL	Positive
	refr-multi_lat-4631	41_100665_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100665	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	600	U/mL	Positive
	refr-multi_lat-4632	41_100672_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100672	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	606	U/mL	Positive
	refr-multi_lat-4633	41_100672_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100672	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	16.8	U/mL	Positive
	refr-multi_lat-4634	41_100672_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100672	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	600	U/mL	Positive
	refr-multi_lat-4635	41_100672_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100672	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	67.8	AU/mL	Positive
	refr-multi_lat-4636	41_100673_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100673	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	10	U/mL	Positive
	refr-multi_lat-4637	41_100673_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100673	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-4638	41_100673_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100673	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	18.1	U/mL	Positive
	refr-multi_lat-4639	41_100673_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100673	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	22.5	U/mL	Positive
	refr-multi_lat-4640	41_100674_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100674	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	1.5	U/mL	Positive
	refr-multi_lat-4641	41_100674_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100674	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	113	U/mL	Positive
	refr-multi_lat-4642	41_100674_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100674	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	600	U/mL	Positive
	refr-multi_lat-4643	41_100674_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100674	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	1.77	Index	Positive
	refr-multi_lat-4644	41_100681_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100681	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	1.4	U/mL	Positive
	refr-multi_lat-4645	41_100681_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100681	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-4646	41_100681_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100681	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	47.6	U/mL	Positive
	refr-multi_lat-4647	41_100681_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100681	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	18.8	AU/mL	Positive
	refr-multi_lat-4648	41_100682_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100682	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	10	U/mL	Positive
	refr-multi_lat-4649	41_100682_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100682	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	113	U/mL	Positive
	refr-multi_lat-4650	41_100682_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100682	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	600	U/mL	Positive
	refr-multi_lat-4651	41_100683_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100683	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-4652	41_100683_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100683	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	64.4	U/mL	Positive
	refr-multi_lat-4653	41_100683_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100683	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	59.7	U/mL	Positive
	refr-multi_lat-4654	41_100683_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100683	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	253	AU/mL	Positive
	refr-multi_lat-4655	41_100683_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100683	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	1.65	Index	Positive
	refr-multi_lat-4656	41_100690_100	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100690	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	10	U/mL	Positive
	refr-multi_lat-4657	41_100690_100	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100690	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	231	U/mL	Positive
	refr-multi_lat-4658	41_100690_100	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100690	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	95	U/mL	Positive
	refr-multi_lat-4659	41_100690_100	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100690	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	119	AU/mL	Positive
	refr-multi_lat-4660	41_100690_100	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100690	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	8.08	Index	Positive
	refr-multi_lat-4661	41_100694_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100694	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	203	U/mL	Positive
	refr-multi_lat-4662	41_100694_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100694	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	402	U/mL	Positive
	refr-multi_lat-4663	41_100698_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100698	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	193	U/mL	Positive
	refr-multi_lat-4664	41_100698_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100698	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	15.6	U/mL	Positive
	refr-multi_lat-4665	41_100698_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100698	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	124	U/mL	Positive
	refr-multi_lat-4666	41_100698_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100698	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	51.4	AU/mL	Positive
	refr-multi_lat-4667	41_100699_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100699	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	730	U/mL	Positive
	refr-multi_lat-4668	41_100699_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100699	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	452	U/mL	Positive
	refr-multi_lat-4669	41_100711_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100711	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	716	U/mL	Positive
	refr-multi_lat-4670	41_100711_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100711	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	26.5	U/mL	Positive
	refr-multi_lat-4671	41_100711_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100711	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	139	U/mL	Positive
	refr-multi_lat-4672	41_100712_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100712	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	445	U/mL	Positive
	refr-multi_lat-4673	41_100712_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100712	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	385	U/mL	Positive
	refr-multi_lat-4674	41_100719_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100719	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	5.7	U/mL	Positive
	refr-multi_lat-4675	41_100719_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100719	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	43.6	U/mL	Positive
	refr-multi_lat-4676	41_100721_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100721	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	196	U/mL	Positive
	refr-multi_lat-4677	41_100724_100	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100724	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	97.5	U/mL	Positive
	refr-multi_lat-4678	41_100724_100	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100724	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	52.9	U/mL	Positive
	refr-multi_lat-4679	41_100726_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100726	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	172	U/mL	Positive
	refr-multi_lat-4680	41_100726_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100726	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	600	U/mL	Positive
	refr-multi_lat-4681	41_100726_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100726	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	53.5	AU/mL	Positive
	refr-multi_lat-4682	41_100730_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100730	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	4.8	U/mL	Positive
	refr-multi_lat-4683	41_100737_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100737	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	10	U/mL	Positive
	refr-multi_lat-4684	41_100737_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100737	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-4685	41_100737_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100737	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	55.2	U/mL	Positive
	refr-multi_lat-4686	41_100737_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100737	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	151	U/mL	Positive
	refr-multi_lat-4687	41_100738_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100738	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	5.4	U/mL	Positive
	refr-multi_lat-4688	41_100738_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100738	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-4689	41_100738_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100738	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	48.2	U/mL	Positive
	refr-multi_lat-4690	41_100739_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100739	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	35	AU/mL	Positive
	refr-multi_lat-4691	41_100740_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100740	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-4692	41_100740_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100740	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	185	U/mL	Positive
	refr-multi_lat-4693	41_100742_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100742	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	10	U/mL	Positive
	refr-multi_lat-4694	41_100742_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100742	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-4695	41_100742_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100742	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	600	U/mL	Positive
	refr-multi_lat-4696	41_100742_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100742	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	400	AU/mL	Positive
	refr-multi_lat-4697	41_100743_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100743	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-4698	41_100743_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100743	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	277	U/mL	Positive
	refr-multi_lat-4699	41_100743_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100743	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	400	AU/mL	Positive
	refr-multi_lat-4700	41_100743_101	41_483	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100743	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 IgM Assay	SARS-CoV-2 Virus, Spike, SD	Chemiluminescent Assay		IgM	36.1	Index	Positive
	refr-multi_lat-4701	41_100744_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100744	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-4702	41_100744_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100744	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	600	U/mL	Positive
	refr-multi_lat-4703	41_100745_100	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100745	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	238	U/mL	Positive
	refr-multi_lat-4704	41_100747_100	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100747	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-4705	41_100747_100	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100747	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	283	U/mL	Positive
	refr-multi_lat-4706	41_100748_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100748	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	10	U/mL	Positive
	refr-multi_lat-4707	41_100748_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100748	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-4708	41_100748_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100748	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	24.7	U/mL	Positive
	refr-multi_lat-4709	41_100748_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100748	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	194	U/mL	Positive
	refr-multi_lat-4710	41_100749_100	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100749	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	10	U/mL	Positive
	refr-multi_lat-4711	41_100749_100	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100749	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	523	U/mL	Positive
	refr-multi_lat-4712	41_100749_100	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100749	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	72.7	U/mL	Positive
	refr-multi_lat-4713	41_100754_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100754	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	368	U/mL	Positive
	refr-multi_lat-4714	41_100754_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100754	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	470	U/mL	Positive
	refr-multi_lat-4715	41_100755_100	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100755	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	150	U/mL	Positive
	refr-multi_lat-4716	41_100755_100	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100755	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	14.5	U/mL	Positive
	refr-multi_lat-4717	41_100755_100	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100755	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	62.9	U/mL	Positive
	refr-multi_lat-4718	41_100756_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100756	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	717	U/mL	Positive
	refr-multi_lat-4719	41_100757_100	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100757	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	3.9	U/mL	Positive
	refr-multi_lat-4720	41_100757_100	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100757	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-4721	41_100757_100	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100757	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	98	U/mL	Positive
	refr-multi_lat-4722	41_100770_100	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100770	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	4.1	U/mL	Positive
	refr-multi_lat-4723	41_100770_100	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100770	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-4724	41_100770_100	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100770	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	150	U/mL	Positive
	refr-multi_lat-4725	41_100770_100	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100770	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	454	U/mL	Positive
	refr-multi_lat-4726	41_100770_100	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100770	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	29.2	AU/mL	Positive
	refr-multi_lat-4727	41_100771_100	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100771	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	666	U/mL	Positive
	refr-multi_lat-4728	41_100771_100	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100771	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	19.6	U/mL	Positive
	refr-multi_lat-4729	41_100771_100	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100771	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	431	U/mL	Positive
	refr-multi_lat-4730	41_100773_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100773	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	3	U/mL	Positive
	refr-multi_lat-4731	41_100773_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100773	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-4732	41_100773_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100773	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	410	U/mL	Positive
	refr-multi_lat-4733	41_100776_100	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100776	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	419	U/mL	Positive
	refr-multi_lat-4734	41_100776_100	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100776	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	340	U/mL	Positive
	refr-multi_lat-4735	41_100777_100	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100777	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	600	U/mL	Positive
	refr-multi_lat-4736	41_100777_100	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100777	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	65.9	U/mL	Positive
	refr-multi_lat-4737	41_100777_100	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100777	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	600	U/mL	Positive
	refr-multi_lat-4738	41_100779_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100779	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	9.4	U/mL	Positive
	refr-multi_lat-4739	41_100779_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100779	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	326	U/mL	Positive
	refr-multi_lat-4740	41_100779_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100779	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	162	U/mL	Positive
	refr-multi_lat-4741	41_100781_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100781	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	3.4	U/mL	Positive
	refr-multi_lat-4742	41_100781_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100781	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	606	U/mL	Positive
	refr-multi_lat-4743	41_100781_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100781	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	145	U/mL	Positive
	refr-multi_lat-4744	41_100782_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100782	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	10	U/mL	Positive
	refr-multi_lat-4745	41_100782_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100782	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	104	U/mL	Positive
	refr-multi_lat-4746	41_100782_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100782	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	600	U/mL	Positive
	refr-multi_lat-4747	41_100783_100	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100783	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	394	U/mL	Positive
	refr-multi_lat-4748	41_100783_100	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100783	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	214	U/mL	Positive
	refr-multi_lat-4749	41_100783_100	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100783	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	15.3	AU/mL	Positive
	refr-multi_lat-4750	41_100785_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100785	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	358	U/mL	Positive
	refr-multi_lat-4751	41_100785_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100785	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	38.7	U/mL	Positive
	refr-multi_lat-4752	41_100785_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100785	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	160	U/mL	Positive
	refr-multi_lat-4753	41_100787_100	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100787	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	32.5	U/mL	Positive
	refr-multi_lat-4754	41_100798_100	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100798	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-4755	41_100798_100	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100798	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	316	U/mL	Positive
	refr-multi_lat-4756	41_100799_100	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100799	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	3.9	U/mL	Positive
	refr-multi_lat-4757	41_100799_100	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100799	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	286	U/mL	Positive
	refr-multi_lat-4758	41_100799_100	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100799	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	441	U/mL	Positive
	refr-multi_lat-4759	41_100800_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100800	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	10	U/mL	Positive
	refr-multi_lat-4760	41_100800_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100800	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-4761	41_100800_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100800	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	150	U/mL	Positive
	refr-multi_lat-4762	41_100800_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100800	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	299	U/mL	Positive
	refr-multi_lat-4763	41_100801_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100801	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	310	U/mL	Positive
	refr-multi_lat-4764	41_100801_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100801	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	600	U/mL	Positive
	refr-multi_lat-4765	41_100801_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100801	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	17.4	AU/mL	Positive
	refr-multi_lat-4766	41_100802_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100802	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	10	U/mL	Positive
	refr-multi_lat-4767	41_100802_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100802	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-4768	41_100802_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100802	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	150	U/mL	Positive
	refr-multi_lat-4769	41_100802_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100802	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	537	U/mL	Positive
	refr-multi_lat-4770	41_100804_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100804	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-4771	41_100804_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100804	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	23	U/mL	Positive
	refr-multi_lat-4772	41_100804_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100804	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	398	U/mL	Positive
	refr-multi_lat-4773	41_100805_100	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100805	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	4.7	U/mL	Positive
	refr-multi_lat-4774	41_100805_100	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100805	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	566	U/mL	Positive
	refr-multi_lat-4775	41_100805_100	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100805	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	600	U/mL	Positive
	refr-multi_lat-4776	41_100806_100	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100806	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	102	U/mL	Positive
	refr-multi_lat-4777	41_100806_100	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100806	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	600	U/mL	Positive
	refr-multi_lat-4778	41_100808_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100808	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-4779	41_100808_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100808	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	80.4	U/mL	Positive
	refr-multi_lat-4780	41_100808_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100808	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	466	U/mL	Positive
	refr-multi_lat-4781	41_100818_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100818	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	76.7	U/mL	Positive
	refr-multi_lat-4782	41_100818_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100818	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	14.2	U/mL	Positive
	refr-multi_lat-4783	41_100818_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100818	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	146	U/mL	Positive
	refr-multi_lat-4784	41_100819_100	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100819	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	681	U/mL	Positive
	refr-multi_lat-4785	41_100819_100	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100819	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	600	U/mL	Positive
	refr-multi_lat-4786	41_100820_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100820	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	3.4	U/mL	Positive
	refr-multi_lat-4787	41_100820_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100820	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	187	U/mL	Positive
	refr-multi_lat-4788	41_100820_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100820	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	46	U/mL	Positive
	refr-multi_lat-4789	41_100821_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100821	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	3.1	U/mL	Positive
	refr-multi_lat-4790	41_100821_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100821	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-4791	41_100821_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100821	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	600	U/mL	Positive
	refr-multi_lat-4792	41_100821_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100821	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	17.8	AU/mL	Positive
	refr-multi_lat-4793	41_100822_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100822	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	25.4	U/mL	Positive
	refr-multi_lat-4794	41_100822_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100822	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	197	U/mL	Positive
	refr-multi_lat-4795	41_100824_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100824	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	4.1	U/mL	Positive
	refr-multi_lat-4796	41_100824_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100824	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	62.3	U/mL	Positive
	refr-multi_lat-4797	41_100824_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100824	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	259	U/mL	Positive
	refr-multi_lat-4798	41_100826_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100826	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-4799	41_100826_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100826	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	263	U/mL	Positive
	refr-multi_lat-4800	41_100827_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100827	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-4801	41_100827_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100827	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	14.6	U/mL	Positive
	refr-multi_lat-4802	41_100827_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100827	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	380	U/mL	Positive
	refr-multi_lat-4803	41_100830_100	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100830	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-4804	41_100832_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100832	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	1.7	U/mL	Positive
	refr-multi_lat-4805	41_100832_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100832	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	360	U/mL	Positive
	refr-multi_lat-4806	41_100832_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100832	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	575	U/mL	Positive
	refr-multi_lat-4807	41_100832_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100832	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	20.3	AU/mL	Positive
	refr-multi_lat-4808	41_100833_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100833	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	3.1	U/mL	Positive
	refr-multi_lat-4809	41_100833_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100833	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-4810	41_100833_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100833	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	600	U/mL	Positive
	refr-multi_lat-4811	41_100834_100	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100834	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	10	U/mL	Positive
	refr-multi_lat-4812	41_100834_100	41_470	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100834	SeroNet_Reference_Study_visit-01									LIAISON VCA IgM Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgM	144	U/mL	Positive
	refr-multi_lat-4813	41_100834_100	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100834	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-4814	41_100834_100	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100834	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	25.8	U/mL	Positive
	refr-multi_lat-4815	41_100834_100	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100834	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	600	U/mL	Positive
	refr-multi_lat-4816	41_100834_100	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100834	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	30.8	AU/mL	Positive
	refr-multi_lat-4817	41_100836_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100836	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	10	U/mL	Positive
	refr-multi_lat-4818	41_100836_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100836	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	399	U/mL	Positive
	refr-multi_lat-4819	41_100836_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100836	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	52.4	U/mL	Positive
	refr-multi_lat-4820	41_100836_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100836	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	65.4	U/mL	Positive
	refr-multi_lat-4821	41_100836_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100836	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	95.7	AU/mL	Positive
	refr-multi_lat-4822	41_100837_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100837	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	649	U/mL	Positive
	refr-multi_lat-4823	41_100837_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100837	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	190	U/mL	Positive
	refr-multi_lat-4824	41_100840_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100840	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	346	U/mL	Positive
	refr-multi_lat-4825	41_100840_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100840	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	65.9	U/mL	Positive
	refr-multi_lat-4826	41_100841_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100841	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-4827	41_100841_101	41_474	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100841	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Early Antigen Diffuse	Chemiluminescent Assay		IgG	11.6	U/mL	Positive
	refr-multi_lat-4828	41_100841_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100841	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	600	U/mL	Positive
	refr-multi_lat-4829	41_100844_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100844	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	4.9	U/mL	Positive
	refr-multi_lat-4830	41_100844_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100844	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-4831	41_100844_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100844	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	600	U/mL	Positive
	refr-multi_lat-4832	41_100844_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100844	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	374	AU/mL	Positive
	refr-multi_lat-4833	41_100851_101	41_468	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100851	SeroNet_Reference_Study_visit-01									LIAISON CMV IgG Assay	Cytomegalovirus, CMV antigens	Chemiluminescent Assay		IgG	10	U/mL	Positive
	refr-multi_lat-4834	41_100851_101	41_472	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100851	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Viral Capsid Antigen 	Chemiluminescent Assay		IgG	750	U/mL	Positive
	refr-multi_lat-4835	41_100851_101	41_476	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100851	SeroNet_Reference_Study_visit-01									LIAISON VCA IgG Assay (EBV)	Epstein-Barr Virus, Nuclear antigen - 1	Chemiluminescent Assay		IgG	567	U/mL	Positive
	refr-multi_lat-4836	41_100851_101	41_481	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100851	SeroNet_Reference_Study_visit-01									LIAISON SARS-CoV-2 S1/S2 IgG Assay	SARS-CoV-2 Virus, Spike, S1/S2	Chemiluminescent Assay		IgG	92	AU/mL	Positive
	refr-multi_lat-4837	14_412766_222	14_050	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_412766	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Assay	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG+IgM	Positive	Not Specified	Positive
	refr-multi_lat-4838	14_831542_222	14_050	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_831542	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Assay	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG+IgM	Positive	Not Specified	Positive
	refr-multi_lat-4839	27_100003_200	27_507	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100003	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT HIV Ag/Ab Combo Assay	HIV, HIV 1 and HIV 2 antigens	Chemiluminescent Assay		IgG + IgM	83.16	S/CO	Positive
	refr-multi_lat-4840	27_100003_200	27_508	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100003	SeroNet_Reference_Study_visit-01									Geenius HIV 1/2 Supplemental Assay	HIV, HIV 1 and HIV 2 antigens	lateral flow assay		IgG	NA	Not Specified	Positive
	refr-multi_lat-4841	27_100008_200	27_507	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100008	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT HIV Ag/Ab Combo Assay	HIV, HIV 1 and HIV 2 antigens	Chemiluminescent Assay		IgG + IgM	658.83	S/CO	Positive
	refr-multi_lat-4842	27_100008_200	27_508	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100008	SeroNet_Reference_Study_visit-01									Geenius HIV 1/2 Supplemental Assay	HIV, HIV 1 and HIV 2 antigens	lateral flow assay		IgG	NA	Not Specified	Positive
	refr-multi_lat-4843	27_100016_200	27_506	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100016	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Assay	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	7.52	S/CO	Positive
	refr-multi_lat-4844	27_100016_200	27_507	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100016	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT HIV Ag/Ab Combo Assay	HIV, HIV 1 and HIV 2 antigens	Chemiluminescent Assay		IgG + IgM	47.05	S/CO	Positive
	refr-multi_lat-4845	27_100016_200	27_508	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100016	SeroNet_Reference_Study_visit-01									Geenius HIV 1/2 Supplemental Assay	HIV, HIV 1 and HIV 2 antigens	lateral flow assay		IgG	NA	Not Specified	Positive
	refr-multi_lat-4846	27_100049_200	27_506	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100049	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Assay	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	3.7	S/CO	Positive
	refr-multi_lat-4847	27_100049_200	27_507	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100049	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT HIV Ag/Ab Combo Assay	HIV, HIV 1 and HIV 2 antigens	Chemiluminescent Assay		IgG + IgM	1028.09	S/CO	Positive
	refr-multi_lat-4848	27_100049_200	27_508	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	27_100049	SeroNet_Reference_Study_visit-01									Geenius HIV 1/2 Supplemental Assay	HIV, HIV 1 and HIV 2 antigens	lateral flow assay		IgG	NA	Not Specified	Positive
	refr-multi_lat-4849	41_100251_100	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100251	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Positive
	refr-multi_lat-4850	41_100278_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100278	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Positive
	refr-multi_lat-4851	41_100304_100	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100304	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Positive
	refr-multi_lat-4852	41_100306_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100306	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Positive
	refr-multi_lat-4853	41_100601_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100601	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Positive
	refr-multi_lat-4854	41_100665_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100665	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Positive
	refr-multi_lat-4855	41_100748_101	41_485	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	41_100748	SeroNet_Reference_Study_visit-01									Abbott ARCHITECT anti-HBc Kit	Hepatitis B Virus, Core Antigen	Chemiluminescent Assay		IgG + IgM	-1000000000	Not Specified	Positive
	refr-multi_lat-4856	14_120858_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_120858	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	82	Au/mL	Positive
	refr-multi_lat-4857	14_123753_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_123753	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	71	Au/mL	Positive
	refr-multi_lat-4858	14_127552_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_127552	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	69	Au/mL	Positive
	refr-multi_lat-4859	14_148341_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_148341	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	58	Au/mL	Positive
	refr-multi_lat-4860	14_160668_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_160668	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	62	Au/mL	Positive
	refr-multi_lat-4861	14_217514_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_217514	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	206	Au/mL	Positive
	refr-multi_lat-4862	14_239836_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_239836	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	72	Au/mL	Positive
	refr-multi_lat-4863	14_241807_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_241807	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	102	Au/mL	Positive
	refr-multi_lat-4864	14_249066_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_249066	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	266	Au/mL	Positive
	refr-multi_lat-4865	14_278647_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_278647	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	47	Au/mL	Positive
	refr-multi_lat-4866	14_311544_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_311544	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	125	Au/mL	Positive
	refr-multi_lat-4867	14_324493_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_324493	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	51	AU/mL	Positive
	refr-multi_lat-4868	14_339739_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_339739	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	253	Au/mL	Positive
	refr-multi_lat-4869	14_348651_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_348651	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	89	Au/mL	Positive
	refr-multi_lat-4870	14_367355_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_367355	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	80	Au/mL	Positive
	refr-multi_lat-4871	14_368073_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_368073	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	237	Au/mL	Positive
	refr-multi_lat-4872	14_379363_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_379363	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	47	Au/mL	Positive
	refr-multi_lat-4873	14_391735_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_391735	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	40	Au/mL	Positive
	refr-multi_lat-4874	14_404768_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_404768	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	44	Au/mL	Positive
	refr-multi_lat-4875	14_409279_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_409279	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	49	Au/mL	Positive
	refr-multi_lat-4876	14_439218_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_439218	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	125	Au/mL	Positive
	refr-multi_lat-4877	14_507701_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_507701	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	76	Au/mL	Positive
	refr-multi_lat-4878	14_512561_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_512561	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	93	Au/mL	Positive
	refr-multi_lat-4879	14_529422_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_529422	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	49	Au/mL	Positive
	refr-multi_lat-4880	14_562035_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_562035	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	137	Au/mL	Positive
	refr-multi_lat-4881	14_573413_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_573413	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	85	Au/mL	Positive
	refr-multi_lat-4882	14_594272_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_594272	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	53	Au/mL	Positive
	refr-multi_lat-4883	14_603328_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_603328	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	112	Au/mL	Positive
	refr-multi_lat-4884	14_628758_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_628758	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	90	Au/mL	Positive
	refr-multi_lat-4885	14_647441_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_647441	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	50	Au/mL	Positive
	refr-multi_lat-4886	14_653364_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_653364	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	73	Au/mL	Positive
	refr-multi_lat-4887	14_654254_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_654254	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	68	Au/mL	Positive
	refr-multi_lat-4888	14_698954_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_698954	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	329	AU/mL	Positive
	refr-multi_lat-4889	14_705478_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_705478	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	143	Au/mL	Positive
	refr-multi_lat-4890	14_724174_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_724174	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	51	Au/mL	Positive
	refr-multi_lat-4891	14_743991_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_743991	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	46	AU/mL	Positive
	refr-multi_lat-4892	14_833094_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_833094	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	301	Au/mL	Positive
	refr-multi_lat-4893	14_841836_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_841836	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	110	Au/mL	Positive
	refr-multi_lat-4894	14_845339_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_845339	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	48	Au/mL	Positive
	refr-multi_lat-4895	14_852274_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_852274	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	44	Au/mL	Positive
	refr-multi_lat-4896	14_873517_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_873517	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	42	Au/mL	Positive
	refr-multi_lat-4897	14_881576_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_881576	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	90	Au/mL	Positive
	refr-multi_lat-4898	14_900776_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_900776	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	46	AU/mL	Positive
	refr-multi_lat-4899	14_931124_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_931124	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	68	Au/mL	Positive
	refr-multi_lat-4900	14_950845_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_950845	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	58	Au/mL	Positive
	refr-multi_lat-4901	14_981447_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_981447	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	57	AU/mL	Positive
	refr-multi_lat-4902	14_994827_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_994827	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	62	Au/mL	Positive
	refr-multi_lat-4903	14_108656_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_108656	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	14	Au/mL	Positive
	refr-multi_lat-4904	14_122173_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_122173	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	11	Au/mL	Positive
	refr-multi_lat-4905	14_185965_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_185965	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	15	Au/mL	Positive
	refr-multi_lat-4906	14_194396_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_194396	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	9	Au/mL	Positive
	refr-multi_lat-4907	14_208286_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_208286	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	15	Au/mL	Positive
	refr-multi_lat-4908	14_212153_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_212153	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	11	Au/mL	Positive
	refr-multi_lat-4909	14_213236_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_213236	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	15	Au/mL	Positive
	refr-multi_lat-4910	14_269103_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_269103	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	5	Au/mL	Positive
	refr-multi_lat-4911	14_304474_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_304474	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	11	Au/mL	Positive
	refr-multi_lat-4912	14_322676_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_322676	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	12	AU/mL	Positive
	refr-multi_lat-4913	14_339154_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_339154	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	10	Au/mL	Positive
	refr-multi_lat-4914	14_339339_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_339339	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	10	AU/mL	Positive
	refr-multi_lat-4915	14_385063_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_385063	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	7	Au/mL	Positive
	refr-multi_lat-4916	14_399432_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_399432	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	11	Au/mL	Positive
	refr-multi_lat-4917	14_427801_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_427801	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	9	Au/mL	Positive
	refr-multi_lat-4918	14_437688_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_437688	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	14	Au/mL	Positive
	refr-multi_lat-4919	14_444128_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_444128	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	13	Au/mL	Positive
	refr-multi_lat-4920	14_541069_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_541069	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	8	Au/mL	Positive
	refr-multi_lat-4921	14_563092_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_563092	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	12	Au/mL	Positive
	refr-multi_lat-4922	14_582321_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_582321	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	9	Au/mL	Positive
	refr-multi_lat-4923	14_591664_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_591664	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	6	Au/mL	Positive
	refr-multi_lat-4924	14_629929_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_629929	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	10	Au/mL	Positive
	refr-multi_lat-4925	14_649515_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_649515	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	11	Au/mL	Positive
	refr-multi_lat-4926	14_670351_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_670351	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	10	Au/mL	Positive
	refr-multi_lat-4927	14_672894_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_672894	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	10	AU/mL	Positive
	refr-multi_lat-4928	14_675231_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_675231	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	10	Au/mL	Positive
	refr-multi_lat-4929	14_719447_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_719447	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	10	Au/mL	Positive
	refr-multi_lat-4930	14_752797_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_752797	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	8	Au/mL	Positive
	refr-multi_lat-4931	14_754797_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_754797	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	7	Au/mL	Positive
	refr-multi_lat-4932	14_795323_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_795323	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	9	Au/mL	Positive
	refr-multi_lat-4933	14_836565_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_836565	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	12	AU/mL	Positive
	refr-multi_lat-4934	14_860194_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_860194	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	10	Au/mL	Positive
	refr-multi_lat-4935	14_896884_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_896884	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	8	AU/mL	Positive
	refr-multi_lat-4936	14_949379_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_949379	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	13	Au/mL	Positive
	refr-multi_lat-4937	14_999724_222	14_010	refr-no_reagents	refr-no_treatments				SeroNet_Reference_Study	refr_Protocol	14_999724	SeroNet_Reference_Study_visit-01									COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit	SARS-CoV-2 Virus, Full Length Spike, Spike, RBD	ELISA		IgG	12	Au/mL	Positive
